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Introduction 
1.1 Pathogens and immunity 
All organisms on earth have evolved and adapted in response to their environment, 
which harbours not only abiotic factors such as climate, but also an immense ecological 
network of other species. From the beginning on, organisms of different kinds started 
persistently to interact with each other, a relationship termed symbiosis (Greek syn bios 
“living together”). Symbiosis has been classified into three main categories according to the 
consequences for the individual species with fluent transitions. The most common and 
probably evolutionary oldest type of relationship is parasitism: one member, the parasite, 
benefits at the expense of the other, the host. Furthermore, there is commensalism: only one 
species benefits without affecting the other; as well as mutualism: both species benefit from 
the relationship (Paracer et al. 2000). Parasites causing disease are also called pathogens 
(Greek pathos “suffering/emotion” genus “to give birth to”). Pathogens comprise subcellular 
organisms (viruses), bacteria, as well as uni- and multicellular eukaryotes (protozoa, fungi, 
worms). They can infect a broad range of organisms, which are usually at a higher taxonomic 
level than themselves. The host organisms, in contrast, combat the constant attacks by the 
pathogens with resistance molecules and mechanisms that together constitute the host immune 
system. The constant battle of pathogens and hosts can provoke co-evolution resulting in a 
pathogen that could either manage to evade the host immune system or adapt to a non-harmful 
symbiont (Roy et al. 2007).  
The immune system (Latin immunis, in a biological sense “exemption from foreign 
agents”) is a multilayered system with increasing specificity. Ancient forms of immune 
systems can be found even in bacteria which protect themselves with invariant restriction 
endonucleases or with the recently discovered adaptive CRIPR/CAS system against foreign 
nucleic acids of bacteriophages (Barrangou et al. 2007; Samson et al. 2013).  
The first lines of defence in eukaryotes are represented by surface barriers that simply 
prevent pathogens from entering the host. They can be mechanical (cuticle, exoskeleton, shell, 
skin, mucus), chemical (antimicrobial peptides, defensins, gastric acid) or biological 
(commensal flora). However, when pathogens succeed in breaching these first surface 
barriers, they are met by non-specific but immediate defence reactions of the innate immune 
system. This second layer of immunity is the dominant defence strategy in plants, insects and 
primitive multicellular organisms and sufficient against attacks by the majority of pathogens 
(Murphy 2012). 
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In vertebrates, the innate mechanisms can be further distinguished in cell-mediated 
and humoral immunity. Specialised immune cells, termed innate leukocytes (neutrophil 
granulocytes, macrophages, dendritic cells or natural killer cells), drive cell-mediated 
immunity by various defence mechanisms. They circulate in the blood or reside in specific 
tissues and sample their environment for foreign particles. Further, they are recruited to the 
site of infection (also to sites of tissue damage or inflammation), where they phagocytose and 
eliminate microbes or cellular debris. Finally, they secrete signalling molecules termed 
cytokines to recruit or activate other immune cells. These cytokines together with the 
complement system drive the humoral immunity. The complement system is characterised by 
an activation cascade of several proteins (mostly zymogens), mediating opsonisation of 
bacteria to enable phagocytosis, attraction of immune cells, formation of pores in the 
membrane of foreign cells and clumping of antigen-bearing agents (Murphy 2012).  
In addition, an even more sophisticated adaptive immune system has evolved in 
vertebrates (Cooper et al. 2006) as an additional third layer. This adaptive immunity is, in 
contrast to the innate layer, highly specific for each particular pathogen and provides long-
lasting protection after a lag-phase of activation. The two major cell types of the adaptive 
immune system are B- and T-lymphocytes. One of their main features is to express a diverse 
array of receptors generated through complex somatic DNA rearrangements, which allow 
them to specifically recognise a great diversity of antigens and secrete specific antigen-
targeting molecules called antibodies (Murphy 2012). 
It is critical for the host to discriminate not only self from non-self to defend against 
potential pathogens (Janeway 1992; Medzhitov 2009), but also to discriminate harmful 
pathogens from essential commensals. To this end, the innate immune system in mammals 
can recognise potential pathogens via invariant compounds that are only produced by 
microbes, so-called microbial-associated molecular patterns (MAMPs), in combination with 
endogenous signals produced upon cell stress or infection, so called danger-associated 
molecular patterns (DAMPs) (Matzinger 1994; Matzinger 2002). The recognition is mainly 
mediated by a variety of germ line-encoded pattern recognition receptors (PRRs), which are 
mainly expressed on sentinel cells but can also be found in non-immune cells. PRRs comprise 
several receptor families: transmembrane Toll-like receptors (TLR) (Trinchieri et al. 2007; 
Kawai et al. 2010), intracellular retinoid acid-inducible gene-1 (RIG-1)–like receptors (RLR) 
(Eisenacher et al. 2012), intracellular nucleotide-binding domain and leucine-rich repeat 
containing protein family (NLR), which can also form large protein complexes 
(inflammasomes) to recognise a variety of MAMPs or DAMPs (Chen et al. 2009), as well as 
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C-type lectins and Scavenger receptors (Canton et al. 2013). Non-self recognition also plays 
an important role for NK-cells or in the adaptive immune system, e.g.in terms of elimination 
of self-antigen receptor, which is essential for self-tolerance (Murphy 2012).  
Another crucial aspect of the immune system is the crosstalk between innate and adaptive 
components. This involves both cell-cell interactions and signalling through messenger 
molecules, the cytokines. Cytokines are a large group of small proteins, which are produced in 
response to microbes, antigenic or inflammatory stimuli. They often act pleiotropically and 
redundantly and they can have synergistic or antagonistic effects (Abbas et al. 2007). 
Cytokines can be classified according to their different functions: chemo-attraction between 
cells (chemokines), communication between leukocytes and other immune cells 
(interleukins), differentiation of haematopoietic cells (hematopoietins, formally colony-
stimulating factors), mediation of acute inflammation (tumour necrosis factor) as well as the 
”virus interfering” interferons (Murphy 2012). Thus, cytokines are not only involved in 
regulating the specialised immune cells, but can also induce resistance mechanisms intrinsic 
to almost every somatic cell. These so called cell-autonomous mechanisms are independent of 
other immune cells or molecules, apart from its first external activation stimulus. Cell-
autonomous immunity enables individual cells to cope with microbial challenge and stress 
and can be interpreted as an additional facet of the innate immune system (Howard 2007; 
MacMicking 2012).  
1.2 Interferon-stimulated genes and their role in immunity 
 Interferons (IFN) were first cytokines discovered and described as a substance that 
“interfered with viral replication” (Isaacs et al. 1957; Isaacs et al. 1957). Interferons are pro-
inflammatory cytokines secreted by immune and non-immune cells in a brief and self-limiting 
manner (Murphy 2012). According to their sequence homology and receptor specificity, the 
glycosylated IFNs can be classified into three groups: Type I, including IFNα (14-20 
members depending on species), IFNβ, IFNω, IFNκ, IFNε, IFNδ (pigs), IFNτ (ruminants); 
Type II with IFNγ as the only member; and Type III with 3 members of IFNλ. Type I IFNs 
are secreted by almost every cell type, whereas IFNα and IFNω are mainly produced by 
hematopoietic cells and IFNβ mainly by fibroblasts (Borden et al. 2007). In contrast, IFNγ is 
mainly produced by T-lymphocytes (Mosmann et al. 1989) and NK-cells (Handa et al. 1983; 
Bancroft et al. 1987; Chan et al. 1991). However, there is increasing evidence that 
macrophages (Munder et al. 1998), professional antigen-presenting cells (Ohteki et al. 1999) 
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as well as neutophils (Sturge et al. 2013) can also secrete limited amounts of IFNγ [reviewed 
in (Farrar et al. 1993; Frucht et al. 2001; Schroder et al. 2004; Bogdan et al. 2006)].  
 
 
 The production of IFN is induced via TLR- or RLR-dependent recognition of viruses, 
microbial products or chemicals and the main transcription factors acting downstream are 
interferon regulatory factor 3 (IRF3), IRF7 and nuclear factor κB (NF-κB). Upon secretion, 
IFNs engage specific high affinity receptors on cell surfaces, and signal via the JAK/STAT 
(Janus kinase/ signal transducer and activator of transcription 1) pathway to induce the 
 
 
Figure 1.1: Interferon induces IFN-stimulated genes (ISGs) via the JAK/STAT pathway.  
Interferon binds to its specific receptor in an autocrine or paracrine manner (e.g. IFNγ binds to a tetramer of two 
interferon-gamma receptor IFNGR1 and two IFNGR2) which triggers the activation of the receptor-associated 
Janus kinases (JAK) and tyrosinkinase 2 (TYK2). The kinases autophosphorylate themselves and tyrosine 
phosphorylate the interferon receptors enabling the recruitment of the signal transducer and activator of 
transcription 1 (STAT1) and STAT2. Phosphorylated homodimers of STAT1 (now termed gamma activation 
factor, GAF) or heterodimers of STAT1 and STAT2 in complex with IRF9 (now termed interferon-stimulated 
gene factor 3, ISGF3) translocate to the nucleus to bind the promoter elements IFNγ-activated site (GAS) or 
IFN-stimulates response element (ISRE), respectively. The activation of this JAK/STAT signalling pathway 
results in the transcription of a huge number of ISGs, which can have overlapping promotes elements or require 
transactivation of additional cofactors (e.g. IRF1 or IRF8). ISGs can act cell-autonomously (listed in blue box) or 
non-cell-autonomously (listed in yellow box) [modified from (MacMicking 2012)].  
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expression of interferon stimulated genes (ISGs) (Figure 1.1; see Figure legend for detailed 
description of JAK/STAT pathway).  
 Nearly 2000 human and mouse ISGs have been identified (Rusinova et al. 2013) 
corroborating the important role of interferons in multiple processes of innate and adaptive 
immunity. IFNs are responsible for (1) activation and accumulation of immune cells, (2) up-
regulation of antigen presentation to T-lymphocytes, (3) isotype switching in B-cells to 
produce opsonising and complement-fixing antibodies, and (4) triggering of defence 
mechanisms in uninfected cells to resist new infections. The resistance mechanisms can act 
systemically (Figure 1.1, yellow box) or cell-autonomously (Figure 1.1, blue boxes) (Borden 
et al. 2007). The names and functions of cell-autonomous ISGs, which are listed in the blue 
boxes of Figure 1.1, will shortly be explained in the following paragraph.  
 Since interference with viral replication was discovered first, many different ISGs 
mediating viral restrictions on a cell-autonomous level are now known. Some prominent 
examples are: (a) blockage of viral entry and uncoating [IFN-inducible transmembrane 
(IFITMs), tripartite motif (TRIMs), or orthomyxovirus resistance gene (Mxs) proteins]; (b) 
interference with transcriptional and translational control [2´,5´-oligoadenylate synthetases 
(OASs), dsRNA-activated protein kinase (PKR), ribunuclease L (RNASEL), or ubiquitin-like 
ISGylation (ISG15)], or (c) prevention of viral assembly, budding and release [tetherin and 
viperin] (MacMicking 2012).  
 Moreover, ISGs mediate cell-autonomous defence against microbes via various 
mechanisms. Firstly, these mechanisms may rely on reactive oxygen species (ROS) and 
reactive nitrogen species (RNS). These cytotoxic gases are generated by the ISGs: NADPH 
oxidases (NOXs for O2
-
), dual oxidases (DUOXs for H2O2), and nitric oxidase synthases 
(NOS2 for NO). Because ROS and RNS can damage DNA, lipids and proteins rather 
unspecifically (Nathan et al. 2013), their production has to be tightly controlled and is often 
compartmentalised to phagolysosomes containing microbes (MacMicking 2012). Besides 
bacterial killing, ROS and NOS function in signal transduction, transcriptional activation, 
inflammation and carcinogenesis (Nathan et al. 2013). Secondly, ISGs can hinder microbes 
from acquiring essential nutrients from the host cell by deprivation, for example restriction of 
intracellular cations by the Mn
2+
 Fe
2+
 efflux pump natural resistance-associated macrophage 
protein1 (NRAMP1) or amino acids by the tryptophan degrading enzyme indoleamine-2,3-
dioxygenase (IDO) and tryptophan-2,3-dioxygenase (TDO). Thirdly, ISGs can also target free 
bacteria via their exposed glycan patterns with galectins or, since they are ubiquitinated in the 
cytosol, with ubiquitin receptors [sequestosome 1 (SQSTM1), NDP52, optineurin], leading to 
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recruitment of the autophagic machinery (Chang et al. 2011; Deretic et al. 2013). Lastly, ISGs 
can directly target and destroy pathogen-containing vacuoles (e.g. Toxoplasma gondii) 
[immunity-related GTPases (IRG), guanylate-binding protein (GBP)] (see 1.4), and it has 
been proposed that they may target vacuolar or cytosolic bacteria (MacMicking 2012).  
1.3 Interferon-inducible GTPases 
 Four GTPase families were found to be strongly upregulated by IFNs: (1) immunity-
related GTPases (IRG, 47 kDa, former p47 GTPases) (Boehm et al. 1998; Bekpen et al. 
2005); (2) the antiviral Mx proteins (72-82 kDa) (Staeheli et al. 1986; Haller et al. 2007); (3) 
guanylate-binding proteins (GBP, 65-67 kDa, former p65 GTPases) (Degrandi et al. 2007; 
Kim et al. 2012); and (4) Very Large Inducible GTPases (VLIG, 200-285 kDa) (Klamp et al. 
2003). With the exception of Mx proteins, which are not induced by type II IFNs (Hug et al. 
1988; von Wussow et al. 1990), all families can be induced by type I, II and III IFNs (Martens 
et al. 2006). In fact, in a pioneer mRNA screen of IFNγ-induced mouse cells, IRG and GBP 
transcripts were the most abundant (35%) induced target genes (Boehm et al. 1998).  
 All GTPases cycle between two alternative conformations: the GDP-bound form, 
which is considered inactive, and the GTP-bound form, which represents the active state 
mediating effector functions. The transition between these two states can be regulated by 
other proteins. According to their function these factors are called: guanine dissociation 
inhibitors (GDI) preventing dissociation of GDP; guanine exchange factors (GEF) releasing 
bound GDP; or GTPase –activating proteins (GAP) accelerating GTP hydrolysis. The GTPase 
domain (G-domain) of almost all GTPases comprises five nucleotide binding motifs termed 
(G1-G5) and two flexible regions called switch 1 and switch 2 (Leipe et al. 2002; Martens et 
al. 2006). IRG and Mx proteins contain the universally conserved G1 (GxxxGKS), G3 
(DxxG) and G4 (N/TKXD) (Bourne et al. 1991), in contrast to GBP and VLIG proteins, 
which have a functionally different G4 motif (Cheng et al. 1991; Praefcke et al. 1999; Klamp 
et al. 2003). The interferon-inducible GTPases share several biochemical features with the 
conserved dynamins (see also 1.3.3). Dynamins are able to deform and tubulate cellular 
membranes, a process required for the scission of clathrin-coated endosomes, and are further 
implicated in vesicular processes, organelle and cell division [reviewed in (Praefcke et al. 
2004; Pucadyil et al. 2009)]. Interestingly, interferon-inducible GTPases occur sporadically 
during evolution in deuterostomia since they have experienced gene gain and loss in different 
chordate (see Figure 1.2). 
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Figure 1.2: Sporadic occurrence of interferon-inducible GTPases during evolution of chordata.  
Number of putatively functional genes and number of pseudogenes in brackets are listed. So far, no interferon-
inducible GTPases have been found in protostomia, which include the model organisms Drosophila melangaster 
and Caenorhabditis elegans. For vertebrate genes, ISRE elements could be identified in the promoter elements 
(yellow background). The blue spheres indicate the diverging positions (modified from (Li et al. 2009)). 
 
 
For example, Mx and GBP genes are lost in opossum and chicken, respectively. IRG genes 
are present in several chordates such as Branchiostoma (lancelet fish, subphylum 
cephalochordate/acrania), teleost fish, dogs, rat and primates. However, IRG genes are 
apparently absent in bird, cat and horse but largely expanded in rodents. (Bekpen et al. 2005; 
Hunn 2007; Li et al. 2009; Gazzinelli et al. 2014).  
1.3.1 Immunity-related GTPase (IRG) gene family  
 The first six IRG genes were identified and sequenced in the 1990s, namely IRG-47 
(now Irgd) (Gilly et al. 1992), LRG-47 (now Irgm1) (Sorace et al. 1995), TGTP/Mg21 (now 
Irgb6) (Carlow et al. 1995; Lafuse et al. 1995), IGTP (now Irgm3) (Taylor et al. 1996) as well 
as IIGP (now Irga6) and GTPI (now Irgm2) (Boehm et al. 1998). The corresponding proteins 
together with Irgb10 still constitute the best studied IRG protein family members.  
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 In 2005, genomic investigations in the C57BL/6 laboratory mouse genome identified a 
group of about 23 IRG genes and pseudogenes and a uniform nomenclature according to their 
phylogeny was introduced (Bekpen et al. 2005). Three genes (Irgm1, Irgm2, Irgm3) encode 
proteins with the non-canonical sequence GX4GMS in the G1 motif of the GTP binding site 
and are therefore informally called the GMS or IRGM subfamily. The second subfamily 
(IRGA, IRGB, Irgc and Irgd) possesses the universally conserved G1 sequence (GX4GKS) 
and are informally called GKS proteins (Boehm et al. 1998; Bekpen et al. 2005). From there 
on, rodent IRGs were written with capital I followed by small letters (in italics for genes, 
regular for proteins) and for other mammals as well as for the gene/protein family in general 
(e.g. Irgm1-3) only capital letters (IRGM) were used (Martens et al. 2006).  
 
 
 The mouse IRG genes are distributed on chromosome 11 in two clusters separated by 
10 Mb (Irgm1/Irgb1-Irgb9/Irgd and Irgb10/Irgm3/ Irgm2), on chromosome 18 in one cluster 
(Irga1-Irga8) (Figure 1.3) as well as a single member on chromosome 7 (Irgc, also known as 
CINEMA). The open reading frame of IRG genes is typically encoded on one long 3´ exon 
following one or more 5´untranslated exons. However, Irgm1-3 genes are encoded on two 
coding exons allowing two possible isoforms for Irgm1 and Irgm2 due to alternative splicing 
(see also Figure 1.3). Another exception are four pairs of tandem genes, namely Irgb2-Irgb1, 
Irgb5-Irgb3, Irgb5-Irgb4, Irgb9-Irgb8, which are transcribed across two chromosomally 
adjacent IRG coding units, resulting in the expression of 94 kDa proteins (Bekpen et al. 2005; 
Lilue et al. 2013). Sequencing analysis of different laboratory and wild mouse strains revealed 
 
Figure 1.3: Linear order of IRG gene clusters on Chr. 11 and Chr. 18 of C57BL/6 mouse strain.  
The black blocks mark the position of the IRG coding unit and the arrowhead the direction of transcription. 
Some genes are transcribed as tandem, connected with a line. Numbers give the position on the chromosome. 
For the four genes in gray boxes, single knock-out mice, as well as an IRG double knock-out mouse strain 
(Irgm1/Irgm3) were generated so far. ψ indicates pseudogenes, * marks the second copy of the gene [modified 
from (Lilue et al. 2013)]. 
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that some members of the IRG family are remarkably polymorphic (e.g. Irgb2-b1, Irgb6) 
whereas others are rather conserved (e.g. Irgm1, Irga6) (Lilue et al. 2013).  
 Humans have only two transcribed IRG genes. IRGC is an orthologue of mouse Irgc 
that matches 90 % on the amino acid level, and is localised on chromosome 19 in a region 
syntenic to mouse chromosome 7. IRGM on human chromosome 5 encodes an amino- and 
carboxyterminally truncated G-domain homologue of mouse Irgm1/2/3 (Bekpen et al. 2005). 
Five mRNA transcripts for 3´-splicing isoforms (IRGM a-e) could be detected so far (Bekpen 
et al. 2010) and were individually examinated (Singh et al. 2010). Interestingly, the 
mammalian IRGM gene family contracted to a single-copy gene that became pseudogenised 
in the ancestral lineage of apes and monkeys due to an AluSc retrotransposition event leading 
to the disruption of the open reading frame. In great apes and human, however, integration of 
an endogenous retroviral EVR9 element serving as a functional promoter along with a 
mutation generating a new ATG codon could revive IRGM gene. Thus, the human IRGM can 
be considered as a “resurrected gene” that is homologous to all three mouse IRGM genes but 
clearly differs in size, promoter region and splicing (Bekpen et al. 2009). 
 Lastly, an IRG homologous gene family, so-called quasi-IRG, could be identified in 
the zebrafish (irgq1-irgq3), mouse (Irgq, Fksg27) and human (IRGQ, also FKSG27) genome 
(Bekpen et al. 2005; Martens et al. 2006) and other chordates (Hunn 2007). It differs from the 
canonical family members by a radically modified GTP-binding site that shows a clear 
disruption of the universally conserved G1 motif. Mammalian IRGQ is closely linked to 
IRGC in human and mouse, but despite its phylogenetic relationship, it is not a functional 
GTPase (Bekpen et al. 2005; Martens et al. 2006). In the following, only mouse IRG or 
human IRG (hIRG) genes and proteins will be discussed. 
1.3.2 Induction and Expression of IRG proteins 
 Almost all mouse IRG gens have ISRE and GAS sequences in their promotor region 
and can therefore be induced with Type I and Type II IFNs (Lafuse et al. 1995; Sorace et al. 
1995; Gilly et al. 1996; Taylor et al. 1996; Boehm et al. 1998; Carlow et al. 1998; Collazo et 
al. 2001; Zerrahn et al. 2002; MacMicking et al. 2003; Bekpen et al. 2005). Upon IFN 
stimulation IRG proteins can be detected in any IFN-responsive mouse cell. Irga6 has an 
additional liver-specific promoter that allows expression of an alternative isoform in the liver, 
which however has the same amino acid sequence (Zeng et al. 2009). Some studies reported 
IRG transcription upon other stimuli (e.g. LPS or TNFα) (Taylor et al. 1996; Zerrahn et al. 
2002; Lapaque et al. 2006; Bafica et al. 2007; Yamada et al. 2009), but since no NF-κB 
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binding sites were identified in their promoter region (Bekpen et al. 2005), this may reflect 
secondary induction of interferons. As an exception, the Irgc promoter carries weak Sox 
elements but no ISRE or GAS sequences and is therefore not induced by IFN stimulation or 
Listeria infection (Bekpen et al. 2005). Instead, Irgc can be detected in tissue of adult testis 
and is expressed constitutively and exclusively in haploid spermatids suggesting a role in 
reproduction or development (Bekpen et al. 2005; Rohde 2006).  
 None of the human IRG genes are IFN-inducible, because hIRGM has an altered 
promoter region and hIRGC is homologous to the exceptional mouse IRG without GAS or 
ISRE elements (see 1.3.1). Endogenous hIRGM as well as mRNA for hIRGMa/b/c/d isoforms 
could be detected in human cell lines and overexpression of isoform-specific fusion proteins 
is possible (Bekpen et al. 2005; Singh et al. 2006; Singh et al. 2010). In contrast, hIRGC is 
strongly expressed only in testis but not in brain or liver, similar to observations in mice 
(Bekpen et al. 2005; Rohde 2006). Thus, human IRG proteins are not considered to exert an 
interferon-dependent immunity-related function.  
1.3.3 Structural and biochemical properties of IRG proteins  
 Initial biochemical studies on GTPase activity were performed for immunoprecipitated 
Irgm3 and recombinant GST-Irgm3 (Taylor et al. 1996; Taylor et al. 1997) as well as for 
recombinant GST-Irgb6 (Carlow et al. 1998). Using GTP hydrolysis assays with radiolabelled 
nucleotides followed by thin layer chromatography, it was demonstrated that these IRG 
proteins are able to hydrolyse GTP to GDP, even though it was only a minor percentage for 
Irgm3 (Taylor et al. 1996; Taylor et al. 1997). Soon after, recombinant Irga6 was 
biochemically and enzymatically characterised in detail (Uthaiah et al. 2003). Irga6 binds 
GTP and GDP with a dissociation constant in the micromolar range, with a 10-15 fold higher 
affinity for GDP (1 µM) than GTP (15 µM). Because intracellular concentrations of GTP and 
GDP are approximately 330 µM and 120 µM respectively (Kleineke et al. 1979), it is very 
likely that Irga6 resides in the cytosol predominantly in the GDP-bound form. In uninfected 
cells, endogenous Irga6 can indeed hardly be detected microscopically with the 10D7 
monoclonal antibody specific for GTP-bound Irga6 (Papic et al. 2008). Upon GTP-binding, 
Irga6 homo-oligomerises in vitro without external GEF (Uthaiah et al. 2003). Furthermore, it 
is suggested that Irga6 activation by binding of GTP is accompanied by a conformational 
change of the protein, probably in the flexible switch I region (Papic et al. 2008; Pawlowski et 
al. 2011). The oligomers can resolve upon GTP hydrolysis and the correlation of increased 
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protein concentration with increased GTP hydrolysis demonstrates that there is a cooperative 
mechanism between Irga6 molecules (Uthaiah et al. 2003).  
 
  
The Irga6 crystal was resolved in 2004 as dimer in a nucleotide-free, GDP-bound or 
GppNHp-bound state (Ghosh et al. 2004). Since it is the only IRG protein for which the 
crystal structure has been resolved so far and IRG proteins have a high sequence homology, 
Irga6 serves as a model for other IRG family members. It reveals a Ras-like G-domain 
consisting of six β-strands (S1-S6) and six helices (H1-H5 and αD) connected by a linker 
helix (αE) to a helical domain that is formed by three helices (αA, αB, αC) of the N-terminal 
domain and seven helices (αF-αL) and loops of the C-terminus (Figure 1.4 and (Ghosh et al. 
2004)). Because the first 13 amino acids could not be resolved in the crystal structure (Ghosh 
et al. 2004), there is little information concerning the N-terminus of the Irga6. Irga6, as well 
as other IRG proteins (IRGA, Irgb2/5/9/10), carry an N-terminal myristoylation motif at 
Glycine 2 (Bekpen et al. 2005). Indeed, endogenous Irga6 is myristoylated and this lipid 
 
Figure 1.4: Crystal structure of Irga6.  
(A) Ribbon presentation of the GDP/Mg
2+
-bound Irga6 crystal consisting of an N-terminal helical region (cyan), 
a Ras-like G-domain (blue), a linker helix (grey) and a C-terminal region formed by helices and loops. The N-
terminus of Irga6 is myristoylated, and together with the αK helix and two loops opposing the G-domain they 
may mediate membrane-binding (modified from (Ghosh et al. 2004)). (B) Schematic models for Irga6 
interactions showing the GDP-bound monomers and the GDP-bound crystal dimer with an interface of parts of 
the G-domain and the N-terminal helical domain. A second catalytic interface essential for GTP hydrolysis for 
has been identified on the G-domain which is also necessary for Irga6 oligomerisation. The αK-helices and the 
myristoylation may directly bind membranes [prepared according to (Pawlowski et al. 2011)].  
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modification has been shown to play a role in membrane-binding (Martens et al. 2004) as well 
as in GTP-dependent Irga6 homo-oligomerisation (Papic et al. 2008).  
 In 2011, the catalytic interface of Irga6 essential for GTP hydrolysis was defined by an 
extensive mutagenesis screen of surface-exposed residues (Pawlowski et al. 2011). The 
catalytic interface is localised in the G-domain including the nucleotide-binding site and the 
switch regions. In addition, the bound nucleotide itself could be demonstrated to be part of the 
catalytic interface, which interacts reciprocally in a dimer via the 3´hydroxyls and the 
γ-phosphates of the opposed nucleotides in trans. This conserved catalytic interface is 
furthermore responsible for GTP-dependent interaction with Irgb6 and GDP-dependent 
interaction with Irgm3 (Pawlowski et al. 2011). 
 Some of the biochemical features of Irga6, namely GTP-dependent oligomerisation, 
micromolar affinities for guanine nucleotides, as well as cooperative hydrolysis of GTP, are 
shared with other interferon-inducible GTPases and the conserved dynamins (also see 1.3.) 
(Praefcke et al. 2004). However, the observed higher affinity for GDP than GTP and the low 
GTPase activity are unique to Irga6 (and probably other IRG proteins). In contrast, GBP 
proteins bind GTP, GDP and GMP with the same affinity (Cheng et al. 1991) and hydrolyse 
GTP in two consecutive cleavage reactions to GDP and GMP (Schwemmle et al. 1994; Neun 
et al. 1996; Praefcke et al. 1999; Ghosh et al. 2006). Moreover, the crystal structure of hGBP1 
reveals an N-terminal G-domain and C-terminal helical domain (Prakash et al. 2000).  
1.3.4 Membrane-binding of IRG proteins and other interferon-inducible 
GTPases  
 IRG proteins seem to have an intrinsic ability to interact with lipids, because 
recombinant Irga6 co-sediments with phosphatidylserine vesicles (Martens et al. 2004) and 
bacterially expressed GKS proteins can co-sediment with Folch liposomes (Nikolaus 
Pawlowski, unpublished data). Moreover, GST-tagged Irgm1 was shown to interact with the 
following immobilised lipids on nitrocellulose filters: PtdIns(3,4)P2, PtdIns(3,4,5)P3, 
cardiolipin and weakly with phosphatic acid (Tiwari et al. 2009). 
 It is not entirely understood how IRG proteins mediate membrane-binding. For GMS 
proteins, it has been shown that a C-terminal sequence, which corresponds to the αK helix of 
Irga6 (Figure 1.4), is essential for membrane targeting to their respective subcellular 
compartment (see also 1.3.5) (Martens 2004; Martens et al. 2004; Martens et al. 2006; Zhao et 
al. 2010). In case of Irgm1, the responsible amino acids 350 – 374 are predicted to constitute 
an amphipathic helix. Disruption of the amphipathic character by mutation of more than one 
hydrophilic residue or insertion of glutamate completely abolishes membrane-binding 
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(Martens et al. 2004; Zhao et al. 2010). However, this protein region including the αK helix is 
highly divergent among IRG proteins. Therefore, it remains elusive whether the mechanism 
of membrane targeting via an amphipathic helix applies also to other IRG proteins (Martens 
2004). Based on these results, a role for Irga6 in membrane attachment has been proposed not 
only for the helix αK, but also for the αK-αL and αF-αG loops, which are also exposed on the 
surface of Irga6 distal to the G-domain (see Figure 1.4) (Ghosh et al. 2004). Furthermore, the 
N-terminal myristoylation of Irga6 has been shown to partially mediate or enhance binding to 
the endoplasmatic reticulum (ER) (Martens et al. 2004). However, the non-myristoylated 
Irga6 (G2A mutant) is still associated with membranes (Martens et al. 2004), but is strongly 
impaired in relocalising to the parasitophorous vacuolar membrane (PVM) upon infection 
with Toxoplasma gondii (T. gondii) (Papic 2007).  
 A mutagenesis attempt to define the interface on Irga6 responsible for binding to the 
PVM of T. gondii provided only an unstructured region on the crystal structure of the 
GDP/GppNHp-bound Irga6 protein (Fleckenstein 2012). Because predominantly active GTP-
bound Irga6 accumulates on the PVM (Papic et al. 2008) and since a GTP-bound dimer is 
likely to undergo conformational change, it remains unclear which part of Irga6 actually 
mediates binding to the PVM (Fleckenstein 2012). 
 There is increasing knowledge on how other interferon-inducible GTPases mediate 
membrane-binding via lipid modifications or via membrane-binding domains. Some GBP 
proteins possess a C-terminal CaaX box enabling either farnesylation (hGBP1 and mGBP5) 
or geranylgeranyliation (hGBP2, hGBP5, mGBP1, mGBP2) (Vestal et al. 2011). Indeed, 
protein prenylation has been confirmed for hGBP1 (Nantais et al. 1996; Modiano et al. 2005), 
mGBP2 (Vestal et al. 2000) and weakly for mGBP1 (Stickney et al. 2000). Human GBP1 
requires farnesylation, GTP-binding and an interferon-inducible cofactor for Golgi targeting 
(Modiano et al. 2005). In contrast, Irgm1 targeting of the Golgi is GTP-independent and 
myristoylation of Irga6 only facilitates ER membrane-binding (Martens 2004). Mx proteins 
carry neither a lipid modification motif nor a pleckstrin-homology (PH) domain, which is a 
typical membrane-binding domain in dynamins (Haller et al. 2007). However, MxA has 
recently been shown to bind negatively charged membranes and tubulate liposomes via an 
unstructured L4 loop of the oligomer-forming Stalk domain (von der Malsburg et al. 2011).  
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1.3.5 Subcellular localisation of IRG proteins  
 IRG proteins associate with membranes to different degrees and distribute among 
distinct subcellular compartments. GMS proteins are almost exclusively membrane bound, 
whereas GKS proteins are mainly cytosolic (Martens 2004). Irgm1 localises to Golgi, 
endosomes, and lysosomes (Martens et al. 2004; Butcher et al. 2005; Tiwari et al. 2009; Zhao 
et al. 2010). Irgm1 requires functional integrity of the nucleotide binding site for targeting to 
the endolysosomal system but not to Golgi (Zhao et al. 2010). C- or N-terminal EGFP-tagging 
of Irgm1 shift the protein to the endolysosomal system, and mutations in the nucleotide 
binding site revert the tagged Irgm1 back to Golgi. Thus, artificial tagging can result in 
anomalous subcellular distributions of IRG proteins and may influence the nucleotide-bound 
state (Martens 2004; Zhao et al. 2010). Furthermore, studies reported that Irgm1 could be 
detected at mitochondria (Tiwari et al. 2009; Chang et al. 2011). Irgm2 localises to the Golgi 
(Martens et al. 2006; Hunn et al. 2008) but has also the largest cytosolic pool among the GMS 
proteins (Martens 2004). Irgm3 localises to the ER (Taylor et al. 1997; Martens 2004; Hunn et 
al. 2008). Moreover, a large proportion of Irgm3 and a part of Irgm1 have been detected at 
lipid droplets, a storage compartment for neutral lipids (Bougneres et al. 2009; Haldar et al. 
2013). Except for the plasma membrane, all endomembranes seem to be covered by 
endogenous GMS proteins. In artificial overexpression systems, the GFP-tagged G-domain of 
Irgm1 localised also to the plasma membrane (Martens et al. 2004).  
 Irga6 partitions roughly 60:40 between ER and cytosol (Zerrahn et al. 2002; Martens 
et al. 2004), whereas native Irgb6, Irgb10 and Irgd are predominantly cytosolic (Martens 
2004; Coers et al. 2008). IRG protein localisation in uninfected cells is largely independent of 
GTPase activity, because ectopically expressed nucleotide-binding mutants show similar 
subcellular localisation as the endogenous proteins (Taylor et al. 1997; Martens 2004; Zhao et 
al. 2010). Ectopic expression of GKS protein (Irga6, Irgb6, Irgb10, Irgd) in IFNγ-
unstimulated cells results in the formation of aggregates (Martens et al. 2004; Hunn et al. 
2008) (and Jelena Maric, unpublished data). For Irga6, these aggregates were found to be 
GTP-bound oligomers (Papic et al. 2008) that can be resolved by the co-expression of GMS 
proteins or induction of GMS proteins with interferon (Hunn et al. 2008). Since loss of GMS 
proteins causes premature activation of GKS proteins and unregulated oligomerisation, it can 
be concluded that GMS proteins are essential regulators to keep GKS proteins in an inactive 
GDP-bound state, suggestion a function as GDI (Hunn et al. 2008; Papic et al. 2008; Henry et 
al. 2009; Traver et al. 2011) (and Jelena Maric, unpublished data).  
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1.4 Role of IRG proteins in (cell-autonomous) immunity 
1.4.1 IRG resistance system to certain pathogens  
 The analysis of IRG-deficient mice suggested that IRG proteins play an pivotal role in 
resistance against intracellular protozoa and bacteria [reviewed in (MacMicking 2004; Taylor 
et al. 2007; Hunn et al. 2011)].  
Table 1.1: IRG mediated resistance against intracellular pathogens 
Pathogen 
in vivo (knock-out mice) Ref. in vivo data in vitro 
Ref. in vitro 
data 
  
 w
t 
  
 I
F
N
γ-
/-
 
  
 I
rg
m
1
-/
-  
  
 I
rg
m
3
-/
-  
  
 I
rg
m
1
-/
-  
  
 I
rg
m
3
-/
-  
  
 I
rg
a
6
-/
-  
  
 I
rg
d
-/
-   
Impaired IFNγ-
mediated growth 
inhibition?  
(subcellular 
localization) 
 
Toxoplasma 
gondii 
R S S S S S S 
(Scharton-Kersten 
et al. 1996; Taylor 
et al. 2000; 
Collazo et al. 
2001; Butcher et 
al. 2005; Ling et 
al. 2006; Henry et 
al. 2009; Zhao et 
al. 2009; 
Liesenfeld 2011) 
 in all IRG KO 
cells 
 
(Irgm2, Irgm3, 
Irga6, Irgb2-b1, 
Irgb6, Irgb10and 
Irgd relocalise to 
the PVM) 
s. a. +  
(Halonen et al. 
2001; Butcher 
et al. 2005; 
Martens et al. 
2005; Zhao et 
al. 2009; 
Khaminets et al. 
2010; 
Fleckenstein et 
al. 2012; Lubitz 
et al. 2013) 
Neospora 
caninum 
R S      
(Nishikawa et al. 
2001) 
(Irga6, Irgb6 and 
Irgd relocalise to 
the PVM) 
(Reid et al. 
2012; Spekker 
et al. 2013) 
Leishmania 
major 
L. mexicana 
R S S S  R  
(Swihart et al. 
1995; Taylor et al. 
2004; Liesenfeld 
2011) 
  
Trypanosoma 
cruzi 
R S S R    
(Michailowsky et 
al. 2001; de Souza 
et al. 2003; 
Santiago et al. 
2005) 
 in Irgm1KO 
cells 
 upon siRNA-
KD of Irgd 
s. a. +  
(Koga et al. 
2006) 
Plasmodium 
berghei 
ANKA 
S R    R  
(Amani et al. 
2000; Liesenfeld 
2011; Inoue et al. 
2013) 
NO relocalisation 
of IRG proteins to 
the PVM 
s. a.  
Chlamydia 
trachomatis 
R S S S S* R  
(Cotter et al. 1997; 
Nelson et al. 2005; 
Coers et al. 2008; 
Coers et al. 2011) 
 upon siRNA-
KD of Irgb10 
in Irgm3KO and 
Irga6KO cells 
(Irgb6, Irgb10 and 
Irgd relocalise to 
the PVM, 
conflicting data for 
Irgm3 and Irga6) 
s. a. +  
(Bernstein-
Hanley et al. 
2006; Al-Zeer 
et al. 2009; 
Haldar et al. 
2013) 
Chlamydia 
psittaci 
R   S    
(Miyairi et al. 
2007) 
 upon siRNA-
KD of Irgm2 
s. a. 
Chlamydia 
muridaum 
R R      
(Nelson et al. 
2005) 
 No IFNγ-
mediated growth 
inhibition in MEFs  
(Coers et al. 
2008; Al-Zeer 
et al. 2009) 
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Table 1.1 provides a detailed list of susceptibility or resistance of different IRG knock-out 
mice (Irgm1
-/-
, Irgm3
-/-
, Irgm1/Irgm3
-/-
, Irga6
-/-
, Irgd
-/-
) to all intracellular pathogens tested so 
Listeria  
mono-
cytogenes 
R S S R  R  
(Collazo et al. 
2001; Liesenfeld 
2011) 
(conflicting data 
about Irgm1 
localisation at the 
phagosome) 
(Shenoy et al. 
2007) and this 
study 
Legionella 
pneumophila 
R S       
 in Irgm3KO 
cells but not 
Irgm1KO or 
Irgm1/Irgm1KO 
unpublished 
data in (Henry 
et al. 2009) 
Myco-
bacterium 
avium 
R S 
chronic 
S     
also R in  
Irgm1
-/-IFNγR-/- 
mice (Doherty et 
al. 1997; Feng et 
al. 2004; Feng et 
al. 2008) 
  
M. 
tuberculosis 
 
M. bovis 
BCG 
R S S R R R R 
(Cooper et al. 
1993; Dalton et al. 
1993; Flynn et al. 
1993; 
MacMicking et al. 
2003; Feng et al. 
2004; Henry et al. 
2009; Liesenfeld 
2011) 
(conflicting data 
about Irgm1 
localisation at the 
phagosome) 
this study and 
(Gutierrez et al. 
2004; Singh et 
al. 2006; 
Deghmane et al. 
2007; Shenoy et 
al. 2007; Saban 
et al. 2008; 
Tiwari et al. 
2009; Tischler 
et al. 2013) 
Salmonella 
typhimurium 
R S S R R  R 
(Henry et al. 2007; 
Henry et al. 2009) 
 in Irgm1KO 
cells but not  
Irgm3KO or 
Irgm1/Irgm3KO 
s. a. 
Rhodococcus 
equi  
R.aurantiacus  
R S      
(Yimin et al. 2001) 
for R. aurantiacus 
 No growth 
inhibition in 
Irgm1KO BMM 
(von Bargen et 
al. 2011) for R. 
equi 
Anaplasma 
phagocyto-
philum 
R     R  (Liesenfeld 2011)   
Brucella 
abortus 2308 
        
 enhanced 
bacterial killing 
upon IFNγ-
stimulation in 
Irgm1KO BMM 
compared to in wt 
(Ritchie et al. 
2012) 
Schistosoma 
mansoni 
R R R     (Feng et al. 2008) 
Schistosoma 
japonicum 
R S* S* n. e.   
S
* 
(Chen et al. 2010; Du et al. 2011) 
Murine 
cytomegalo-
virus  
R S R R   R 
(Pomeroy et al. 1998; Taylor et al. 2000; Collazo et al. 
2001) 
Ebola virus R S*  R    (Taylor et al. 2000; Gupta et al. 2005) 
Vesicular stomatitus 
virus 
Overexpression of Irgb6 in fibroblasts inhibits VSV but not HSV plaque formation 
(Carlow et al. 1998) 
Coxsackievirus B3 
(CVB3) 
Overexpression of Irgm3 in HeLa cells inhibits CVB3 replication (Zhang et al. 2003; 
Liu et al. 2008) 
R resistant; S susceptible; wt wildtype; KO knock-out; KD knock-down; n. e. no effect; s. a. see above (in 
references for in vivo data), S* weak susceptibility; an empty field means not determined 
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far in comparison to IFNγ-deficient mice or wildtype C57BL/6 mice. Information obtained 
from in vitro studies about impaired IFNγ-mediated growth inhibition in IRG-deficient cells 
or subcellular relocalisation of IRG proteins is also included in the table 1.1.  
 All IRG-knock-out mice show enhanced susceptibility to the protozoan Toxoplasma 
gondii, underscoring the outstanding role of the IRG resistance system to this pathogen, which 
will be further introduced in chapter 1.4.2.  
 A close phylogenetic relative of T. gondii, Neospora caninum, which is not a mouse 
pathogen, is proposed to be restricted by the IRG resistance system as well. Though in vivo 
data for infection of IRG-deficient mice is still missing, in vitro observations imply that IFNγ-
mediated cell-autonomous immunity correlates with GKS proteins relocalisation to the 
intracellular parasitophorous vacuolar membrane (PVM). Irga6, Irgb6 and Irgd have been 
observed to accumulate on the PVM of N. canium in infected murine mesenchymal stromal 
cells and fibroblasts. However, in contrast to virulent T. gondii strains (see 1.4.2) 
phosphorylation of IRG proteins seem not to be an immune evasion strategy of the parasite, 
since no phosphorylated Irga6 could be detected at the PVM of N. caninum.  
 For all other pathogens, the picture is more complicated and still incomplete. In 
general, IRG-deficient mice are resistant to most other protozoa and intracellular bacteria. For 
mice deficient in Irgm1
-/-
 or Irgm3
-/-
, enhanced susceptibility to Leishmania major, Chlamydia 
trachomastis and Chlamydia psittaci has been reported, whereas Irgm1
-/-
/Irgm3
-/-
 deficient 
mice show a delayed clearance of Chlamydia trachomatis. However, both GKS-deficient 
mice, Irga6
-/-
 and Irgd
-/-
, are resistant to all pathogens tested so far, except for T. gondii. A 
remarkable exception is Irgm1, which will be introduced in chapter 1.4.4. Irgm1-deficient 
mice showed increased susceptibility to all intracellular bacteria and protozoa tested so far. In 
contrast, mice with a second knock-out in addition to Irgm1 can show resistance to infection 
with Salmonella typhimurium (Irgm1
-/-
/Irgm3
-/-
) or Mycobacteria avium (Irgm1
-/- /IFNγ-/-).  
 Parasites that do not induce IFNγ-response in the host are controlled independent of 
the IRG resistance system. For example, initial infection studies with the extracellular 
parasitic flatworm Schistosoma showed no or only little restriction in IRG-deficient mice.  
 Even tough, an antiviral function for Irgm3 and Irgb6 was suggested by two in vitro 
studies, Irgm1
-/-
, Irgm3
-/-
 and Irgd
-/- 
showed normal resistance to murine cytomegalo-virus and 
Ebola virus infection. Therefore, there is currently no data supporting an antiviral role of the 
IRG resistance system in vivo.  
In summary, only the protozoa Toxoplasma and Neospora as well as two strains of the 
bacteria Chlamydia have been shown to be controlled by the IRG system, while many other 
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organisms, including Salmonella, Listeria, Mycobacteria, Trypanosoma or Plasmodium are 
not engaged by the IRG resistance system. Irgm1-deficient mice show a general susceptibility 
to all pathogens that stimulate an IFNγ-mediated immune response. (see table 1.1 for all 
references).  
1.4.2 Toxoplasma gondii as a model to study IRG protein function  
 The consistent susceptibility of all IRG-deficient mice to the protozoan T. gondii 
implies that this parasite is a good model to study IRG protein function. Upon infection, 
T. gondii-derived MAMPs like profilin are recognised by TLRs triggering IL-12 and 
subsequent IFNγ secretion mainly by NK-cells and T-cells. IFNγ is crucial in controlling 
replication and dissemination of T. gondii in both the haemopoietic and non-haemopoietic 
compartment [(Suzuki et al. 1988; Gazzinelli et al. 1994; Scharton-Kersten et al. 1996; 
Scharton-Kersten et al. 1998; Yap et al. 1999) reviewed in (Yarovinsky 2014)]. In vitro 
studies with mobile unicellular T. gondii infecting cell monolayers revealed a profound IFNγ-
mediated cell-autonomous resistance mechanism in myeloid cells such as macrophages as 
well as in non-myeloid cells such as fibroblasts. Experiments with IRG-deficient mouse cells 
confirmed that this IFNγ-mediated resistance is conducted by IRG proteins [(Halonen et al. 
2001; Butcher et al. 2005; Martens et al. 2005) reviewed in (Howard et al. 2011)].  
 T. gondii actively invades host cells and resides in a parasitophorous vacuole (PV) 
((Morisaki et al. 1995), see chapter 1.6 for PV). Immediately after parasite entry, effector 
GKS proteins relocalise from their cytosolic phase to the parasitophorous vacuolar membrane 
(PVM) [(Martens et al. 2005; Melzer et al. 2008; Zhao et al. 2009; Khaminets et al. 2010); 
and later confirmed by (Lubitz et al. 2013)] in a nucleotide-dependent manner (Hunn et al. 
2008; Papic et al. 2008) (Figure 1.5 A). IRG proteins accumulate in a cooperative and 
hierarchical manner, probably by formation of mixed GTP-dependent heterooligomers 
(Khaminets et al. 2010; Pawlowski et al. 2011). GMS proteins however do not target the 
PVM at all (Irgm1) or only to a limited extent (Irgm2, Irgm3) (Butcher et al. 2005; Martens et 
al. 2005; Khaminets et al. 2010; Haldar et al. 2013).  
 In mouse cells infected with an avirulent T. gondii strain, it appears that IRG proteins 
reduce the effective surface area of the PVM by vesiculating or ruffling it as observed by 
electronmicroscopy (Martens et al. 2005; Ling et al. 2006; Zhao et al. 2008), putting the 
membrane under tension and leading ultimately to its rupture (Howard et al. 2011) (Figure 1.5 
B-D). Once exposed to the cytosol, the parasite dies for unclear reasons followed by death of 
the infected host cell (Martens et al. 2005; Ling et al. 2006; Melzer et al. 2008; Zhao et al. 
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2009). While several markers for apoptosis and other cell death types are absent (AnnexinV 
staining at the plasma membrane, cytochrom C release from mitochondria, cleavage of 
Caspase 1, Caspase 3 or IL-1β, LC3-co-localisation), this host cell death is  
 
 
Figure 1.5: Vesiculation and disruption parasitophorous vacuolar membrane (PVM) of avirulent 
Toxoplasma gondii strains in IFNγ-stimulated cells.  
Coloured inset boxes indicate magnified area shown next to it. (A) Picture series of time-lapse microscopy video 
showing IFNγ-induced mouse fibroblasts overexpressing Irga6-GFP and infected with T. gondii (ME49) for the 
indicated time points. Irga6-GFP intensely loads the PVM and seems to extract surface area from the PVM, 
thereby creating tension. Vacuoles and the included parasites round up (white arrows) just before the PVM 
ruptures (white arrow) and the disrupted vacuole springs back to a more banana-like form. Scale bar: 5 µm, from 
(Zhao et al. 2009; Howard et al. 2011) (B) Transmission electron microscopy (TEM) images of IFNγ-induced 
mouse asterocytes infected with T. gondii (ME49) for 2 h. The white arrow marks the “stemmed” vesicular and 
tubular structures and the black arrow PVM indentations. Scale bars: from left to right 1 µm, 0.1 µm, and 50 nm; 
from (Melzer et al. 2008). (C) TEM images of IFNγ-/LPS-activated primary macrophages infected with 
T. gondii (PTG) for 5 h. Arrows indicate vesiculation and membrane blebbing “protruding from” the PVM. Scale 
bars: 0.5 µm; from (Zhao et al. 2008). (D) Cryo-EM images of IFNγ-induced mouse asterocytes infected with 
T. gondii (ME49) for 6 h. Immunogold particles indicating the presence of Irga6 are located on the outside of the 
PVM and on vesicles next to the PVM (black arrows). Scale bar: 250 nm; from (Martens et al. 2005; Howard 
2008). (E) Cryo-EM images of IFNγ-induced mouse macrophages infected with T. gondii (CTG). Irgb6 is 
detected by FluoreNanogold on the outside of the PVM (black arrow heads). Scale bar: 500 nm; from (Fentress 
et al. 2010).  
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 characterised by plasma membrane permeabilisation and release of the inflammatory high-
mobility group protein 1 (HMGB1) and is therefore currently considered as necrosis-like cell 
death (Zhao et al. 2009). 
 In contrast, during the infection with virulent strains of T. gondii only a low number of 
vacuoles are loaded with IRG proteins (Zhao et al. 2009; Zhao et al. 2009; Khaminets et al. 
2010; Spekker et al. 2013). Virulent T. gondii strains can secrete kinases that act as virulence 
factors to counteract IRG protein function [reviewed in (Hunter et al. 2012)]. The secreted 
polymorphic kinase ROP18 together with the pseudokinase ROP5 trap Irga6 in a GDP-bound 
conformation. The threonines in the switch 1 loop of the target IRG protein are 
phosphorylated by ROP18 resulting in a permanent biochemical inactivation, partial 
inhibition of IRG protein loading and further action at the PVM and ultimately allowing 
unrestricted replication of the parasite (Fentress et al. 2010; Steinfeldt et al. 2010; Behnke et 
al. 2012; Fleckenstein et al. 2012; Niedelman et al. 2012). The virulent outcome of T. gondii 
infection (killing of the mouse as intermediate host by an exaggerated inflammatory immune 
response) is not beneficial for the parasite, because this ends the life cycle before the parasite 
can get into its definitive host, the cat. However, T. gondii must trigger a certain level of the 
immune response in order to form semidormant cysts in brain and muscle. In order to fight 
infection with virulent T. gondii strains, polymorphic IRG genes of wild mice counteract the 
T. gondii virulence factors. In wild-derived CIM mice the Irgb2-Irgb1 tandem protein 
prevents ROP18-mediated phosphorylation of Irga6, probably acting as decoy (Lilue et al. 
2013). 
1.4.3 Chlamydia as a model to study IRG protein function  
 Another pathogen, the gram-negative bacterium Chlamydia, has been shown to be 
mainly controlled by the IRG resistance system. As in case of T. gondii, the same IRG 
proteins Irga6, Irgb6, Irgb10 and Irgd accumulate on parasitophorous vacuoles termed 
inclusions of C. trachomatis (Coers et al. 2008; Al-Zeer et al. 2009), whereas GMS proteins 
are largely absent (Coers et al. 2008; Haldar et al. 2013). GMS–deficient mice but not Irga6-
deficient mice are susceptible to C. trachomatis infection (Coers et al. 2008; Coers et al. 
2011). In vitro studies with IRG-deficient cells (single siRNA knock-down or cells from 
knock-out mice) confirmed an essential role of GMS proteins and Irgb10 in bacterial growth 
restriction of the human pathogenic strain C. trachomatis and well as the avain (parrot) 
pathogenic strain C. psittaci (Nelson et al. 2005; Bernstein-Hanley et al. 2006; Miyairi et al. 
2007; Coers et al. 2008). However, IRG proteins do not accumulate on inclusions of the 
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mouse pathogenic strain C. muridarum which is not restricted by IFNγ in mice (Nelson et al. 
2005; Coers et al. 2008; Al-Zeer et al. 2009). The differences in IRG restriction to Chlamydia 
strains are likely to be due to C. muridarum being the only natural pathogen of mice. This 
may cause a selective pressure to develop strategies to counteract the IRG attack. 
C. muridarum secretes a cysteine protease, YopT, that was proposed to bind Irga6 since it has 
been shown to cleave and inactivate other host cell GTPases (Nelson et al. 2005), but this idea 
has not been substantiated up till now. 
 The entry mechanism of Chlamydia is less well understood. It comprises some 
features of clathrin-mediated endocytosis but not those of usual phagocytosis, caveola-
mediated endocytosis, or macropinocytosis (Hybiske et al. 2007). Upon electrostatic-mediated 
cell association, the elementary body (EB), the Chlamydia metabolically inert “spore-like” 
form, and the host cell undergo an irreversible secondary binding. Host cell actin is recruited 
to the attachment site and the cytoskeleton undergoes rearrangements (Dautry-Varsat et al. 
2004; Dautry-Varsat et al. 2005). After internalisation by the host cell, Chlamydia 
differentiates into the replicative form, the reticulate body (RB), which resides in an inclusion 
(Valdivia 2008; Betts et al. 2009) and 1.6).  
In summary, GKS proteins have been shown to accumulate on four different vacuolar 
parasites: T. gondii, N. caninum and C. trachomatis and C. psittaci.  
1.4.4 Proposed functions of Irgm1 
 Irgm1 seems to be a special IRG family member and several different aspects have 
been explored in Irgm1
-/-
 mice or in in vitro experiments. In addition to the susceptibility to a 
large number of intracellular bacteria and protozoa (see 1.4.1), Irgm1
-/-
 mice are also highly 
susceptible to endotoxin-induced shock (Bafica et al. 2007) and show increased clinical 
symptoms for acute colitis after dextran sodium sulphate exposure (Liu et al. 2013). In 
parallel, studies demonstrated that Irgm1-deficient macrophages are less motile and impaired 
in actin-remodelling (Henry et al. 2007; Henry et al. 2009). Moreover, a recent series of 
publications suggested firstly Irgm1 being implicated in experimental autoimmune 
encephalomyelitis (Xu et al. 2010; Wang et al. 2012), secondly upregulated upon permanent 
middle cerebral artery occlusion in the ischemic side of the brain (mouse model of stroke) (He 
et al. 2012), and thirdly regulating oxLDL uptake by macrophages during atherosclerosis (Xia 
et al. 2013). However, all of these studies should await further experimental validation.  
 Remarkably, several studies noted that Irgm1-deficient mice infected with a number of 
different organisms such as M. avium, T. cruzi and S. typhimurium are not only susceptible to 
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these pathogens, but also suffered a striking collapse of their lymphomyeloid systems (Feng et 
al. 2004; Santiago et al. 2005; Henry et al. 2007). This effect of Irgm1 deficiency on the 
lymphomyeloid system is critically dependent on IFNγ expression, because in trematodes , 
which excite exclusively Th2 immunity without IFNγ expression, no collapse of the 
lymphomyeloid system in Irgm1-deficient mice could be observed (Feng et al. 2008). A 
reduced proliferative potential in the lymphoid system as well as in hematopoietic stem cells 
has been described in vitro. Mature CD4+ T-lymphocytes from Irgm1-deficient mice undergo 
IFNγ-induced cell death and this effect disappears if the responding cells are also deficient in 
IFNγ expression (Feng et al. 2008; Xu et al. 2010). IFNγ-mediated self-renewal of 
hematopoietic stem cells after exposure to pathogens is also impaired in Irgm1-deficient mice, 
but this is abrogated in Irgm1
-/-
IFNγR1-/-, and Irgm1-/-Stat1-/- double knock-out animals (Feng 
et al. 2008; Baldridge et al. 2010; King et al. 2011). 
 
 
 
Figure 1.6: Proposed models of Irgm1.  
Microscopic images in the left hand panel show IFNγ-induced mouse macrophages infected with Mycobacterium 
bovis BCG and stained for Irgm1 with A19 pAB; modified from (Shenoy et al. 2007). Microscopic images in the 
right hand panel show IFNγ-induced mouse embryonic fibroblasts from wt or Irgm1-deficient mice stained for 
Irgb6 or Irga6; modified from (Traver et al. 2011). See text 1.4.4 for other references. 
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 Different models try to explain these Irgm1-associated phenotypes describing either 
cell-autonomous or systemic effects (Figure 1.6) (Taylor et al. 2007; Feng et al. 2009; Hunn 
et al. 2010; Deretic 2011; MacMicking 2012). The earliest model, which is still widely 
accepted, proposes a cell-autonomous role for Irgm1 in facilitating destruction of 
phagocytosed bacteria. Irgm1 was suggested to be recruited to the mycobacterial phagosome 
by recognition of specific host phosphoinositide lipids (PtdInsP2 and PtdInsP3) and then 
regulate the SNARE adaptor protein snapin enabling fusion with lysosomes (MacMicking et 
al. 2003; Shenoy et al. 2007; Tiwari et al. 2009). This model gained some support from the 
initial finding that Irgm1 could be found at the phagocytic cup and phagolysosomes of 
phagocytosed latex beads (Martens et al. 2004).  
 The second model discusses Irgm1 as regulator of autophagy. On the one hand it was 
suggested that Irgm1 can stimulate the formation of autophagosomes and thereby participate 
in IFNγ-dependent control of Mycobacteria (Gutierrez et al. 2004; Singh et al. 2006); in case 
of human IRGM by affecting mitochondrial fission (Singh et al. 2010). Deregulated 
autophagy and mitophagy was also observed in IFNγ-stimulated or untreated cells from 
Irgm1
-/-
 mice (Traver et al. 2011; He et al. 2012; Liu et al. 2013). On the other hand Irgm1 
was suggested to protect from autophagic cell death (Feng et al. 2008; King et al. 2011). 
 Lastly, the lymphopenia in infected Irgm1
-/-
 mice suggested an alternative explanation 
for the systemic failure of immunity, based on the role of Irgm1 as an essential regulator of 
the IRG protein-based resistance mechanism. As noted in chapter 1.3.5, failure of GMS-
mediated regulation causes accumulation of the GKS proteins into aggregates (Hunn et al. 
2008). These aggregates may have cytopathic effects in dividing lymphomyeloid cells (Feng 
et al. 2009; Hunn et al. 2010) and also hematopoietic stem cells (King et al. 2011). In IFNγ-
induced Irgm1/Irgm3
-/-
-double-deficient cells, the concentrations of GKS proteins are greatly 
reduced, plausibly reducing the hypothetical cytopathic effects and reversing the susceptible 
Irgm1 phenotype (Henry et al. 2009). In fact, the bone marrow stem cell defect in 
Irgm1/Irgm3
-/-
-, Irgm1/IFNγR1-/-- and Irgm1/Stat1-/--double deficient mice as well as the 
immunological defect in Irgm1/IFNγR1-/--double-deficient mice are reversed (Feng et al. 
2008; King et al. 2011). An alternative interpretation is that Irgm1, acting as promoter of cell 
survival, antagonizes possible cytopathic effects of Irgm3, which acts as inducer of cell death, 
thus fine-tuning T-cell homeostasis (Henry et al. 2009; Coers et al. 2011). 
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1.4.5 Human IRGM 
 Since the mouse Irgm1 protein has been implicated in many immunity-related 
processes, more than 100 studies have been published in the last 10 years attempting to link 
human IRGM to immunity, even though hIRGM is truncated, not conserved and not 
interferon-inducible (see 1.3.1, 1.3.2). The first studies adapted experiments from of mIrgm1 
for hIRGM, proposing that hIRGM induces autophagy to eliminate phagosomal Mycobacteria 
via mitochondria (Singh et al. 2006; Singh et al. 2010). Polymorphisms in the hIRGM gene 
have been proposed to increase the risk to clinical tuberculosis in diverse human populations 
against different mycobacterial species [reviewed in (Kim et al. 2012)]. Moreover, genome-
wide association analysis has also recently shown that IRGM acts as a major predisposing 
locus for Crohn’s disease but not ulcerative colitis [meta-analysis (Lu et al. 2014)]. Deletion 
polymorphisms upstream of the hIRGM gene regulate different expression levels of hIRGM 
associated with the disease phenotype suggesting hIRGM as regulator of autophagy may 
dysregulate homeostasis with the microbial gut flora resulting in enhanced susceptibility to 
Crohn´s disease (McCarroll et al. 2008).  
 
1.5 Encephalitozoon cuniculi 
 E. cuniculi belong to the abundant and diverse group of microsporidia, recently 
re-classified as fungi (Corradi et al. 2009) that are obligate intracellular eukaryotic parasites 
of many animal groups including mammals. There are approximately 1200 microsporidian 
species, but just 14 have been documented to infect humans including E. cuniculi, E. hellem 
and E. intestinalis. Encephalitozoon species can cause the mainly gasteroenteric disease 
microsporidiosis, primarily in immunocompromised patients, such as HIV-infected patients or 
organ transplant recipients (Didier et al. 2011). Three genotypes of E. cuniculi have been 
identified so far named I (rabbit and mouse), II (mouse and dog), and III (dog and fox) strain, 
according to their natural host. The genotypes differ in the number of 5´-GTTT-3´repeats 
present in the internal spacer region of the rRNA (Didier et al. 1995). E. cuniculi serves as a 
convenient model organism for microsporidia, since it is possible to maintain E. cuniculi by in 
vitro culture and its genome is fully sequenced (Katinka et al. 2001). Genome research 
revealed that E. cuniculi has one of the most compact genomes of all eukaryotic organisms 
(2.9 Mbp) with low intraindividual genetic variation (Selman et al. 2013). Consistent with 
such an extreme genome reduction, small mitosomes carrying mitochondrial HSP70 protein 
instead of mitochondria were recently identified in microsporidia [(Williams et al. 2002),  
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Figure 1.7: Encephalitozoon cuniculi host cell invasion.  
The E. cuniculi spore is composed of an exo- and endospore layer and the plasma membrane enclosing the 
cytosol, nucleus, posterior vacuole, polaroplast and anchoring disc. The polar tube (cyan) is extruded and 
invaginates the host plasma membrane within seconds. The sporoplasm is transferred trough the polar tube and 
develops within a parasitophorous vacuole in the host cytosol, now termed meront. The meronts grow and divide 
by binary fission (merogony) and differentiate into sporonts and spores (sporogony) which are finally released 
by host cell lysis. Spore Figure (top left) modified from (Franzen et al. 2005) and large intracellular PV 
containing spores (bottom) from (Bohne et al. 2011).   
 
 
reviewed in (Makiuchi et al. 2013)]. With regard to this project it is noteworthy that several 
studies have now established IFNγ as strong inducer of cell-autonomous immunity against 
Encephalitozoon ssp. [see results 3.3.1 and reviewed in (Mathews et al. 2009)]. 
 In order to gain entry into the host cell, microsporidia have evolved a peculiar 
injection-based entry mechanism (Figure 1.7). The thick-walled spore of E. cuniculi carries a 
polar filament, which is expelled probably under osmotic pressure and invaginates the host 
cell plasma membrane. Thereafter, the sporoplasm, which is the cytosol and organelles of the 
organism, is transferred trough the polar tube and placed into the host cell cytoplasm. It is 
then termed meront and develops inside a parasitophorous vacuole (Ronnebaumer et al. 
2008). The meront acquires nutrients and resources from the host cell, grows and divide by 
binary fission (merogony) and differentiates into sporonts and spores (sporogony), finally 
lysing the host cell to release the mature, environmentally-resistant spores (Bigliardi et al. 
2001). Phagocytosis of spores by macrophages is also observed and was suggested as major 
entry route (Couzinet et al. 2000; Franzen et al. 2005). However, phagocytosis inhibition does 
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not affect the intracellular meront population (Orlik et al. 2010); therefore phagocytosis does 
not seem to be the natural entry mechanism of E. cuniculi or E. intestinalis (Leitch et al. 
2005) into host cells. 
1.6 Parasitophorous and inclusion vacuoles as intracellular niche  
 Different intracellular parasites evolved the strategy to replicate inside a 
parasitophorous or inclusion vacuole, which provides an intracellular niche that shields the 
invader from several endogenous host defence mechanisms [reviewed in (Sibley 2011)]. To 
enter the host cell, T. gondii establishes a protein complex called the moving junction at the 
parasite host cell interface, through which the parasite gains traction to pull itself with its own 
actin-myosin based motor system actively into the host cell [(Morisaki et al. 1995), reviewed 
in (Sibley 2004; Carruthers et al. 2007)].  
 The PVM is formed from the invaginated host cell plasma membrane (Suss-Toby et 
al. 1996) and is permissive for molecules under 1300 Da (Schwab et al. 1994). Apart from a 
transient activation of host actin, the host cortical cytoskeleton does not seem to be associated 
with the nascent vacuole (Gonzalez et al. 2009; Delorme-Walker et al. 2012). The PV does 
not fuse with endolysosomal compartments in macrophages or non-phagocytic cells, and is 
also devoid of several other host cell markers (Jones et al. 1972; Mordue et al. 1997; Mordue 
et al. 1999). Thereby, T. gondii blocks vacuole acidification (Sibley et al. 1985). In 1999, a 
detailed study revealed that during the invasion process, certain host cell surface proteins like 
the glycosylphosphatidylinositol (GPI)-anchored Sca-1 and CD55 are incorporated into the 
PVM, but transmembrane proteins including CD44, Na+/K+ ATPase and β1-integrin are 
excluded from the PVM (Mordue et al. 1999). It was suggested that the parasite-derived RON 
protein complex at the moving junction might act as a molecular sieve to selectively exclude 
host plasma membrane proteins (Tyler et al. 2011). This highly complex and not fully 
understood process is independent of lipid microdomains as both raft and non-raft-associated 
lipids and cytosolic leaflet proteins pass through the moving junction and are included into the 
PVM (Charron et al. 2004).  
 From the earliest studies it was noted that host cell mitochondria congregate around 
the PV (Gustafson et al. 1954) as well as strands of the rough ER (Jones et al. 1972; Endo et 
al. 1981; de Melo et al. 1992; Sinai et al. 1997) (reviewed in (Dubremetz et al. 2009)). 
Functional interactions of the PV and host cell organelles in terms of antigen delivery via the 
ER for MHC class I presentation (Goldszmid et al. 2009) or nutrient acquisition (Mordue et 
al. 1999; Coppens et al. 2006; Crawford et al. 2006; Romano et al. 2012; Romano et al. 2013) 
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are under debate. The invasion is accompanied by discharge of specialised secretory 
organelles filled with rhoptry (ROP, RON), microneme (MIC), and dense granule (GRA) 
proteins that fulfil various functions, e.g. composing the moving junction complex or 
interfering with host cell signalling [reviewed in (Hunter et al. 2012)]. Moreover, some of 
these virulence factors (ROP5, ROP18, and GRA7) decorate the PVM to counteract the IRG 
attack (see 1.4.2). 
 The Chlamydia inclusion is a membrane-bound vacuole also derived from the plasma 
membrane, but again segregated from the endolysosomal system (Scidmore et al. 2003). 
However, it can selectively orchestrate vesicles from several host cell organelles such as the 
exocytic pathway to acquire nutrients and host lipids [reviewed in (Saka et al. 2010; Scidmore 
2011)]. Moreover, lipid scavenging is facilitated by either host Golgi fragmentation, whose 
mini stacks can be observed in close proximity to Chlamydia inclusions (Heuer et al. 2009), 
or direct transport of ceramide from the host ER to the inclusion (Subtil 2011). The inclusion 
membrane is extensively modified by insertion of diverse Chlamydia type III secreted 
effectors, termed inclusion membrane (Inc) proteins (Dehoux et al. 2011).  
 The polar tube of E. cuniculi invaginates the host cell plasma membrane extremely 
fast, suggesting that this invasion is independent of cytoskeletal rearrangements since those 
processes are slower than the observed >1.3 s (Ronnebaumer et al. 2008). The bulk lipids of 
this PVM were shown to be host cell derived, since both raft and non-raft microdomains of 
the host plasma membrane are incorporated. Moreover, the PVM possesses pores with an 
exclusion size of <10 kDa to allow nutrient uptake (Ronnebaumer et al. 2008). The PVM of 
E. cuniculi does not acquire host endolysosomal or ER markers (Weidner 1975; Fasshauer et 
al. 2005; Ronnebaumer et al. 2008) and the vacuole does not acidify (Weidner et al. 1985).  
 In summary, the specialised vacuoles of Toxoplasma, Chlamydia and Encephalitozoon 
are mainly or entirely derived from the host plasma membrane and non-fusogenic with the 
host endolysosomal system providing a safe niche for intracellular replication 
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1.7 Aim of Study 
 IRG proteins constitute a powerful resistance system against the protozoan T. gondii 
and its close relative N. caninum as well as against two strains of the bacteria Chlamydia in 
mice. However, it remains a great mystery why all other organisms tested so far are not 
restricted by the IRG system. Even though T. gondii and Chlamydia are so dissimilar, they 
have some features in common: (I) an unusual route of host cell entry, neither of which 
resembles conventional phagocytosis, and (II) replication within non-fusogenic intracellular 
vacuoles that are formed by invaginated host plasma membrane. To explain why the IRG 
system only targets these organisms, one can hypothesise that critical modulations during host 
cell entry, e.g. specific exclusion host plasma membrane proteins as shown for T. gondii, 
results in the formation of parasitophorous vacuoles, that clearly differ from host cell 
endomembranes. Such a protein-depleted PVM can thus be recognised as “non-self” by the 
IRG proteins and targeted for destruction.  
 The aim of this PhD thesis was to clarify the subcellular localisation of Irgm1 in order 
to understand its role in cell-autonomous immunity and moreover, to elaborate on which 
artificial membrane systems and potential target organisms the IRG system becomes active.  
 The proposed model for Irgm1 as a direct effector on bacterial phagosomes stands in 
striking contrast to the above mentioned hypothesis. The direct effector model has gained 
considerable support from successive observations of Irgm1 associated with mycobacterial 
and listerial phagosomes in IFNγ–induced cells. Therefore, the first part of this study 
re-examined the subcellular localisation of Irgm1 during bacterial infection with several 
staining techniques. Moreover, the existence and properties of two Irgm1 isoforms was 
investigated.  
 The second part focussed on the question whether IRG proteins target protein-
deficient membranes. IRG association with pure liposomes, its correlation with residual host 
surface proteins on T. gondii PVM, as well as co-localisation to artificial Chlamydia Inc 
protein-induced vesicles was examined.  
 In the last part, a novel role of the IRG system in resistance to the microsporidian 
Encephalitozoon cuniculi was elucidated. This intracellular parasitic fungus that is restricted 
by IFNγ also enters the host cell by an unusual mechanism and resides in a non-fusogenic 
vacuole. It was tested whether E. cuniculi-infected cells show similar IRG-mediated 
phenomena as observed upon T. gondii and partially also Chlamydia infection. This 
information will help to understand, whether the IRG resistance system uses a universal 
mechanism to exert its PVM-destructive function.   
 M
at
er
ia
ls
 a
n
d
 M
et
h
o
d
s 
29 
 
Materials and Methods 
2.1 Instruments 
Only instruments are listed, which are not commonly used for laboratory work.  
Instrument Company 
Optima
TM
 TLX Ultracentrifuge 
Beckman Coulter GmbH, 
Krefeld, Germany 
EmulsiFlex-C5 microfluidiser Avestin, Ottawa, Canada 
LiposoFast-Basic and Stabiliser (Liposome extruder) Avestin 
Rocky 1010 
Labortechnik Fröbel, Lindau, 
Germany 
Film developing machine AGFA Curix 60 AGFA, Mortsel, Belgium 
Spektrophotometer Cary100 Bio UV-Visible 
Spectrometer Varian, Darmstadt, 
Germany 
ÄTKA fast performance liquid chromatography (FPLC)  
Amersham Biosciences, 
Freiburg, Germany,  
now GE Healthcare 
Zeiss Axioplan II fluorescence microscope/ 
AxioCam MRm camera 
Zeiss, Oberkochen, Germany 
Zeiss Axiovert 200 M motorized microscope Zeiss 
 
2.2 Chemicals and other materials 
All chemicals and reagents were purchased from Carl Roth GmbH + Co. KG, (Karlsruhe, 
Germany), Sigma-Aldrich (Saint Louis, MO, USA), Merck KGaA (Darmstadt, Germany), or 
Serva (Heidelberg, Germany) if not otherwise stated.  
Chemicals and other materials Company 
4’,6-Diamidino-2-phenylindol (DAPI) 
Roche Diagnostics, Mannheim, 
Germany  
µ-slide I chambers Ibidi, Munich, Germany 
Avanti 1x100Me Brain Polar Lipid Extract 
141101P 
Avanti Polar Lipids, Inc., Alabaster, AL, 
USA 
Bisbenzimide Hoechst 33342 Sigma-Aldrich 
CellTiter 96 AQueous non-radioactive cell 
proliferation assay  
Promega, Mannheim, Germany 
cOmplete ULTRA Tablets Mini, EDTA-free Roche Diagnostics 
Alexa-546 labelled human Transferrin Molecular Probes, Invitrogen 
 M
at
er
ia
ls
 a
n
d
 M
et
h
o
d
s 
30 
 
EZ-Link Sulfo-NHS-LC-LC-Biotin Pierce, Rockford, IL, USA 
FuGENE HD and XtremeGene 9  Roche Diagnostics 
Propidium iodide  Sigma-Aldrich 
Polybead Carboxylate Microspheres 2 µm 
(#18327) 
Polyscience, Inc., Warrington, PA, USA 
Protran nitrocellulose membrane (0.45 µm) 
Schleicher & Schüll, Dassel, Germany , 
now GE Healthcare 
Nucleopore Track-Etch Membrane Filters, 
100 nM 
Whatman International Ltd., Maidstone, 
UK 
Page Ruler Prestained Protein Ladder 
Fermentas, Thermo Scientific, 
Schwerte, Germany 
Protein A Sepharose 4 CL-4B GE Healthcare, Uppsala, Sweden 
GSTrap FF 5 ml GE Healthcare 
HiLoad 26/60 Superdex 75 or 200 prep grade Amersham  
ProLong Gold anti-fade reagent 
Invitrogen Life Technology, Darmstadt, 
Germany 
Puromycin 
Clontech Saint-Germain-en-Laye, 
France 
Recombinant mouse IFNγ PeproTech, Rocky Hill, NJ, USA 
Streptavidin-Cy3 conjugate # 6402 Sigma-Aldrich 
Super RX films Fujifilm, Tokyo, Japan 
Thrombin Serva 
Whatman paper 
Macherey-Nagel GmbH & Co. KG, 
Düren, Germany 
Vivaspin 20 centrifugal concentrator,  
10 kDa cut-off 
Vivascience, Lincoln, USA 
 
2.3 Antibodies and enzymes 
Antibodies used for immunofluorescence microscopy (IF) or immunobotting (IB) are listed 
below.  
Primary antibodies against IRG proteins   
Name  
recognised 
antigen  
type  dilution  
source and/ or 
reference 
αIGTP clone 7  
mouse Irgm3 
(aa 283-423)  
mouse 
monoclonal 
AB 
WB 1:2000  
IF 1:500  
 
BD Transduction 
Laboratories  
now Santa Cruz 
Biotechnology, 
Inc., Santa Cruz, 
CA 
165/3  
(3
rd
 bleed)  
165/4 (4
th
 bleed) 
recombinant 
mouse Irga6  
rabbit 
polyclonal 
AS 
WB 1:25000 IF 
1:8000  
(Uthaiah et al. 
2003; Martens et al. 
2004) 
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10D7  
recombinant 
mouse Irga6  
mouse 
monoclonal 
AB 
WB 1:2000  
IF: 1:500 
J. Zerrahn, Berlin 
(Zerrahn et al. 
2002; Martens et al. 
2005; Papic et al. 
2008) 
10E7  
recombinant 
mouse Irga6  
mouse 
monoclonal 
AB  
WB 1:1000 
 
J. Zerrahn, Berlin 
(Zerrahn et al. 
2002; Martens et al. 
2005; Papic et al. 
2008) 
2078  
mouse Irgd 
peptides 
CKTPYQHPK-
YPKVIF; 
CDAKHLLRKI
ETVNVA  
rabbit 
polyclonal 
AS 
WB 1:1000  
IF 1:500  
Eurogentec  
(Khaminets et al. 
2010) 
L115 
mouse Irgm1 
peptides 
QTGSSRLP-
EVSRSTE, 
NESLKNSLGV
RDDD  
rabbit 
polyclonal 
AS 
WB 1:2000  
Eurogentec 
(Khaminets et al. 
2010) 
1B2 mouse Irgm1 
mouse 
monoclonal 
AB 
undiluted 
hybridoma 
supernatant 
(Butcher et al. 
2005) 
rbMAE15 A 
peptide of the 
N-terminus of 
the short mouse 
Irgm1 isoform 
MAETHYAPLS
SAFPC 
rabbit 
polyclonal 
AS 
WB IF:  
A.1  1:2000 
A.2, A.3  1:4000 
Innovagen, Lund, 
Sweden 
this study 
rbMAE15 B 
mouse Irgm1 
(peptide  
MAETHYAPLS
SAFPC) 
rabbit 
polyclonal 
AS 
IF:  
B.1 1:2000 
B.2, B.3 1:4000 
Innovagen 
this study 
chMAE15 A 
mouse Irgm1 
(peptide  
MAETHYAPLS
SAFPC) 
chicken 
polyclonal 
IgY 
WB: 1:1000 
IF: 1:250 
Innovagen 
this study 
A19 (sc-11075) 
and  
P20 (sc-11074) 
mouse Irgm1 N-
terminal peptide  
goat 
polyclonal 
AB 
WB 1:200  
IF 1:100  
Santa Cruz 
Biotechnology, Inc.  
A20 (sc-11079) 
mouse Irgb6 N-
terminal peptide  
goat 
polyclonal 
AS 
WB 1:500  
Santa Cruz 
Biotechnology, Inc.  
142/1 mouse Irgb6 
rabbit poly-
clonal AS 
IF 1:2000 
Innovagen         
(Lilue et al. 2013) 
H53  
mouse Irgm2 N-
term. Peptide 
MEEAVESPEV
KEFEY  
rabbit 
polyclonal 
AS 
WB 1:1000  
IF 1:1000  
Eurogentec 
(Khaminets et al. 
2010) 
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The goat polyclonal antibodies M-16 and M-95 from Santa Cruz Biotechnology, Inc. directed 
against C-terminal peptides did not specifically detect Irgm1 (Steffi Koenen-Waisman, 
personal communication).  
 
ab69494 
human IRGM, 
mouse Irgm1, 
mouse Irgm2 
strongly 
rabbit 
polyclonal 
IF 1:1000 
o/n 4°C 
Abcam plc, 
Cambridge, U. K. 
ab69495 
human IRGM, 
mouse Irgm1, 
mouse Irgm3 
rabbit 
polyclonal 
IF 1:1000 
o/n 4°C 
Abcam plc 
B34 Irgb6 
mouse 
monoclonal 
WB 1:1000 (Carlow et al. 1995) 
C15A (954) Irgb2-b1 
rabbit 
polyclonal 
IF 1:8000 
Innovagen (Lilue et 
al. 2013) 
940/6 
Irgb10 
(crossreactive) 
rabbit 
polyclonal 
WB 1:5000 
IF 1:4000 
Innovagen (Howard 
Lab unpublished) 
Primary antibodies against marker proteins 
Name  
recognised 
antigen  
type  dilution  source  
α-ActA 
ActA  
(50-126 aa) 
mouse 
monoclonal 
AB 
IF: 1:1000 
Pascal Cossart and 
Edith Gouin, Institut 
Pasteur, Paris, 
France 
α-calnexin 
C-terminal 
peptide of 
canine 
calnexin    (aa 
575-593)  
rabbit 
polyclonal AB 
WB 1:5000  
IF 1:250  
Calbiochem at 
Merck KgaA, 
Darmstadt, Germany 
α-complex II 
#459200 
complex II  
mouse 
monoclonal 
AB 
IF: 1:1000 
Molecular Probes, 
Invitrogen Life 
Technology 
α-cytochrom C Cytochrom C 
mouse 
monoclonal 
AB 
IF: 1:1000 
BD Bioscience, 
Heidelberg, 
Germany 
a-GM130 
mouse 
GM130 
Golgi marker 
mouse 
monoclonal 
AB 
IF 1:1000 
BD Bioscience, 
Heidelberg, 
Germany 
1D4B LAMP1 
rat monoclonal 
AB, hybridoma 
supernatant 
IF 1:2000 
Developmental 
Studies Hybridoma 
Bank, University of 
Iowa 
α-GRA7  
JH.3.1.2 
T. gondii 
GRA7  
(GST-GRA7 
aa 24-100 in 
rat CC2-3) 
rat 
monoclonal,  
hybridoma 
supernatant   
1:1000 
(Fleckenstein et al. 
2012) 
 M
at
er
ia
ls
 a
n
d
 M
et
h
o
d
s 
33 
 
 
 
anti-Listeria 
Listeria 
surface 
protein 
rabbit 
polyclonal AB 
IF: 1:1000 
US Biologicals, 
Salem, MA, USA 
 
 
α-M. tuberculosis 
#B65601R 
Mycobacteria 
surface 
protein 
rabbit 
polyclonal AB 
IF 1:8000 
Meridian, Memphis, 
TN, USA 
Phalloidin Alexa 
Flour 546 
Actin  IF: 1:250 
Molecular Probes, 
Invitrogen Life 
Technology 
6G2 
meronts of 
E. cuniculi 
mouse 
monoclonal 
IF: 1:50 WB 
1:100 
(Fasshauer et al. 
2005) 
SWP1 
Spore wall 
protein of 
E. cuniculi 
rabbit 
polyclonal 
antiserum 
IF 1:2000 
WB 1:2000 
(Bohne et al. 2000) 
Secondary antibody 
Name  conjugate  dilution  source  
Donkey α-mouse IgG Alexa Fluor 488 IF 1:1000  
Molecular Probes, 
Invitrogen Life 
Technology 
Donkey α-rabbit  IgG Alexa Fluor 488 IF 1:1000 Life Technologies 
Donkey α-goat IgG Alexa Fluor 488 IF 1:1000 Life Technologies 
Donkey α-rat  IgG Alexa Fluor 488 IF 1:1000 Life Technologies 
Donkey α-chicken IgY Alexa Fluor 488 IF 1:1000 Life Technologies 
Donkey α-mouse IgG Alexa Fluor 555 IF 1:1000  Life Technologies 
Donkey α-rabbit IgG Alexa Fluor 555 IF 1:1000 Life Technologies 
Donkey α-goat IgG Alexa Fluor 555 IF 1:1000 Life Technologies 
Donkey α-rat IgG Alexa Fluor 555 IF 1:1000 Life Technologies 
Donkey α-mouse IgG Alexa Fluor 647 IF 1:1000  Life Technologies 
Donkey α-rabbit IgG Alexa Fluor 647 IF 1:1000 Life Technologies 
Donkey α-goat IgG Alexa Fluor 647 IF 1:1000 Life Technologies 
Donkey α-rat IgG Alexa Fluor 647 IF 1:1000 Life Technologies 
Donkey-α-rabbit IgG 
horse radish 
peroxidase (HRP) 
WB 1:5000  GE Healthcare 
donkey anti-goat IgG HRP WB 1:5000 Abcam plc 
donkey anti-rat IgG HRP WB 1:5000 
Jackson ImmunoResearch 
Laboratories, Inc., West 
Grove, PA, USA 
goat anti-mouse IgG HRP WB 1:5000  
Pierce, Biotechnology, 
Rockford, IL, USA 
donkey anti-chicken IgY HRP WB 1:2000 Pierce 
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2.4 Buffers and media 
All buffers and solutions were prepared with deionized, sterile (Seral
TM
) or Milli-Q Synthesis 
(Millipore) water and autoclaved or sterilely filtered if required.  
Buffer/ media Compounds 
Luria Bertani 
(LB-) media 
1% Bacto
TM
 Tryptone (w/v) (10 g) 
0.5% Bacto
TM
 Yeast Extract (w/v) (5 g) 
0.5% NaCl (M: 58.44 g/mol, 5 g) (w/v) 
add to 1 l dH2O and autoclave 
LB media agar 
plates 
1 l LB media 
add 15 g Bacto
TM
 Agar and autoclave 
cool down to 50°C 
add antibiotics Kanamycin 1:1000 (stock 50 mg/ml, final 50 µg/ml) or  
                         Ampicillin 1:1000 (stock 100 mg/ml, final 100 µg/ml) 
pour 20 ml per petri dish and store upside down at 4°C 
Cell culture 
medium for mouse 
fibroblasts 
(DMEM)  
Dulbecco’s modified Eagle’s medium (DMEM), high glucose            
(PAA, Pasching, Austria now sold to Invitrogen Life Technologies) 
10% fetal calf serum (FCS, from PAA, now Biochrom, Berlin, 
Germany) 
2 mM L-glutamine (PAA, now Invitrogen),  
1 mM sodium pyruvate (PAA, now Invitrogen), 
1x MEM non-essential amino acids (PAA, now Invitrogen),  
100 U/ml penicillin and 100 µg/ml streptomycin (PAA, now 
Invitrogen), 
Cell culture 
medium for Hs 
cells (IMDM)  
Iscove´s modified Dulbecco´s medium (IMDM) (Invitrogen)  
5% FCS 
1x MEM non-essential amino acids,  
100 U/ml penicillin and 100 µg/ml streptomycin. 
Cell culture 
medium for 1B2 
cells (IMDM)  
Iscove´s modified Dulbecco´s medium (IMDM) (Invitrogen)  
10% FCS 
1x MEM non-essential amino acids,  
100 U/ml penicillin and 100 µg/ml streptomycin. 
Cell culture 
medium for mouse 
macrophages 
(RPMI) 
Roswell Park Memorial Institute (RPMI) 1640, Invitrogen)  
25% FCS 
10% L929 P2 cell-conditioned medium 
2 mM L-glutamine  
100 U/ml penicillin and 100 µg/ml streptomycin. 
Freeze Mix  
90% FCS  
10% dimethylsulfoxid (DMSO)  
10x Trypsin 
5% Trypsin (1:250) (w/v) (5 g) (Gibeco BRL now Invitrogen) 
17 mM EDTA (2 g or 10.8 ml of 0.5 M EDTA solution) 
145 mM NaCl (M: 58.44 g/mol, 8,5 g) 
10x PBS buffer 
1.37 M NaCl (M: 58.44 g/mol, 81.8g) 
27 mM KCl (M: 74.56 g/mol, 2g) 
101 mM Na2HPO4 x 2 H2O (M: 177.99 g/mol, 17.97 g) 
18 mM KH2PO4 (M: 136.09 g/mol, 2.4 g) 
add to 1 l dH2O, pH = 7.4 and autoclave 
IF Fixing buffer 3% Paraformaldehyde (PFA) (w/v) in PBS 
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IF Washing buffer 0.1% Saponin (w/v) in PBS (1 g in 1 l PBS) 
IF Blocking buffer 
3% bovine serum albumin (BSA) (w/v) (1.5 g in 50 ml)  
0.1% Saponin (w/v) in PBS (1 g in 1 l PBS) 
Cell lysis buffer 
1% Triton X-100 (v/v) (647 g/mol, prepare 10% Stock solution) 
1 x cOmplete ULTRA Tablet Mini 
10 ml PBS 
10x SDS sample 
buffer (Laemmli) 
0.5 M Tris-HCl, pH 6.8 
50% Glycerol (v/v) 
10% SDS (w/v) 
0.025% Bromphenol blue (w/v) 
7% β-Mercaptoethanol (v/v)  
make 1ml aliquots and add freshly 70 μl β-mercaptoethanol before use 
SDS-running 
buffer (1x)  
250 mM Tris-(hydroxymethyl)-aminomethan (M: 121.1 g/mol, 30.3 g) 
1.92 M glycine (M: 75.07 g/mol, 144.1 g) 
34.67 mM SDS (M: 288.38 g/mol, 10 g) 
add to 10 l dH2O 
SDS-PA gel (10%) 
separation gel 
12 ml H2O millipore 
10 ml 30% Acrylamide solution (acryl/bisacryl) 
7.6 ml 1.5 M Tris-HCl, pH 8.8 
0.3 ml 10% SDS 
100 µl 10% Ammonium peroxydisulphate (APS) 
50 µl Tetramethylethylenediamine (TEMED) 
SDS-PA gel (4%) 
stacking gel 
6.1 ml H2O millipore 
1.3 ml 30% Acrylamide solution (acryl/bisacryl) 
2.5 ml 0.5 M Tris-HCl, pH 6.8 
0.1 ml 10% SDS 
50 µl 10% APS 
25 µl TEMED 
10x 
Electrophoresis 
Transfer buffer 
250 mM Tris-(hydroxymethyl)-aminomethan (M: 121.1 g/mol, 30.3 g) 
1.92M glycine (M: 75.07 g/mol, 144.1 g) 
Add to 1 l dH2O 
Ponceau S solution 
0.2% Ponceau S (2 g) 
3% acetic acid (30 g) 
in 100 ml dH2O 
1x PBS/T 1 buffer dilute 10x PBS 1:10 and add 0.1% Tween 20 (v/v) (1 ml in 1 l) 
1x PBS/T 2 buffer dilute 10x PBS 1:10 and add 0.3% Tween 20 (v/v) (3 ml in 1 l) 
Blocking buffer 
WB 
5% Milkpowder (2.5 g) in 50 ml PBS/T I 
Dilution buffer 
WB 
1% FCS in PBS (100 µl in 10 ml) 
Detection  
solution 1 
88.5 ml H2O 
10 ml 1M Tris-HCl, pH 8.5 
1 ml 250 mM Luminol (3-Aminophthalhydrazide) in DMSO  
0.44 ml 90 mM p-Coumaric acid in DMSO 
Detection  
solution 2 
90 ml H2O 
10 ml 1 M Tris-HCl pH 8.5 
60 µl 30% H2O2 
10x B1 buffer 
500 mM Tris-(hydroxymethyl)-aminomethan (M: 121.1 g/mol, 60.5 g) 
50 mM MgCl2 (M: 95.21 g/mol, 10.16 g) 
add to 1 l dH2Oand adjust pH = 7.4 
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DTT Stock 
1M Dithiothreitol (154.25 g/mol, 1.54 g in 10 ml dH2O) 
dilute 1:500 (add 1 ml 1M DTT for 0.5 l PBS) for final concentration 
of 2 mM, store 1 ml aliquods at -20°C 
Elution buffer 
10 mM reduced L-glutathione (307.32 g/mol, 30.7 g per 100 ml) 
in PBS/2 mM DTT 
IPTG Stock 
1 M Isopropyl β-D-1-thiogalactopyranoside (238.30 g/mol, 2.38 g 
in10 ml dH2O)  
dilute 1:10.000 (200 µl per 2 l LB medium) for final concentration of 
0.1 mM, store aliquods at 4°C 
GuaHCl washing 
buffer 
6 M Guanidinium chloride (95.53 g/mol, 573.24 g in 1 l dH2O) 
Coomassie 
Staining solution 
0.1% (w/v) Coomassie Brilliant Blue R-250 (Serva) 
40% (v/v) ethanol 
10% (v/v) acetic acid in H2O 
Coomassie 
Destain. solution 
40% (v/v) ethanol 
10% (v/v) acetic acid in H2O 
  
 
2.5 Expression vectors  
The following expression vectors were used in this study. 
plasmid constructs Reference 
pGEX-4T2 
bacterial protein expression vector (Amersham Biosciences, now 
GE Healthcare) 
pGEX-4T2-Irgm1 generated by Sascha Martens, (Martens et al. 2004) 
pGEX-Irgm1-short  
(= Irgm1∆1-16) 
performed by Rita Lange: 
The first 16 aa of pGEX-Irgm1-short (= Irgm1Δ1–16) were 
deleted using the QuikChange site-directed mutagenesis kit 
protocol (Stratagene, La Jolla, CA) of pGEX-Irgm1 construct with 
the following primer   
5`-CCCAGGAATTCCCGGGTCGACCACCA 
TGGCAGAGACCCATTATGCTCCCCTGAGC-3´ 
pGEX-4T2-Irgm2 generated by Revathy Uthaiah, Howard lab collection 
pGEX-4T2-Irgm3 generated by Revathy Uthaiah, (Pawlowski et al. 2011) 
pGEX-4T2-Irga6 generated by Revathy Uthaiah, (Uthaiah et al. 2003) 
pGEX-4T2-Irgb6-TevUp generated by Nikolaus Pawlowski, (Pawlowski et al. 2011) 
pGEX-4T2-Irgd generated by Revathy Uthaiah, Howard lab collection 
pGW1H mam. expression vector (British Biotechnology, Oxford, U. K.)  
pGW1H-Irgm1 generated by Sascha Martens, (Martens et al. 2004) 
pGW1H-Irgm1-short 
pGW1H-Irgm1-short was generated by subcloning the Irgm1Δ1–
16 fragment from pGEX-Irgm1-short into pGW1H using SalI 
digestion 
pEGFP-N3/Irga6-cTag generated by Sascha Martens, (Khaminets et al. 2010) 
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2.6 Unicellular Organisms  
Bacterial strains  
- Escherichia coli BL21: B, F-, hsdS (rB-, mB-), gal, dcm, ompT  
- Listeria monocytogenes, strain EGD, serotype 1/2a (wildtype) 
- Listeria monocytogenes Δhly (listeriolysin-deficient) 
- Mycobacterium bovis bacillus Calmette-Guerin (BCG) 
Toxoplasma gondii 
ME49: type II strain, avirulent, originally isolated from sheep muscle (California, USA) in 1965 
(Guo et al. 1997). 
Encephalitozoon cuniculi 
E. cuniculi spores were obtained from Wolfgang Bohne, who got them from Professor Peter 
Deplazes (University of Zürich, Switzerland). This E. cuniculi stain had the genotype I 
(Jingtao Li and Marialice Heider, personal communication).  
 
2.7 Mammalian primary cells and cell lines  
All cells were cultivate at 37°C, 7.5% CO2 and 90% humidity and kept under sterile 
conditions.  
Primary human foreskin fibroblasts (Hs27)  
Hs27 were purchased from ATCC (CRL-1634) and cultured in supplemented IMDM.  
Human Embryonic Kidney (HEK293FT) cell line 
HEK293FT is an adherent cell line, kindly provided by Thomas Langer. It is a highly 
transfectable derivative of the HEK293 cell line, which stably express the SV40 large 
T-antigen. This allows amplification of transfected plasmids, which contain the SV40 origin 
of replication. 
pPur 
mammalian expression vector with Puromycin resistance 
(Clontech Saint-Germain-en-Laye, France) 
pSV3-neo 
mammalian expression vector with T-large antigen of SV40 virus 
for immortalisation of cell lines, Howard lab collection 
pCDNA3.1-GFP-TOPO-
CT229 
N-terminal fusion of GFP to CT229, generated and provided by 
Ted Hackstadt, (Clifton et al. 2004)  
pmCherry-C1-IncB generated and provided by Ted Hackstadt, (Mital et al. 2013) 
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Primary mouse embryonic fibroblasts  
MEFs were prepared from C57BL/6 mice at day 14 post coitum (by Claudia Poschner) and 
cultured in supplemented DMDM until a maximum passage number of 15. 
Irgm1-/- T MEFs  
Immortalised MEFs from Irgm1
-/-
 mice (cells provided by Greg Taylor) spontaneously 
transformed (T) in culture conditions with supplemented DMDM and are very suitable for 
microscopy and transfection. 
Immortal Irgm1-/- MEFs, Irgm3-/- MEFs, Irga6-/- MEFs, Irgd-/- MEFs, 
Irgm1-/-/Irgm3-/- MEFs and immortal wt MEFs as control line 
Irgm1
-/-
, Irgm3
-/-
, Irgm1/Irgm3
-/-
, Irgd
-/-
 and wt MEFs (kindly provided by Greg Taylor ) or 
Irga6
-/-
MEFs  (Liesenfeld 2011) were immortalised by the simian virus 40 large T-antigen, 
which alters the effect of the tumour suppressor proteins pRb and p53 (Southern et al. 1982). 
Because the knock-out cells were already neomycin resistant, an additional plasmid carrying a 
puromycin resistance gene was transfected. Therefore, 5 µg pSV3-neo plasmid and 0.5 µg 
pPur were mixed with 10 µl FuGENE HD in 400 µl serum-free medium, incubated 20 min at 
RT and dropped onto 90% confluent cells in a 10 cm dish. After 24 h, cells were put under 
selection with 3 µg/ml puromycin. 
Mouse epithelial cell line CMT-93 
CMT-93 is an epithelial cell line derived from a rectal carcinoma of a C57BL/6 mouse in 
1978. It was purchased from ATCC (CCL-223), and cultured in supplemented DMDM.  
Mouse macrophage cell line RAW 269.7 
RAW269.7 is a macrophage cell line transformed by Abelson murine leukemia virus in a 
BALB/c mouse. It was purchased from ATCC (TIB-71), and cultured in supplemented 
DMEM. 
Primary bone-marrow-derived macrophages (BMM)  
BMMs were prepared from femurs and tibia of C57BL/6 mice (by Claudia Poschner) and 
cultivated in supplemented RPMI. Frozen BMMs were thawn for each experiment and seeded 
directly on uncoated glass slides.  
Hybridoma cells 1B2  
Hybridoma cells 1B2 produce monoclonal antibodies against Irgm1 and were provided by 
Greg Taylor. Subclones generated by limiting dilution were selected for highest antibody 
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titres, pooled and cultivated in IMDM supplemented with 10% FCS in roller bottle (2 l) 
cultures. Antibody purification via Protein A as described in (Papic et al. 2008) or ammonium 
persulphate precipitation was unfortunately not successful, because the purified antibody was 
not functional in immunostainings anymore. To this end, only undiluted hybridoma 
supernatant + 0.2% sodium azide was used for immunostainings.  
 
2.8 Cell-biological methods  
Freezing and thawing of mammalian cells 
Mammalian cells were harvested, pelleted at 400 g for 5 min, and resuspended 
(4*10
6
 cells/ml) in ice cold sterile FCS/10% DMSO (v/v). Frozen cells were stored in liquid 
nitrogen for long-term storage. Cells were thawn at 37°C, immediately transferred into 10 ml 
of medium, pelleted and plated in fresh medium in a T75 flask.  
 
Passaging of mammalian cells 
For passaging, cells were first washed once with sterile PBS and then detached with 1x 
trypsin solution 1-2 min at 37°C. After addition of 8 ml medium, cells were pelleted and 
plated in a new flask in a dilution 1:3 (primary fibroblasts) or 1:5 to 1:10 (cell lines). 
 
Transient DNA transfection  
Transient transfection of cells was conducted with 2*10
5
 in 6-wells plates with 1:3 or 2:5 ratio 
of µg DNA per µl FuGENE 6 or XtremeGene 9 according to the manufacturer’s instructions. 
Protein overexpression was analysed 24 h later.  
 
Induction and stimulation of cells 
Cells were stimulated with 200 U/ml of recombinant mouse IFNγ for 24 h. For IDO-
inhibition, L-tryptophan (W) was added 15 min prior to infection. 
 
Bacterial labelling and host cell infection  
performed by Michael Schramm 
For bacterial infection assay, L. monocytogenes were grown overnight in brain-heard infusion 
(BHI) medium, resuspended in fresh BHI medium and harvested during mid-log phase. 
Before harvesting M. bovis BCG, suspensions were centrifuged at 25 g to remove clumps. 
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After washing once with PBS, concentration of the bacteria was estimated by optical density 
measurement. M. bovis BCG were incubated with 1 mM Tetramethylrhodamine 
isothiocyanate (TRITC) isomer R -X succinimidyl ester in 0.1 M NaHCO3 in H2O, pH 9 for 
1 h at room temperature (RT). Unbound dye was removed by repeated washing with PBS. 
Heat-killed L. monocytogenes (HKLM) were prepared by incubating L. monocytogenes at 
60°C for 60 min. Inactivation of HKLM was proven by plating on sheep blood agar plates 
before use.  
The bacterial suspensions were diluted, L. monocytogenes was added to cells at an 
multiplicity of infection (MOI) of 5-10 (fibroblasts) or 0.5 (macrophages) and M. bovis BCG 
at an MOI of 5 (macrophages) in ice cold DMEM with 10% FCS. Adherence of bacteria was 
synchronized by centrifugation at 850 g, 4°C for 5 min. Subsequently, non-adherent 
L. monocytogenes were removed by triple washing with ice cold PBS. Infected cells were 
incubated in pre-warmed DMEM with 10% FCS. At specific times after infection, samples 
were fixed with 3% PFA in PBS for 20 min at RT followed by washing once with PBS.  
Passaging and host cell infection with T. gondii ME49 
Tachyzoites from T. gondii strain ME49 were maintained by serial passage in confluent 
monolayers of human foreskin fibroblasts in T25 flasks with supplemented IMDM, 
incocculating either 2*10
6
 for harvesting after 2 days or 0.5*10
6
 parasites for 3 days. 
Extracellular parasites, which replicated and egressed from the lysed host cells, were 
harvested from the supernatant and purified from host cell debris by differential centrifugation 
(5 min at 100 g; 15 min at 500 g). Parasites were resuspended in fresh medium, counted using 
a Neubauer chamber and immediately used for infection of host cells at an MOI of 5. 
In vitro passaging of E. cuniculi and host cell infection 
E. cuniculi spores were routinely propagated in Hs27 cells. Infected monolayers were 
scrapped 7-12 days post infection and the suspension was passed through a 26G needle. The 
differential centrifugation (10 min at 500 rpm; 20 min at 2500 rpm) first removed the host cell 
debris and then sedimented the spores. A stock solution with 2.5*10
7
 spores/ml PBS was 
stored at 4°C for max. 3 month. For infection assays, 8-12*10
4
 host cells were seeded in 
6-wells 48 h prior infection, optionally stimulated, and infected with an MOI of 5 parasites 
per host cell unless otherwise stated. In order to obtain a synchronic infection, spores were 
allowed to infect the cells for 2-4 h followed by one careful washing step with PBS and 
addition of fresh medium. Cells were fixed or harvested at the indicated time points post 
infection.  
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Indirect Immunofluorescense microscopy 
For immunocytochemistry, cells were grown on cover slips in 6-well plates or 24-well plates. 
After treatments, cells were carefully rinsed once with PBS to remove the medium, fixed in 
3% paraformaldehyde for 20 min at RT and then triple washed with PBS. The conventional 
staining included permeabilisation and blocking in blocking buffer (3% BSA and 0.1% 
saponin in PBS) for 1 h at RT, followed by staining with primary antibodies diluted in 
blocking buffer for 1 h at RT and staining with secondary antibodies diluted in blocking 
buffer for 30 min at RT. Between all steps cells were triple washed with 0.1% saponin in 
PBS.  
The differential staining was extended by a first staining without permeabilisation. 
Exclusively extracellular bacteria were stained by blocking with 3% BSA in PBS for 1 h at 
RT followed by staining the unpermeabilised cells with the primary antibody against bacteria 
and Alexa Fluor 647-conjugated secondary antibody. Between all steps cells were triple 
washed with PBS. Thereafter, intra- and extracellular bacteria as well as the protein of interest 
(Irgm1) were stained by permeabilisation and blocking in conventional blocking buffer (3% 
BSA and 0.1% saponin in PBS) for 1 h at RT, followed by staining with both primary 
antibodies diluted in blocking buffer 2 for 1 h at RT as well as Alexa Fluor 488/555-
conjugated secondary antibodies for 30 min at RT. Between all steps cells were triple washed 
with 0.1% saponin in PBS and then mounted on glass microscopic slides in ProLong Gold 
anti-fade reagent. The images were taken with an Axioplan II fluorescence microscope and 
AxioCam MRm camera at 630x magnification and processed by Axiovision 4.7. Confocal 
Images were taken with the Zeiss Meta Confocal microscope at 630x magnification and 
processed by Zen 2011 software (all Zeiss, Oberkochen, Germany). 
Biotin labelling of host surface proteins 
To label host surface proteins, cells were incubated with 1 mg/ml EZ-Link Sulfo-NHS-LC-
LC-Biotin for 20 min on ice. The NHS-activated biotin forms stable amide bonds with 
primary amino groups of proteins and is connected by a non-cleavable spacer arm to the 
charged sulfo group, which provides water solubility and membrane impermeability. Cells 
were then triple washed with ice cold PBS and subsequently infected with T. gondii ME49. 
Streptavidin-Cy3 diluted 1:1000 was used in the staining procedure to detect biotinylated 
proteins. Quenching with 100 mM glycin did not improve the staining and was therefore not 
performed.  
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Transferrin uptake to label endosomes 
Cells were first starved 1 h in FCS-free medium at 37°C, and then medium was exchanged 
with FCS-free medium containing 5 μg/ml Alexa-546 labelled human Transferrin. After 5 
minutes of incubation, cells were fixed with ice cold fixing buffer 20 min at RT in order to 
label early endosomes. For recycling endosomes, the cells were incubated with FCS-free 
medium with diluted transferrin for 10 minutes after starvation and then triple washed with 
ice cold PBS. Thereafter, the full medium was added and the cells were incubated at 37°C for 
30 minutes. Finally, cells were fixed with ice cold fixing buffer followed by triple washing 
with PBS and subjected to the immunofluorescence staining. 
Live cell imaging 
For live cell imaging, 30.000 wt MEFs in a volume of 100 µl were seeded in the channel of 
µ-slide I chambers and the reservoirs were filled with 600 ml of medium. The next day cells 
were at the same time transiently transfected with pEGFP-N3-Irga6-ctag1 (1 µg DNA and 
2 µl Fugen HD) and induced with 200 U/ml IFNγ. After 24 hours cells were infected with 
E. cuniculi spores at an MOI of 50, carefully washed after 2 h and kept in phenol red-free 
RPMI 1640. The samples at 37°C were observed at 630x magnification with a Zeiss Axiovert 
200 M motorized microscope fitted with a wrap-around temperature-controlled chamber 
(Zeiss). The time-lapse images were obtained and processed by Axiovision 4.6 software.  
Cell viability assay 
Viable cells were quantified by the CellTiter 96 AQueous non-radioactive cell proliferation 
assay, that is based on constitutively expressed dehydrogenase enzymes in metabolically 
active cells, which can reduce the membrane-permeable substrate [3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] (MTS). In the 
presence of the electron coupling compound phenazine methosulphate (PMS), the enzymatic 
reduction leads to the formation of coloured formazan. 
To this end, primary MEFs (5000 cells/96-well) were seeded in triplicates and stimulated with 
IFNγ for 24 h or left untreated. The cells were then infected with E. cuniculi spores at the 
indicated MOI for 24 h or 48 h. Infection with T. gondii ME49 served as positive control. The 
medium was carefully removed and the reaction mix of 19 μl MTS, 1 μl PMS and 100 µl 
medium was added to each 96-well followed by incubation at 37°C for 2 h. The absorption at 
495 nm, proportional to formazan compound and thus viable cells, was measured using a 
Paradigm
TM
 Detection Platform. 
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Cell necrosis assay  
performed by Marialice Heider 
MEFs grown in 6cm-dishes were induced with IFNγ for 24 h and infected with E. cuniculi 
spores at an MOI of 10. At 24 h post-infection, Bisbenzimide Hoechst 33342 and Propidium 
iodide were added to the medium (1 µg/ml final concentration for both) and incubated at 37°C 
for 15 min. 10 fluorescent pictures per sample were photographed with the Zeiss Axiovert 200 
M microscope with a 10x magnification. Total cell number (Hoechst-positive nuclei) and 
dead cells (PI-positive nuclei) were automatically enumerated using the Volocity software 
(PerkinElmer, Santa Clara, CA, USA). At least 500 cells were counted per sample and 
percentage of dead cells per total cell number was calculated. In five independent 
experiments, a total of 10.000 cells or more was counted per sample. 
 
2.9 Protein biochemistry methods 
Transformation 
1 ng of the plasmids was mixed with 50 µl E. coli BL21 bacteria cells and kept on ice for 
20 min. A heat shock was performed for 2 minutes at 42°C to induce the uptake of the 
plasmid and chilled 2 min on ice. Subsequently, 400 µl LB media was added and incubated 
for 1 h at 37°C.The cell suspension was transferred in 20 ml LB medium supplemented with 
50 µg/ml Kanamycin or 100 µg/ml Ampicillin and grown as a pre-culture over night at 37°C 
to select plasmid-containing bacteria.  
Protein Expression 
1 l or 2 l antibiotic-supplemented LB medium were inoculated with the pre-culture and grown 
to an OD600nm of 0.8 – 0.9 at 37°C while shaking. Protein expression was induced by addition 
of 0.1 mM isopropyl-β-D-thiogalactoside (IPTG) (100-200 µl of 1 M stock) and let grown at 
18°C overnight. Cells were harvested at 4500 g for 15 min at 4°C. Bacterial cell pellets were 
transferred into 50 ml falcons and frozen at -20°C.  
Bacterial cell disruption 
On ice, bacterial cell pellets were resuspended and vortexed in 10 ml PBS containing 2 mM 
dithiothreitol (DTT), and one tablet complete mini protease inhibitors EDTA free per 1 l 
bacterial culture. The suspension was passed three times through the EmulsiFlex-C5 
microfluidiser at 150 MPa directly on ice. Centrifugation at 50.000 g (JA 25.50 rotor), 4°C for 
60 min was used to separate cell debris and undisrupted bacteria from the soluble protein.  
 M
at
er
ia
ls
 a
n
d
 M
et
h
o
d
s 
44 
 
Protein purification via Glutathion sepharose affinity and Gel filtration 
columns (Irga6, Irgb6, Irgd) 
Glutathione Sepharose (GST) affinity column (size: 5 ml) were pre-equilibrated with 25 ml 
PBS containing 2 mM DTT (PBS/DTT), loaded with the soluble protein fraction and then 
washed with 40 ml PBS/DTT. The GST-tag was cleaved off Irga6 and Irgd with 100 U 
thrombin in 5 ml PBS/DTT o/n at 4°C directly on the column. The IRG protein was then 
eluted from the column with 20 ml PBS/DTT and monomeric IRG protein-containing 
fractions were pooled. For Irgb6, GST-Irgb6 was first eluted from the column with 20 ml 
10 mM Gluthation in PBS/DTT and pooled protein-containing fractions were cleaved with 
approximately 200 U recombinant Tev Protease (provided by Gerrit Praefcke), because Irgb6 
has an internal Thrombin cleavage site. Protein precipitates were removed by 
ultracentrifugation at 45.000 rpm (TLA-22 rotor) for 30 min at 4°C. Soluble protein solutions 
were subjected to size exclusion gel filtration chromatograpy on a HiLoad 26/60 Superdex 75 
(Irga6, Irgb6) or Superdex 200 (Irgd) prep grade column, which were pre-equilibrated with 
600 ml PBS/DTT. 300 ml PBS/DTT ran through the column and the last 200 ml were 
collected in 4 ml fractions. Fractions with monomeric protein were pooled and concentrated 
by a centrifugal concentrator Vivaspin 20, which have a 10 kDa cut-off, at 5000 g at 4°C. 
Aliquots were shock-frozen in liquid nitrogen and stored at -80 °C.  
Protein-containing fractions were identified and analysed by subjecting equal amounts to 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE, see below) and 
staining with Coomassie Blue. To this end, SDS-PAGE gels were incubated for about 10 min 
with Coomassie Staining solution at RT, rinsed with H2O and destained with Coomassie 
Destaining solution for at least 2 h. GST- and GeFi-columns were stored in 20% Ethanol, and 
GST-columns were regularly washed with 6 M GuaHCl.  
 
Determination of protein concentration 
Protein concentrations (c) were determined using an Ultrospec 210 pro with a fixed path 
length (pl) of 1 cm. The absorbance at 280 nm (A280) was measured. The extinction 
coefficient ε280 (M-1 cm-1) for the tested proteins were: Irga6 = 35320, Irgb6 = 40230,        
Irgd= 33150. The dilution factor (df) was variable. The protein concentration can then be 
calculated with the following formula: c = A280 : (E280*pl) * df. 
 M
at
er
ia
ls
 a
n
d
 M
et
h
o
d
s 
45 
 
Cell lysis for protein analysis of post-nuclear supernatants 
Cells were rinsed once with cold PBS and scraped in 1 ml PBS on ice. Cells were sedimented 
by a quick centrifugation step and cell pellets were lysed in cell lysis buffer (app. 100 µl per 
3*10
5
 cells) by strong pipetting trough a yellow tip and incubation for 30 min at 4°C while 
rotating. For immunoprecipitation experiments with MEFs and L929 fibroblasts, 0.5% NP-40, 
140 mM NaCl, 20 mM Tris/HCl (pH 7.6), 2 mM MgCl2 supplemented with Protease Inhibitor 
was used as lysis buffer. For protein analysis of post-nuclear supernatants, MEFs were lysed 
in cell lysis buffer, which contains Triton X-100 as detergent (see above). Cells were 
centrifuged for 30 min at 17.000 g to remove the DNA-containing nuclei. 10% 10x Laemmli 
buffer was added to the post-nuclear supernatants and boiled 5 min at 95°C to denaturate 
proteins. 10 to 25 µl per lane were subjected to SDS-PAGE. 
 
Quick cell lysis for protein analysis of whole cell lysates 
HEK293FT, CMT-93 and MEFs, which were used in E. cuniculi experiments, were rinsed 
once with cold PBS and directly lysed in the 6-well with 200 µl 2x Laemmli buffer. Whole 
cell lysates of were boiled 5 min at 95°C. 15 to 20 µl per lane were subjected to SDS-PAGE. 
500 µl bacterial BL21 cell suspension with transformed with pGEX-Irgm1-long, pGEX-
Irgm1-short, pGEX-Irgm2 or pGEX-Irgm3, was harvested at 5000 g for 15 min at 4°C. 
Pellets were resuspended in 500 µl 2x Laemmli buffer and boiled 5 min at 95°C. 5 to 10 µl 
per lane were subjected to SDS-PAGE.  
 
Immunoprecipitation  
Irgm1 was immunoprecipitated from post-nuclear supernatants of 10
7
 L929 and C57BL/6 
MEFs and incubated with 30 µl rbMAE15 antiserum (3
rd
 bleed) overnight followed by 2 h 
incubation with 150 µl of protein A–Sepharose suspension both at 4°C. Beads were washed 
three times with ice cold lysis buffer without detergent and boiled in 70 µl 2xLaemmli buffer 
for 5 min at 95°C. All immunoprecipitated protein (70 µl) was subjected at once to 8 – 13.5% 
gradient SDS-PAGE  
 
Separation of proteins 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was used to 
separate proteins of protein purifications, cell lysates as well as precipitated protein extracts. 
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A discontinuous gel-system concentrates polypeptides on the intersection of two gel phases 
before they get separated according to their molecular weight in the resolving gel (Laemmli 
1970). Therefore, ¾ of the gel consist of the separating gel, which has 8 - 13.5% acrylamid 
and pH 8.8, and an upper ¼ of the gel consists of the stacking gel, with has 4% acrylamid and 
pH 6.8. Gels were casted in between two glass plates, which are separated by plastic spacers. 
In most of the experiments, a 10% separating gel was used; however for immunoblots with 
the rbMAE15 antiserum, gradient separating gels with a 13.5% (bottom) to 8% (top) gradient 
were mixed with a self-made gradient mixer. Additionally to equal amounts of the protein 
samples PageRuler™ Prestained Protein Ladder was loaded onto gels as a size marker. The 
SDS-PAGE was run in electrophoresis buffer at a current of 6 milliampere (mA) o/n or 
20 mA for several hours for medium gels (15 cm), 1 h at 40 mA for small gels (6 cm) or over 
night at 30 mA for Maxi gels (45 cm).  
 
Transfer and immobilization of proteins (Western Blot)  
For immunodetection the separated proteins were transferred from the polyacrylamide gel 
onto nitrocellulose membrane by wet Western Blotting. Therefore, the gel was carefully 
placed on top of the membrane, sandwiched between eight sheets of Whatman paper and two 
electrodes and placed in a blotting chamber. The chamber was filled with 1x Electrophoresis 
Transfer buffer and 0.5 Volts were applied, so that the negatively charged proteins were 
migrating towards the anode onto the membrane. After 1 h at RT the successful transfer was 
confirmed by unselective staining of proteins on the membrane with Ponceau S solution.  
 
Immunoblot staining 
First the unspecific binding sites on the membrane were blocked with 5% milk powder in 
PBS/T 1 for about 1 h at RT. The primary antibody was diluted according to chapter 2.3 in 
1% FCS in PBS an incubated with the membranes over night at 4°C or 1 h at RT. The next 
day, the membranes were washed three times with washing buffer PBS/T 1 for a minimum of 
10 min and subsequently incubated with HRP-conjugated secondary reagents diluted in 1% 
FCS in PBS according to chapter 2.3. The membranes were washed again three times in 
washing buffer PBS/T 2. Detection buffer 1 and 2 were mixed in a ratio 1:1 and incubated 
with the membranes for 60 s. Membranes were dried, and chemiluminescence was visualised 
by exposure of Super RX films (usually 5 s, 30 s, 1 min to 5 min) and film development. 
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Silver Staining 
Gels from Maxi SDS-PAGE were fixed with 40% ethanol/ 10% acetic acid for 30 min. After 
washing in H2O, the gels were sensitized with 0.2% sodium thiosulfate in 30% ethanol/6.8% 
sodium acetate for 30 min followed by several washes with H2O and incubated in 0.5% silver 
nitrate for 30 min. After several washes with H2O, gels were developed with 0.0185% 
formaldehyde in 2.5% sodium carbonate/0.0024% sodium thiosulfate and the reaction was 
terminated with 0.5% glycin. All steps were performed under gentle agitation. 2-4 bands with 
an approximate size of 40 kDa were immediately cut out and analysed by mass spectrometry 
or stored at 4°C. 
Tryptic in-gel digest and Nano-LC coupled ESI mass spectrometry  
performed by Tobias Lampkemeyer 
After dehydration of minced bands in 100% acetonitrile (ACN), proteins were reduced 2x with 
10 mM DTT in 10 mM NH4HCO3 for 45 min at 56°C and alkylated with 55 mM iodacetamide in 
10 mM NH4HCO3 at RT in the dark. After dehydration in 100% ACN, gel pieces were 
equilibrated with 10 mM NH4HCO3 containing porcine trypsin (12.5 ng /ml) on ice for 2 h. 
Excess trypsin solution was removed and hydrolysis was performed for 4 h at 37°C in 10 mM 
NH4HCO3. Digests were acidified with 5% trifluoroacetic acid (TFA), and peptides were 
extracted with 0.1% TFA followed by extraction with 60% ACN/ 40% H2O/ 0.1% TFA followed 
by a two-step treatment using 100% ACN. Extractions were combined, concentrated by vacuum 
centrifugation, and desalted. 
Peptide and protein identification 
Sequest as implemented in the Proteome Discoverer 1.3 software (Thermo Scientific) was 
used for protein identification by searching the Uniprot database of Mus musculus using 
carbamidomethylation at cysteine and oxidation at methionine and phosphorylation at serine, 
threonine and tyrosine residues as variable modifications. Since the Mascot algorithm 
(version 2.2, Matrix Science) allows to set N-terminal modifications this search engine was 
used with acetylation at the protein N-terminus in addition to the above mentioned 
modifications. Mass tolerance for intact peptide masses was 10 ppm for Orbitrap data and 
0.8 Da for fragment ions detected in the linear trap. Search results were filtered to contain 
only high confident rank 1 peptides (false discovery rate ≤1%) with a mass accuracy of ≤5 
ppm, and a peptide length of ≥6 amino acid residues. In case of Sequest results peptides had 
to match score versus charge state criteria (2.0 for charge state 2, 2.25 for charge state 3 and 
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2.5 for charge state 4), in case of Mascot results the peptide score had to be at least 20 and the 
expectation value ≤ 0.05.  
Liposome preparation and co-sedimentation assay  
Liposomes were prepared from purchased brain polar lipid extracts, termed “Folch lipids” 
after Jordi Folch Pi, who described quantitative extraction of tissue lipids by using a 
chloroform-methanol mixture and a phase partition with water, which removed of water-
soluble contaminants (Folch et al. 1957). 100 µl lipid stock (25 mg/ml) were mixed with 30 µl 
chloroform were dried under argon while rotating the glass vial and additionally put under 
vacuum for at least 2 h to remove residual chloroform. The lipid film in the glass vial what 
then rehydrated with 1ml 1x B1 buffer, sonified first 2 min in a water bath and then with a 
ultra-sonicator (20 pulses, duty cycle 20, output control 2). The lipid suspension was extruded 
7 times through polycarbonate membranes with a pore size of 100 nm. The liposomes were 
stored at -80°C for 4 weeks. For co-sedimentation assays a 50 µl reaction mix with 1 mg/ml 
(20 µl of 2.5 mg/ml stock solution) liposomes, 5 µM recombinant GKS protein and 1 mM 
nucleotide in 1x B1 buffer were incubated for 10 min at 37°C followed by ultracentrifugation 
for 15 min with 100.000 g at 4°C. Supernatants were transferred in new Eppis and the pellet 
was carefully washed once and then resuspended in 50µl B1 1x buffer. 5.5 µl 10x Laemmli 
buffer was added to each sample and they were boiled 5 min at 95°C. 2 µl or 10 µl were 
subjected to SDS-PAGE for immunoblot stainings or Coomassie stainings, respectively.  
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Results 
3. Part 1: Localisation of Irgm1 isoforms 
3.1 Endogenous long and short isoforms of Irgm1 can be detected on 
transcript and protein level 
 The mouse Irgm1 gene is located on chromosome 11 composed of two introns and 
three exons, and two different mRNA transcripts of Irgm1 generated through alternative 
splicing have been described (Bekpen et al. 2005). The mRNA of the long isoform carries the 
initiator codon for the first methionine at the 3’-end of the second exon and translation gives 
rise to a full-length Irgm1 protein of 409 amino acids. In the shorter alternative splice variant 
the second exon is skipped leading to usage of an initiator codon in the third exon. The first 
methionine of the short isoform corresponds to amino acid position 17 of the long isoform 
(Figure 3.1 A). Expressed sequence tags (ESTs) for both splice variants can be found 
abundantly in the NCBI database in different mouse strains (www.ncbi.nlm.nih.gov). 
A BLAST search of the Irgm1 nucleotide sequence against the C57BL/6 mouse genome 
revealed 17 mRNA sequences including the second exon (encoding the long Irgm1 isoform) 
and 41 mRNA sequences without the second exon (encoding the short Irgm1 isoform) 
(Figure 3.1 B and Appendix Table I). Likewise, transcriptome sequencing of interferon-
induced diaphragm-derived cells from C57BL/6 mice showed that transcripts of both splice 
variants are present at the same ratio (unpublished data, Benedikt Müller and Jingtao Lilue). 
Therefore, both splice variants of Irgm1 are generated at the transcript level.  
 To answer the question whether both isoforms are also translated into proteins, 
endogenous Irgm1 was analysed after immunoprecipitation from IFNγ-stimulated L929 
fibroblasts (C3N/An-derived cell line) or C57BL/6 mouse embryonic fibroblasts (MEFs) 
(Figure 3.1 C for L929 cells). Although after IFNγ-induction corresponding bands with an 
approximate size of 40 kDa were hardly visible in the silver stain after separation by 
SDS-PAGE, they were subjected to mass spectrometry (MS) (in collaboration with Tobias 
Lampkemeyer, Proteomics Facility, CECAD Cologne). In these bands, Irgm1 was the most 
abundant protein and could be recovered with a sequence coverage ranging from 43-82%. The 
tryptic digest of Irgm1 predicts the existence of N-terminal peptides that can discriminate long 
(38 aa peptide) and short Irgm1 (24 aa peptide) isoforms. Both isoform-specific N-terminal 
peptides were indeed detected in the MS analysis demonstrating the presence of both 
endogenous Irgm1 isoforms in IFNγ-stimulated fibroblasts (Figure 3.1 D, line 1 to 5). The N-
terminal peptide of the short Irgm1 isoform was found repeatedly and in three different states:  
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Figure 3.1: Endogenous long and short Irgm1 isoforms can be detected on transcript and protein level 
(A) The Irgm1 gene gives rise to a long and short isoform due to alternative splicing of the second exon.           
(B) N-terminal expressed sequence tags (ESTs in grey) spanning two or three exons of Irgm1, retrieved from a 
BLAST search of Mus musculus Irgm1 nucleotide sequence against C57BL/6 mouse genome. Possible model 
mRNA of Irgm1 gene is shown in black, the scale bar shows the region 48.871.600 bp (left) to 48.864.500 bp 
(right) on Chromosome 11 in 100 bp steps. (C) Endogenous Irgm1 from L929 cells was immunoprecipitated 
with the rbMAE15 antiserum, separated by SDS-PAGE and visualised by silver stain. Differential protein bands 
after IFNγ-induction at 40 kDa (arrows 1 to 4) were cut out for tryptic digestion and analysed by nano-LC ESI-
MS/MS. (D) Identified N-terminal peptides specific for long and short Irgm1 isoform as well as the 
posttranslational modifications such as N-terminal acetylation and phosphorylation are listed. The amino acid 
range of the found peptide is according to the sequence of the long Irgm1 isoform. Sequest and Mascot algorithm 
was used for protein identification by searching the Uniprot database of Mus musculus. The MS analysis was 
performed in collaboration with Tobias Lampkemeyer. See complete data set of B and D in Appendix Table I 
and II, respectively 
 
unmodified, N-terminally acetylated, or N-terminally acetylated and phosphorylated 
(Figure 3.1 D, Appendix Table II). In contrast, the N-terminal peptide of the long Irgm1 
isoform was found only once as an acetylated peptide, maybe due to the large size of this 
peptide.  
Since one phosphorylation site of Irgm1 (Ser202) has been already proposed from the analysis 
of phagosomes in IFNγ-stimulated RAW264.7 mouse macrophages (Trost et al. 2009), 
 R
es
u
lt
s 
51 
 
additional phosphorylation sites of Irgm1 were investigated. Phosphorylation of Ser202 was 
not detected in these measurements. Besides the N-terminally acetylated and phosphorylated 
peptides, another phosphorylated peptide was found. PhosphoRS algorithms implemented in 
the Proteome Discoverer software calculated the highest probability for a phosphorylation site 
of this second peptide at Ser78 or Thr71 (see also Appendix Table II). 
3.2 Irgm1 isoforms can be detected with different immunological reagents 
 Since several immunological reagents against Irgm1 protein have been produced up to 
now, a detailed overview including the respective epitopes is shown in figure 3.2 A. The 
mouse monoclonal antibody 1B2 was raised against the peptide CEAAPLLPNMAETHY 
(residues 8-22) near the N-terminus of Irgm1 (Butcher et al. 2005). This peptide crosses the 
differential splice site at residue 17, and only the C-terminal 6 residues (-MAETHY) of the 
immunising peptide are present in the short Irgm1 isoform. The 1B2 antibody is therefore 
expected to have a preference for the long Irgm1 isoform. The first rabbit polyclonal 
antiserum, which is not available anymore, was raised against the immunising peptide 
YNTGSSRLPEVSRSTE (residues 36-50). This epitope is shared by both isoforms (Collazo et 
al. 2001). The second rabbit polyclonal antiserum L115 was raised against a combination of 
two peptides, QTGSSRLPEVSRSTE (residues 36-50) and NESLKNSLGVRDDD (residues 
284-298) of Irgm1 (Khaminets et al. 2010). These two rabbit polyclonal antisera both showed 
an unspecific band at about 50 kDa, perhaps due to cross-reactivity from the shared N-
terminal immunogen peptide [see * in Figure 3.2 C and (Collazo et al. 2001)]. Two goat 
polyclonal antibodies from Santa Cruz Biotechnology, Inc., A19 and P20, were raised against 
peptides from N-terminal regions of Irgm1. Although the exact sequences of the immunising 
peptides are not available, the A19 antibody was described as having been raised and purified 
against a 15-25 aa peptide derived from a region between amino acids 20 and 70 of Irgm1 
(Christian Gernemann, Santa Cruz Biotechnology, Inc., personal communication). Two 
further rabbit polyclonal antibodies from Abcam plc (ab69464 and ab69465) were produced 
by immunisation with a peptide from the human homologue IRGM and were described as 
cross-reactive on mouse IRGM proteins.  
 Because none of these immunological reagents was working satisfactory for both 
isoforms in immunofluorescence microscopy, two new reagents against the N-terminal 
peptide of the short isoform, MAETHYAPLSSAFPC (residues 17-31), were produced in 
rabbit (rbMAE15) and in chicken (chMAE15) for the present study. These antisera should 
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detect the short isoform but may also recognize the long isoform of Irgm1, depending on the 
degree of immunodominance of the free N-terminal methionine.  
 
 
Figure 3.2: Long and short Irgm1 isoforms are detected by various immunological reagents.  
(A) Immunological reagents used for the detection of Irgm1 and their epitopes on the Irgm1 protein. The 
immunising peptides used for the commercial goat polyclonal antibodies A19 and P20 (Santa Cruz 
Biotechnology, Inc.) map near the N-terminus (dashed lines). The immunising peptides of anti-human IRGM 
rabbit polyclonal antibodies (ab69464/5, Abcam plc) map as shown on human IRGM (dotted line). References 
for the immunological reagents are in Material and Methods. (B, C) Transformed mouse embryonic fibroblasts 
(MEFs) from wildtype C57BL/6 mice and Irgm1-deficient mice were treated with IFNγ for 24 h and lysed in 1% 
Triton X-100. Additionally, HEK293FT cells were transiently transfected with pGW1H-Irgm1-long or pGW1H-
Irgm1-short and lysed after 24 h with 2x Laemmli buffer. Proteins were separated by SDS-PAGE and Western 
Blots were probed with different anti-Irgm1 antibodies (1B2, L115, rbMAE15 chMAE15, A19 and P20). 
Calnexin served as loading control for both panels. The asterisk marks an unspecific band; expo. abbreviates 
exposure time. 1B2, A19 and P20 detect only the long Irgm1 isoform whereas L115, rbMAE15 and chMAE15 
detect both isoforms of Irgm1. (D) GST-tagged Irgm1/2/3 were bacterially expressed and whole cell lysates were 
subjected to SDS-PAGE. Western Blots were probed with anti-human IRGM antibodies ab69464 and ab69465 
(Abcam plc). Anti-Irgm1 (L115), anti-Irgm2 (H53) antisera and anti-Irgm2/3 (anti-IGTP) antibody were used to 
discriminate between IRG proteins. Ponceau Red staining indicate equal loading of proteins. Anti-human IRGM 
ab69464 antibody cross-reacts with bacterially expressed mouse GST-Irgm1 and GST-Irgm2, whereas ab69465 
detects GST-Irgm1 and GST-Irgm3. 
 R
es
u
lt
s 
53 
 
 In order to differentially detect the two isoforms of Irgm1, these antibodies were tested 
by Western Blot analysis. As depicted in Figure 3.2 B and C (lane 1-4), all reagents detected 
an IFNγ-inducible, diffuse band running at or just below 40 kDa in lysates of C57BL/6 MEFs, 
which was absent in MEFs from Irgm1-deficient mice. 
 Two distinct protein bands representing the two endogenous Irgm1 isoforms could not 
be detected. The diffuse running behaviour of endogenous Irgm1 in non-gradient SDS-PAGE 
seems to be characteristic, and has been observed also in earlier studies [see (Khaminets et al. 
2010)]. Gradient SDS-PAGE as performed for the immunoblot with rbMAE15 antiserum did 
not markedly improve the resolution of distinct bands (Figure 3.2 C, lane 2). The reason for 
the diffuse running behaviour and low apparent molecular weight of Irgm1 in SDS-PAGE is 
not known, but might partially be explained by post-translational modifications, as suggested 
by the MS analysis (Figure 3.1 D).  
 In order to clarify the isoform specificity of the different immunological reagents, 
transient transfection of eukaryotic expression plasmids encoding the long and short Irgm1 
isoforms with native N- and C-termini into HEK293FT human cells was carried out. 
Expression of both protein isoforms was possible (Figure 3.2 B and C, lane 5-7), although 
expression of the short form always appeared to be weaker. In cell lysates of Irgm1-deficient 
MEFs, however, the transfected short Irgm1 isoform could not be detected in Western Blots 
(data not shown). Microscopic analysis revealed lower transfection efficiency in 
Irgm1-deficient MEFs in case of the short Irgm1 isoform compared to the long Irgm1 isoform 
(data not shown). Thus, lower expression levels might be due to lower number of transfected 
cells with the short isoform in murine cells. 
 In the transfected HEK293FT cells, monoclonal antibody 1B2 detected indeed only 
the long form of Irgm1 but not the short isoform (Figure 3.2 B lane 6, 7), hence validating the 
specificity of 1B2 for the long Irgm1 isoform. Because 1B2 could detect a signal in IFNγ-
induced MEFs (Figure 3.2 B, lane 2), it is now confirmed that the endogenous long isoform of 
Irgm1 is indeed expressed. The rabbit antiserum L115 detected both long and short isoforms, 
as expected from the locations of the immunising peptides (Figure 3.2 C lane 6, 7). However, 
A19 as well as P20 showed a very strong preference for the long Irgm1 isoform (Figure 3.2 B, 
lane 6), suggesting that the immunogenic peptides for these antibodies in fact derived from 
the amino acid sequence N-terminal of the splice junction. The two new antisera, rbMAE15 
and chMAE15, raised against the N-terminal peptide of the short isoform, also detected both 
long and short Irgm1 isoforms (Figure 3.2 C, lane 6, 7). This indicates that the predominant 
epitopes seen by both rabbit and chicken antisera were not defined by the free N-terminus of 
 R
es
u
lt
s 
54 
 
the short form. A conclusion from these results is that there is still no reagent available that is 
specific for the short isoform of Irgm1.  
 The commercial (Abcam plc) rabbit polyclonal antibodies ab69464 and ab69465 
raised against human IRGM were used to detect specifically Irgm1 in a former study (Chang 
et al. 2011). The specificity of these antibodies was again investigated, since they were raised 
against epitopes shared by all three mouse IRGM proteins. Therefore, both isoforms of 
bacterially expressed GST-Irgm1, GST-Irgm2 and GST-Irgm3 were subjected to SDS-PAGE 
and Western Blot analysis (Figure 3.2 D). Anti-human IRGM ab69464 antibody cross-reacted 
with bacterially expressed mouse GST-Irgm1 and GST-Irgm2, whereas ab69465 detected 
GST-Irgm1 and GST-Irgm3. Thus, these reagents cannot be used to identify Irgm1 
unambiguously in mouse cells.  
 
3.3 The short Irgm1 isoform localises to the Golgi apparatus but does not 
colocalise with endolysosomal markers  
 Both Golgi and endolysosomal localisation of Irgm1 have been shown to depend on the 
amphipathic alpha helix K (αK helix) in the C-terminal domain (Martens et al. 2004; Tiwari et 
al. 2009; Zhao et al. 2010), but in these studies the short isoform was not investigated.  
Since none of the immunological reagents detected only the short form of Irgm1 (see chapter 
3.1.2), Irgm1 expression constructs encoding either the long isoform (Irgm1-long) or the short 
isoform (Irgm1-short) were transfected into Irgm1-deficient MEFs. As expected, because of 
the presence of the targeting αK helix in both isoforms, the short and the long Irgm1 isoforms 
showed a typical adnuclear Golgi signal co-localising with GM130 (Figure 3.3 A), and a 
widely distributed non-Golgi component. The localisation of Irgm1 outside the Golgi was 
shown previously to correspond in large parts with a LAMP1 positive organelle, identifying a 
lysosomal or late endosomal compartment [Figure 3.3 B, (Zhao et al. 2010)]. Unexpectedly, 
however, the non-Golgi signal of the transfected short Irgm1 isoform solidly failed to co-
localise with LAMP1 (Figure 3.3 C). Without a C- or N-terminal EGFP-tag Irgm1 is only 
weakly associated with early or recycling endosomes which can be identified by incubation 
with fluorescent transferrin (Zhao et al. 2010). Whereas the long Irgm1 isoform co-localised 
with early endodomes (Figure 3.3 D), the transfected short Irgm1 isoform again failed to do 
so (Figure 3.3 E). Thus, despite the presence of the αK helix in both long and short isoforms, 
the short differential sequence at the N-terminus of the long isoform is required for significant 
targeting of Irgm1 to the endolysosomal system.  
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3.4 Both Irgm1 isoforms partially colocalise with mitochondria 
 Endogenous, IFNγ-induced mouse Irgm1 has been reported to be associated with 
mitochondria in RAW264.7 (Tiwari et al. 2009) and ML-14a  hepatoma cells (Chang et al. 
2011), using A19 and rabbit anti-human IRGM antisera respectively to detect Irgm1, and 
cardiolipin or O-N-nonyl acridine orange and Tom40 respectively as mitochondrial markers. 
However, A19 is a relatively weak reagent in immunofluorescent microscopy, and the rabbit 
anti-human IRGM serum used by Chang and colleagues does not discriminate between Irgm1 
and Irgm2 (see Figure 3.2 C). Therefore, the mitochondrial localisation of mouse Irgm1 in 
 
 
Figure 3.3: Short Irgm1 isoform localises to Golgi, but not to endolysosomal compartment.  
Transformed Irgm1-deficient MEFs were transiently transfected with pGW1H-Irgm1-long or pGW1H-Irgm1-
short and fixed after 24 h. Cells were stained for Irgm1 using rbMAE15 pAS. (A) Golgi marker protein GM130 
was stained with anti-GM130 and (B, C) late endosomal-lysosomal marker protein LAMP1 with 1D4B 
antibodies. In (D, E) cells were incubated with Alexa-Fluor-546-labelled transferrin for 5 min prior fixation to 
stain early endosomes. Nuclei were labelled with DAPI. Both Irgm1 isoforms strongly co-localise with Golgi 
markers, but only the long Irgm1 isoform clearly overlaps with the vesicular structures of endosomes and 
lysosomes. 
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MEFs was examined with the rbMAE15 antiserum. Confocal images show that IFNγ-induced 
Irgm1 as well as transfected long and short isoforms clearly co-localise partially with the 
mitochondrial markers complex II and cytochrome C (Figure 3.4). However, even with this 
powerful antiserum the staining intensity on mitochondria is weak. 
 
 
 To sum up, the long isoform of Irgm1 can be detected with all immunological reagents 
(A19, 1B2, L115, rbMAE15 and chMAE15) and is associated strongly with Golgi, and 
weakly with mitochondrial and lysosomal membranes. In contrast, the short isoform of Irgm1 
is not detected by 1B2 and A19, localises strongly to the Golgi and weakly to mitochondrial 
membranes but does not localise to the endolysosomal compartment.  
 
3.5 Irgm1 does not localise to listerial phagosomes 
 An association of Irgm1 with bacterial phagosomes was first proposed in a 
cell-fractionations protocol in macrophages infected with Mycobacterium tuberculosis 
(MacMicking et al. 2003). Subsequently, striking co-localisation with listerial and 
mycobacterial phagosomes detected by immunofluorescence microscopy was reported for 
Irgm1 in RAW264.7 macrophages shortly after infection (Shenoy et al. 2007; Tiwari et al. 
 
 
Figure 3.4: Endogenous Irgm1 and both transfected Irgm1 isoforms partially colocalise with 
mitochondria.  
(A) MEFs from wildtype C57BL/6 mice were induced with IFNγ for 24 h. (B) Transformed Irgm1-deficient 
MEFs were transiently transfected with pGW1H-Irgm1-long or pGW1H-Irgm1-short for 24 h. The cells were 
fixed and stained for Irgm1 and mitochondrial markers using rbMAE15 pAS and anti-cytochrome C or anti-
complex II antibodies. Nuclei were labelled with DAPI. Images were taken with a confocal microscope. Irgm1 
can weakly be detected at mitochondria.  
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2009). These former studies had some drawbacks, because only A19 was used as the Irgm1 
detection reagent and a control to discriminate between intracellular and extracellular bacteria 
was missing. Therefore the question whether Irgm1co-localises with bacterial phagosomes 
was revisited in the present study with differential staining method (see Materials and 
Methods) and better characterized immunological reagents. The bacterial infections were 
performed in collaboration with Michael Schramm (University Clinic Cologne). 
 
Figure 3.5: Endogenous Irgm1 is not detected at intracellular Listeria monocytogenes.  
(A) MEFs were induced with IFNγ for 24 h, and infected with L. monocytogenes for 15 min. The cells were 
washed, fixed and stained initially without permeabilisation against L. monocytogenes with Alexa Fluor 647-
conjugated secondary antibody. Thereafter, cells were permeabilised (0.1% saponin) and stained for Irgm1 using 
mAB 1B2, pAS rbMAE15 or chMAE15 with Alexa Fluor488-conjugated secondary antibody and for 
L. monocytogenes with Alexa Fluor555-conjugated secondary antibody. Nuclei were labelled with DAPI. 
Transects were drawn through extracellular bacteria (far-red, shown in magenta) and intracellular bacteria (red). 
The profiles show the pixel intensity of the 4 different detection channels within this transect. (B) Quantification 
of (A) as well as for the infection of RAW264.7 macrophages and of later time points post infection. For the 
30 min, 60 min, and 120 min p. i., cells were infected with the L. monocytogenes mutant ∆hly. 300 - 500 host 
cell nuclei were evaluated per sample, n indicates number of replicated samples. No local increase in the Irgm1 
(green) signal is associated with intracellular L. monocytogenes, and no Irgm1-positive intracellular 
L. monocytogenes can be detected in all the samples. 
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Figure 3.6: Endogenous Irgm1 does not localise to the phagolysosome of heat-killed or living 
Listeria monocytogenes.  
(A) RAW264.7 cells were induced with IFNγ for 24 h, and infected with the L. monocytogenes mutant ∆hly for 
2 h. (B) MEFs were induced with IFNγ for 24 h, and treated with heat-killed L. monocytogenes wt for 2 h. The 
cells were washed, fixed and stained for Irgm1 and LAMP1 using pAS rbMAE15 and mAB 1D4B. Nuclei were 
labelled with DAPI. Arrows indicated the magnified area shown below. (C) MEFs were induced with IFNγ for 
24 h, and then 2 µm latex beads were added for 4h. Cells were stained as in B. Images were taken with a 
confocal laser microscope in (A) or a conventional fluorescence microscope in (B, C); scale bars: 10 µm. Irgm1 
is not detected at bacterial phagolysosomes but can be detected at LAMP1-positive latex bead phagosomes. 
 
In Figure 3.5, MEFs were treated with IFNγ, infected with Listeria monocytogenes, and 
analysed for Irgm1 localisation by immunofluorescence with the antibodies 1B2, rbMAE15, 
and chMAE15.Strong Golgi-like staining and weaker cytoplasmic staining with all three anti-
Irgm1 reagents was consistent with positive identification of Irgm1 (Figure 3.5 A, see also 
Figure 3.3). Transects across cells containing intracellular bacteria were quantified for Irgm1 
fluorescence intensity associated with bacteria. By these criteria, co-localisation of Irgm1 was 
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never detected at the phagosome of intracellular wildtype L. monocytogenes. The possibility 
that this result was due to early escape from the phagosome was excluded by applying the 
same techniques to IFNγ-induced cells infected with the listeriolysin O-deficient 
L. monocytogenes (∆hly) which cannot escape from the phagosome (Beauregard et al. 1997). 
After 30 min, 60 min and 120 min of infection in MEFs, no intracellular L. monocytogenes 
∆hly were found to be Irgm1-positive (Figure 3.5 B). The experiment was repeated in 
RAW264.7 macrophages and again no co-localisation of Irgm1 with intracellular bacteria 
could be detected (Figure 3.5 B). 
 The DNA of ingested Listeria in phagolysosomes can be detected with DAPI in 
LAMP1-positive compartments. RAW264.7 macrophages infected with L. monocytogenes 
(∆hly) had ingested Listeria into LAMP1-positive compartments 2 h after infection (Figure 
3.6 A). These bacterium-containing compartments were never found to carry Irgm1 protein. 
Irgm1 was also never seen on LAMP1-positive phagosomes containing heat-killed 
L. monocytogenes (Figure 3.6 B). This is surprising in view of the repeated observation of 
Irgm1 on latex bead phagosomes (Martens et al. 2004; Butcher et al. 2005; Zhao et al. 2010), 
which can also be confirmed for the new rbMAE15 antisera (Figure 3.6 C).  
 
3.7 Irgm1 does not localise to the phagosome of Mycobacterium bovis BCG 
 The effector model attributing Irgm1 function to accelerate maturation of bacterial 
phagosomes is based partly on observations suggesting an association of Irgm1 with M. bovis 
BCG phagosomes in mouse macrophages. In a first report of this association, Irgm1 was 
detected by Western Blot analysis of BCG phagosomes isolated 20 minutes after infection of 
mouse bone marrow-derived macrophages (BMM) in vitro (MacMicking et al. 2003). 
Subsequent publications have illustrated co-localisation of anti-Irgm1 antibodies or 
fluorescent Irgm1 fusion constructs with BCG phagosomes (Deghmane et al. 2007; Shenoy et 
al. 2007; Saban et al. 2008; Tiwari et al. 2009).  
 In view of the contrasting results obtained with new immunological reagents against 
Irgm1 in the context of L. monocytogenes phagosome association (see Figure 3.5 - 3.6), the 
localisation of Irgm1 to the mycobacterial phagosome was examined with similar methods. 
RAW264.7 cells were infected with M. bovis BCG, serologically stained to discriminate 
intracellular and extracellular organisms and stained for Irgm1 using 1B2. Chicken MAE15 
could not be used because it cross-reacted with the surface of extracellular Mycobacteria. 
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Figure 3.7: Endogenous Irgm1 is not detected at intracellular Mycobacterium bovis BCG.  
RAW264.7 cells were induced with IFNγ (B, C) for 24 h or left untreated (A), and infected with M. bovis BCG 
for 1 h (A, B) or 4 h (C). The cells were washed, fixed, and stained initially without permeabilisation against 
Mycobacteria with Alexa Fluor647-conjugated secondary antibody. Thereafter, cells were permeabilised (0.1% 
saponin) and stained for Irgm1 using mAB 1B2 with Alexa Fluor488-conjugated secondary antibody, and 
against Mycobacteria with Alexa Fluor555-conjugated secondary antibody. Nuclei were labelled with DAPI. 
Transects were drawn through extracellular bacteria (in far-red, shown in magenta) and intracellular bacteria 
(red). The profiles show the pixel intensity of the different channels within this transect. No Irgm1 (green) signal 
is associated with intracellular Mycobacteria. 
 
 In contrast to published findings, Irgm1 detected by the monoclonal 1B2 antibody was 
absent at the mycobacterial phagosome at any time point analysed (from 15 min until 4h p. i., 
Figure 3.7). Rabbit MAE15 antiserum could not be used in combination with the rabbit anti-
Mycobacterium antibody used to define intracellular organisms. As a second method 
macrophages were infected with TRITC-labelled M. bovis BCG instead. In order to validate 
bacterial ingestion, intracellular bacteria were visualised via co-staining with LAMP1. No 
Irgm1 was detected at bacterial phagolysosomes from 1 h to 4 h post infection in RAW264.7 
macrophages (Figure 3.8 A and B) or BMMs (Figure 3.8 C, D).  
 Summarising the first part of the results, it has been unambiguously demonstrated that 
both Irgm1 isoforms are expressed in mouse fibroblasts upon IFNγ-induction and 
differentially  
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Figure 3.8: Endogenous Irgm1 does not localise to the phagolysosome of Mycobacterium bovis BCG.  
(A, B) RAW264.7 cells or bone marrow-derived macrophages from (C) wildtype C57BL/6 mice or (D) Irgm1-
deficient mice were treated with IFNγ for 24 h, and infected with TRITC-labelled M. bovis BCG for 1 h (A, C, 
D) or 4 h (B). The cells were washed, fixed and stained with Irgm1 and LAMP1 using pAS rbMAE15 and mAB 
1D4B. Nuclei were labelled with DAPI. Transects were drawn through bacteria (in red) and LAMP1 (in far-red, 
shown in magenta) to demonstrate their residence in the phagolysosome, profiles show the pixel intensity of the 
different channels within this transect. No Irgm1 signal (green) is associated with the mycobacterial phagosomes 
 
localise to subcellular endomembranes (both isoforms to the Golgi and partially to 
mitochondria but only the long isoform to the endolysosomal compartment).Moreover, in 
striking contrast to earlier studies, Irgm1 could never be detected at listerial or mycobacterial 
phagosomes.   
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Results Part 2: IRG binding to protein-deficient membranes 
3.8 GKS proteins can co-sediment with liposomes in a GTP-dependent manner 
 Extensive microscopical analysis demonstrated binding of GKS proteins to subcellular 
membranes of ER or to parasitophorous vacuoles (PV) (see chapter 1.3.5). However, the 
biochemical features of this membrane-binding are only poorly understood. Initial co-
sedimentation experiments with phosphatidylserine or Folch liposomes suggested that Irga6 
and Irgb6 but not Irgd can bind to these lipid vesicles in a GTP-dependent manner [(Martens 
et al. 2004) and Niko Pawlowski unpublished data].  
 
Figure 3.9: GKS proteins can co-sediment with Folch liposomes in the presence of GTP.  
Recombinant untagged Irga6, Irgb6 or Irgd protein was incubated with Folch liposomes in the 
presence of GDP or GTP for 10 min at 37°C followed by ultracentrifugation. Proteins of the 
pellet (P) or supernatant (SN) fraction were separated by SDS-PAGE and stained with 
Coomassie Blue in (A). In (B-D) equimolar amounts of two GKS proteins were mixed for the 
co-sedimentation assay and detected in Western Blots with specific antibodies (mAB10E7 for 
Irga6, mAB B34 for Irgb6 and pAS 2078 for Irgd). Irga6 and Irgb6 always bind liposomes in 
presence of GTP (white arrows), whereas Irgd co-sediments only in presence of Irgb6 and 
GTP (grey arrow). 
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In order to define the intrinsic membrane-binding capacities of these IRG proteins, co-
sedimentation assays of bacterially-expressed Irga6, Irgb6 and Irgd with Folch liposomes 
were performed. Figure 3.9 shows that Irga6 as well as Irgb6 could directly associate and co-
sediment with liposomes in presence of GTP. In contrast, Irgd alone was not able to co-
sediment with the liposomes at the same concentration (5 µM) or at even higher 
concentrations (20 µM) confirming previous results (Figure 3.9 A). To examine whether GKS 
proteins can influence each other in membrane-binding, two recombinant proteins were mixed 
in equimolar amounts and the same co-sedimentation assays were performed. In these mixed 
preparations, Irga6 and Irgb6 associated with liposomes similar to the individual preparations 
(Figure 3.9 B). Interestingly, Irgd could co-sediment with liposomes in presence of GTP when 
it was mixed with Irgb6, but not when it was mixed with Irga6 (Figure 3.9 C, D).  
3.9 Host cell plasma membrane proteins do not negatively correlate with GKS 
proteins loading on the PVM of Toxoplasma gondii 
 IRG proteins accumulate onto the parasitophorous vacuolar membrane (PVM) of 
avirulent T. gondii, but never onto all PVMs. Furthermore, there is always large variation of 
labelling intensity of individual vacuoles independent of a synchronous parasite entry 
(Khaminets et al. 2010). In the current model, IRG proteins target those PVs of T. gondii that 
efficiently excluded most of the host cell surface proteins during parasite invasion and 
formation of the nascent PVM (Mordue et al. 1999). This hypothesis argues that the exclusion 
of host cell plasma membrane proteins is sometimes inefficient and remaining host cell 
plasma membrane proteins can inhibit IRG loading onto the PVM. These 10-20% of IRG-
negative PVs would carry remaining host cell surface proteins. As a consequence, one would 
expect a negative correlation of IRG proteins and host cell proteins at the PVM.  
 To test this hypothesis, plasma membrane proteins of MEFs were unspecifically 
labelled with Biotin prior infection with the avirulent Toxoplasma strain ME49. After 30 
minutes of infection, cells were fixed and stained for GKS proteins Irga6 and Irgb6 as well as 
the parasite-derived GRA7 protein as marker for the PVM. Furthermore, biotinylated proteins 
were stained with fluorophore-conjugated Streptavidin (Figure 3.10). Independent of 
infection, the host cell surface of the very thin fibroblasts was mostly smoothly stained by 
Streptavidin-Cy3 but sometimes had an intensive spotted staining in the centre in the cell (see 
Figure 3.10 A, merged image, next to the blue nucleus). Therefore, those intracellular PVs 
were chosen for analysis that were in an area of smooth host surface staining. 
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Figure 3.10: Biotinylated host cell plasma membrane proteins do not negatively correlate with GKS 
protein loading at the Toxoplasma gondii parasitophorous vacuolar membrane. (see next page) 
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(continued Figure 3.10) MEFs were induced with IFNγ for 24 h, and the host cell surface was labelled with 
Sulfo-NHS-LC-LC-Biotin for 20 min followed by infection with T. gondii ME49 for 30 min. The cells were 
washed, fixed, and stained for Irga6 (165/3 pAS) or Irgb6 (142/1 pAS) with Alexa Fluor488-conjugated 
secondary antibody (green), for biotinylated proteins with Cy3-conjugated Streptavidin (red) and for GRA7 (JH 
3.1.2 mAB) with Alexa Fluor647-conjugated secondary antibody (far-red, shown in magenta). Nuclei were 
labelled with DAPI. (A, B) Images were taken with a conventional fluorescence microscope and merged images 
as well as magnified areas indicated by the white box in their single channels (1 phase contrast, 2 GRA7, 3 
Irga6/Irgb6, 4 Biotin) are shown. (C) Positive or negative staining of Irgb6 and biotinylated host proteins at the 
PVM of T. gondii was evaluated from pictures as shown in B. Mean +/- SD of four individual experiments is 
shown, a total of 313 vacuoles was counted. In (D) images taken with a confocal laser microscope are shown. (E, 
F) Scattered Plot of fluorescence intensities of Irgb6 vs. fluorescence intensities of biotinylated host proteins per 
single PVM and a linear regression curve are shown in arbitrary units (AU). (E) Vacuoles of 42 fluorescence 
images were measured with the Axiovision software by averaging four data points, which were manually set on 
the PVM and background staining was subtracted. (F) Vacuoles of 35 confocal images were automatically 
evaluated with the Volocity software, which measured the entire fluorescent intensity of Irga6 or Biotin on 
GRA7-positive selected areas. Intensities of Biotin-labelled host cell proteins do not negatively correlate with 
Irga6 or Irgb6 intensities at the PVM of T. gondii. 
 
A weak Biotin staining could be found at some IRG/GRA7-positive PVs (Figure 3.10 A and 
B right PVs) but most PVs were Biotin-negative (Figure 3.10 A and B left PVs). 
Quantification of four experiments revealed that almost 70% of the PVs were Irgb6-
positive/Biotin-negative, but Irgb6-negative/Biotin-positive vacuoles represented the smallest 
fraction (2.9%) (Figure 3.10 C). However, the intensity of Biotin-labelling was always very 
difficult to determine due to the host surface labelling. Nevertheless, some PVs strongly 
stained for Irgb6 were still Biotin-positive (as seen in Figure 3.10 A, the right PV). Thus, 
there was no negative correlation of IRG and Biotin staining (Figure 3.10 E). To exclude that 
the Biotin-labelling at the PVM in Epi-fluorescence microscopy was due to the superimposed 
host plasma membrane, which folds around the PV, the samples were also analysed using 
confocal laser microscopy. Here, the Biotin-labelling was more spotted, but again no 
correlation of IRG loading and Biotin staining at the PV was observed (Figure 3.10 D, F). 
Under these staining conditions applied here, no negative correlation of the presence of host 
cell surface proteins versus IRG proteins could be seen.  
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3.10 Inc-induced membrane compartments are not targeted by GKS proteins 
 The Chlamydia type III effector inclusion (Inc) proteins relocalise to the inclusion 
membrane in order to orchestrate several host-parasite interactions (Dehoux et al. 2011). 
Interestingly, it has been shown recently that artificial overexpression of individual Inc 
proteins in HeLa cells induces de novo formation of membranous vesicular compartments, 
that do not carry any host organelle markers and are also non-fusogenic (Mital et al. 2013). 
Because the absence of all host cell organelle markers is also a common characteristics for 
PVs (see 1.6), it was tested whether IRG proteins might also target these intracellular artificial 
Inc-induced vesicles. To this end, fluorescently-tagged Inc proteins (either cherry-tagged IncB 
or GFP-tagged CT229) were transiently expressed in wt MEFs that were induced with IFNγ 
or left uninduced. After 24 h, cells were fixed and stained for the GKS proteins Irga6 or Irgb6. 
In Figure 3.11 it is shown that independent of IFNγ, transfected IncB formed big specks 
compared to CT229, which formed smaller specks resembling the published membranous 
vesicles that form upon overexpression of Incs in HeLa cells (Mital et al. 2013). Moreover, 
Irga6 and Irgb6 showed their typical cytosolic distribution upon IFNγ-induction. However, 
Irga6 and Irgb6 clearly did not co-localise with Inc proteins or accumulate near these vesicles. 
Thus, GKS proteins did not target these artificially Inc-induced vesicles of unknown origin. 
Summarising the second part of the results, it has been shown that certain GKS proteins, Irga6 
and Irgb6 but not Irgd, had an intrinsic property to bind liposomes in a GTP-dependent 
manner. Irgd could only co-sediment with the liposomes in presence of Irgb6 suggesting 
formation of heterodimers. Characterisation of IRG-positive T. gondii PVMs revealed no 
negative correlation with residual host cell plasma membranes, which are mainly excluded 
during parasite entry. A non-fusogenic character of a vacuole was also not sufficient for IRG 
recognition, since Inc protein-induced membranous vesicle compartments were not targeted 
by IRG proteins. 
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Figure 3.11: GKS proteins do not localise to Chlamydia Inc protein–induced membrane compartments  
Wildtype MEFs were transiently transfected with pmCherry-IncB (A-C) or pGFP-TOPO-CT229 (D-F). 
Simultaneously cells were stimulated with IFNγ for 24 h (B, C, E, F) or left untreated (A, D). Fixed cells were 
stained for Irga6 (165/3 pAS) or Irgb6 (142/1 pAS). Nuclei were labelled with DAPI. White boxes indicate the 
magnified area shown below each panel; scale bar: 10µm. Irga6 or Irgb6 smoothly distribute in the cytosol and 
do not accumulate on the Inc-protein-induced vesicles. 
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Results Part 3: Encephalitozoon cuniculi as novel IRG target 
3. 11 IFNγ restricts E. cuniculi growth in primary mouse fibroblasts  
 The first evidence about microsporidial growth restriction induced by IFN was 
provided by in vitro studies in 1995 (Didier 1995) using E. cuniculi infection of murine 
peritoneal macrophages. Subsequent studies confirmed the suppressive effect of IFNγ on 
E. cuniculi as well as on E. intestinalis using murine peritoneal macrophages (Khan et al. 
1999; Jelinek et al. 2007), murine enterocyte cell line CMT-93 and human enterocyte cell line 
Caco-2 (Choudhry et al. 2009) as well as primary human monocyte-derived macrophages 
(Fischer et al. 2008). Furthermore, IFNγ-deficient mice were shown to be highly susceptible 
to E. cuniculi and E. intestinalis infection (Khan et al. 1999; El Fakhry et al. 2001; El Fakhry 
et al. 2001; Salat et al. 2004).  
 Because it is characteristic of the IRG resistance system to also be effective in non-
myeloid cells, IFNγ-dependent resistance during E. cuniculi infection was tested in 
fibroblasts. Uninduced and IFNγ-induced MEFs were infected with E. cuniculi spores and the 
replication of the parasite followed by immunofluorescence microscopy and by Western Blot 
analysis. The meront as earliest infectious stages of E. cuniculi was detected with a mouse 
monoclonal antibody (mAB 6G2) directed against a cytoplasmic protein of the meronts. The 
spore was detected with a polyclonal antiserum against a spore wall protein 1 (pAS anti-
SWP1), which is synthesized later in infection (Fasshauer et al. 2005). 
 A time series from 30 min to 24 h post infection showed that IFNγ-mediated inhibition 
on E. cuniculi growth in MEFs increased significantly over time (determined by 
immunofluorescent microscopic counting of 6G2-positive meronts per host nuclei). At early 
time points (30 min to 2 h p. i.) the number of intracellular parasites was only slightly higher 
in uninduced than in IFNγ-induced host cells, showing that E. cuniculi invasion into the host 
cells was not affected by prior IFNγ treatment (Figure 3.12 A). Next, not only single meronts 
but also meronts, which replicated by binary fission (double meronts), were quantified and 
compared between uninduced and IFNγ-induced MEFs. Multiplication of meronts was largely 
inhibited in IFNγ-induced cells 24 h post infection (Figure 3.12 B). 
 In addition, Western Blot analysis of whole cell lysates from infected MEFs showed 
that meront development as well as the formation of new spores was blocked by IFNγ. In 
uninduced MEFs, E. cuniculi dependent protein bands were detected with the meront-specific 
antibody 6G2, indicative of replication; and with the spore-specific antiserum SWP1, 
indicative of maturation, at 2 days post infection. 
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Figure 3.12: IFNγ restricts Encephalitozoon cuniculi growth in mouse embryonic fibroblasts.  
(A) Primary wt MEFs were induced with IFNγ for 24 h or left uninduced and infected with E. cuniculi spores. 
Cells were fixed after the indicated time post infection and the number of meronts (stained with anti-meront 
antibody 6G2) per 500 host nuclei (stained with DAPI) was counted. The inhibition in the IFNγ-treated samples 
compared to the uninduced control samples (mean +/- SD) of 3-7 technical replicates per timepoint from at least 
2 individual experiments is presented. Significant differences (0.5 h, 1 h and 2-3 h compared to 24-26 h) were 
calculated with a two tailed T-test. (B) MEFs were induced with IFNγ or left uninduced, infected with 
E. cuniculi spores for 24 h and stained as in A. Meronts that divided once (double meront) as well as single 
meronts per 500 host nuclei were counted. Percent of total vacuoles are shown, uninduced controls were set as 
100% per independent experiment. Numbers in the x-axis indicate the counted number of single / double 
meronts per 500 host cells. (C) IFNγ-stimulated or unstimulated MEFs were infected with E. cuniculi spores for 
2 or 5 days or left untreated. Whole cell lysates were separated by SDS-PAGE and Western Blots were stained 
using anti-meront antibody 6G2 as well as anti-spore wall protein 1 antibody SWP1. Calnexin staining served as 
loading control and Irgb6 staining (B34) as IFNγ-induction control. The asterisk marks an unknown E. cuniculi-
derived protein, which is detected by calnexin antibody. IFNγ-treated samples show less E. cuniculi growth and 
development. These Western Blots emerged from one single SDS-PAGE. The 45-70 kDa region was first probed 
with mouse mAB B34, stripped, and then probed for rabbit pAS anti-SWP1. 
 
 
The intensity of these bands further increased at 5 days post infection. In contrast, these bands 
could not be detected in E. cuniculi-infected IFNγ-induced cells, either after 2 days or after 5 
days (Figure 3.12 C). Taken together, IFNγ inhibits meront replication and spore formation of 
E. cuniculi cell-autonomously in primary mouse fibroblasts.  
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3.12 IRG proteins accumulate on the E. cuniculi PVM 
 When T. gondii infects IFNγ-induced mouse fibroblasts, mainly the effector IRG 
proteins accumulate on the PVM leading to the disruption of the vacuole (Martens et al. 2005; 
Ling et al. 2006; Melzer et al. 2008; Zhao et al. 2009). To examine whether similar IRG-
related phenomena might also apply to the microsporidian vacuole, IFNγ-induced MEFs were 
infected with E. cuniculi. The samples were co-stained for intracellular meronts and with 
immunological reagents against individual GKS effector proteins (Irga6, Irgb6, Irgd) as well 
as against the GMS regulator proteins (Irgm1 and Irgm2) 24 hours post infection (Figure 
3.13). Some meronts were indeed coated with IRG proteins, but the majority of meronts was 
IRG-negative. Both Irga6-coated and uncoated vacuoles could be found together in multiple 
infected host cells as shown for 2 h post infection in panel A of Figure 3.13. In the first hours 
after infection, E. cuniculi meronts were very small and hardly visible. Therefore, 24 h post 
infection was chosen as a time point, in which single meronts, which have acquired more 
material and are therefore bigger, or double meronts could be detected. After 24 h of infection 
replicated meronts were found to be coated with Irga6 or Irgb6 protein (Figure 3.13 B, C). 
Activated GTP-bound Irga6, specifically detected with the mAB 10D7, could also be detected 
at the E. cuniculi PVM (Marialice Heider, personal communication). Irgd and Irgm2 were 
found at lower but consistent frequencies below 5 % (Figure 3.13 D, E), whereas Irgm1 was 
never found to accumulate as a clear ring around the E. cuniculi PVM (Figure 3.13 F). 
 The number of Irga6- and Irgb6-positive vacuoles at different time points post 
infection was examined in more detail (Figure 3.13 G). The frequency of GKS-positive 
vacuoles varies between experiments (1-20%), but did not significantly increase or decrease 
from 0.5 - 24 h post infection (Figure 3.13 G).  
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Figure 3.13: IRG proteins accumulate at the E. cuniculi PVM.                   
MEFs were induced with IFNγ for 24 h and then infected with E. cuniculi spores for 2 h in (A) or 24 h in (B-F). 
Fixed cells were stained with anti-meront mAB 6G2 as well as for endogenous (A, B) Irga6 (165/3 pAS), (C) 
Irgb6 (A20 pAB), (D) Irgd (2078 pAS), (E) Irgm2 (H53 pAS), or (F) Irgm1 (rbMAE15 pAS). Nuclei were 
labelled with DAPI. The magnified area at the end of each panel (in the order upper left: merged image, upper 
right: phase contrast, lower left: anti-meront, lower right anti-IRG) is indicated by yellow arrows for IRG-
positive PVM (A-F) or a white arrow for IRG-negative PVM; scale bars: 10 µm. (G) Quantification of Irga6 and 
Irgb6 loading onto the E. cuniculi PVM at different time points post-infection. 100 vacuoles were evaluated per 
sample; a black dot indicates that the sample was not counted. Three independent experiments are shown. With 
the exception of Irgm1, IRG proteins relocalise to some vacuoles of E. cuniculi. 
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Accumulation of Irga6 or Irgb6 to vacuoles of E. cuniculi could thus consistently be found at 
every time point post infection, but it was not robust and invariable in terms of quantification 
and timing.  
 
3.13 IRG proteins load onto the E. cuniculi PVM in a cooperative manner 
 A detailed view of IRG protein loading onto the T. gondii PVM has been established, 
demonstrating cooperative behaviour of GKS proteins as well as a hierarchical order in which 
IRG proteins accumulate at the PVM (Khaminets et al. 2010). In order to investigate the 
cooperative behaviour of IRG proteins, triple immunofluorescent stainings to identify the 
meront and two GKS proteins, Irga6 and Irgb6, were conducted. Individual vacuoles 
accumulating both IRG proteins were found at early and late time points. Representative 
images of a double-loaded single meront at 12  h post infection (Figure 3.14 A) as well as 
double-loaded replicating meronts at 24 h post infection (Figure 3.14 B, C) are shown. In 
many cases, Irga6 and Irgb6 co-localised (Figure 3.14 B), but not always entirely coincide on 
the PVM (Figure 3 C). Moreover, as observed in Figure 3.13 A, not all vacuoles within one 
host cell were positive for IRG proteins (Figure 3. 14 C). Notably, the number of E. cuniculi 
vacuoles accumulating both IRG proteins was higher than single-coated ones (Figure 3D). In 
view of the low frequencies of accumulation of individual IRG proteins, it is clear that the 
frequency of double-loaded vacuoles is highly non-random, suggesting cooperative 
behaviour, as seen on the T. gondii PVM.  
 In previous studies, live-cell video microscopy with transfected GFP-tagged Irga6 or 
Irgb6 impressively demonstrated how GKS proteins accumulated on T. gondii PVs in a time-
dependent manner followed by disruption of the PVM (Zhao et al. 2009; Khaminets et al. 
2010). Unfortunately, it was impossible to properly identify E. cuniculi meronts in phase 
contrast images. Moreover, infection with fluorescently-labelled E. cuniculi internal lipids 
was only partially successful due to low infection rates of labelled spores (Ronnebaumer et al. 
2008). In the end, live-cell imaging performed for this study could not be established to a 
sufficient level that would allow to investigate the timing of IRG protein accumulation on 
E. cuniculi PVs.  
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Figure 3.14: IRG proteins load onto PVM of E. cuniculi in a cooperative manner.  
MEFs were induced with IFNγ for 24 h and then infected with E. cuniculi spores for 12 h (A) or 24 h (B, C). 
Fixed cells were stained with anti-meront mAB 6G2 in red as well as for endogenous Irga6 (165/3 pAS, green) 
and Irgb6 (A20 pAB, far-red, shown in magenta). Nuclei were labelled with DAPI. White boxes indicate 
enlarged area shown below; scale bar: 10 µm. (D) Quantification of cooperative loading after 24 h; Irgb6-single, 
Irga6-single or Irgb6/Irga6-double (both) positive meronts are shown as % of total 6G2-positive meronts; 100 
vacuoles were counted in each independent experiment. Most IRG-positive PVs were positive for both Irga6 and 
Irgb6.  
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3.14 IFNγ-mediated suppressive effect on E. cuniculi growth is diminished in 
GMS-deficient cells  
 (in collaboration with Marialice Heider) 
 To assess the importance of IRG proteins in the IFNγ-dependent restriction of 
E. cuniculi, growth and development of the parasite were analysed in cells derived from IRG 
knock-out mice. Firstly, E. cuniculi infection in IFNγ-induced primary MEFs derived from 
wildtype (wt) and Irgm1/Irgm3
-/-
 mice was examined. The Irgm1/Irgm3
-/-
 mice do not only 
lack the two regulator GMS proteins, but also express reduced levels of GKS proteins, and are 
exquisitely susceptible to infection with avirulent T. gondii (Henry et al. 2009). Moreover, 
Irgm1/Irgm3
-/-
 MEFs show no IFNγ-inducible resistance to T. gondii (Steffi Koenen-
Waisman, unpublished data). Infection of these cells with E. cuniculi revealed the same 
phenotype as seen for T. gondii. As described in Figure 3.12, the number of meronts in IFNγ-
induced wildtype cells was drastically reduced at 24 h post infection compared with 
uninduced controls (Figure 3.15 A, B). In contrast, the number of meronts observed in 
Irgm1/Irgm3
-/-
 MEFs 24 h post infection was the same whether the cells were induced with 
IFNγ or not.  
 Next, IFNγ-inducible resistance to E. cuniculi was assayed in transformed fibroblasts 
from mice deficient in single IRG genes as well as from double knock-out Irgm1/Irgm3
-/-
mice. In Western Blot analysis parasite growth was assessed with the anti-meront antibody, 
whereas the expression of Irgb6 (or Irga6) confirmed successful IFNγ-induction (Figure 3.15 
C, D). In wildtype cells, IFNγ-induction resulted in complete loss of the 6G2 marker at 2 days 
and 5 days post infection, while in Irgm1/Irgm3
-/- 
double knock-out cells IFNγ-induction did 
not affect the meront growth. Single GKS knock-outs, either Irga6 or Irgd, showed no loss of 
resistance relative to wildtype cells. However, cells lacking one GMS proteins, Irgm1 and 
Irgm3, both showed a clear susceptibility phenotype relative to wildtype cells. The 
susceptibility of the Irgm1-deficient cells was incomplete, while that of the Irgm3-deficient 
cells was similar to Irgm1/Irgm3
-/- 
double-deficient cells.  
 R
es
u
lt
s 
75 
 
 
Figure 3.15: IFNγ suppressive effect on E. cuniculi growth is impaired in GMS-IRG knock-out cells.  
(A) Wildtype or Irgm1/Irgm3
-/-
 knock-out (KO) MEFs were induced with IFNγ for 24 h and then infected with 
E. cuniculi spores for 24 h or left untreated. The cells were fixed and stained for meronts using 6G2 mAB (red) 
and host nuclei with DAPI (pseudocolored in cyan). Representative fluorescence microscopic images are shown. 
(B) Quantification of A. (C, D) Transformed wt or transformed IRG KO MEFs were induced with IFNγ for 24 h 
and then infected with E. cuniculi spores or left untreated. Cells were harvested after 2 and 5 days p. i. and whole 
cell lysates were separated by SDS-PAGE. Western Blots were probed with anti-meront mAB 6G2, anti-
calnexin pAB, which served as loading control and anti-Irgb6 (mAB B34) or anti-Irga6 (mAB 10E7 for MEF 
Irgm1KO and MEF Irgm3KO both at 5 days p. i.; 165/3 pAS for MEF Irgm1/Irgm3KO at 5 days p. i.) as IFNγ-
induction control. The black arrows highlight a 6G2-positive protein band indicating E. cuniculi growth despite 
presence of IFNγ, which is normally impaired (grew arrows). The asterisk marks an unknown E. cuniculi-
derived protein that is detected by the calnexin antibody. The white asterisks mark unspecific bands. 
Experiments in A and B were performed by Marialice Heider. Irgm1/Irgm3
-/-
 and Irgm3
-/- 
as well as partially 
Irgm1
 -/-
 MEFs cannot control E. cuniculi growth upon IFNγ-stimulation. 
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3.15 E. cuniculi infection triggers IFNγ-dependent host cell death  
 (in collaboration with Marialice Heider) 
 Another defining characteristic of the IRG resistance system is the disruption of the 
IRG protein-coated T. gondii PVM, followed by necrosis-like host cell death of the 
IFNγ-induced host cell (Martens et al. 2005; Melzer et al. 2008; Zhao et al. 2009; Zhao et al. 
2009). It was therefore of interest to find out whether this endpoint of IRG protein action 
could also be observed in IFNγ-induced mouse cells infected with E. cuniculi. To this end, 
two different methods measuring either cell death or cell viability were applied on primary 
cells.  
 Firstly, IFNγ-induced and E. cuniculi-infected wt MEFs were stained and analysed 
under live-cell conditions with the membrane-impermeable dye Propidium iodide, which 
stains necrotic cells, and with the membrane–permeable dye Hoechst 33342, which stains all 
nuclei. In Figure 3.16 A, microscopic images show more Propidium iodide (PI)-positive 
nuclei in E. cuniculi-infected and IFNγ-treated MEFs in comparison with IFNγ only or 
E. cuniculi only treated cells. PI-positive cells also often appeard as contracted round cells in 
phase contrast images. Automatic quantification of these photographs revealed that treatment 
with both IFNγ and E. cuniculi results in a significant excess of membrane-permeable cells 
compared to untreated or single-treated control samples (Figure 3.16 B).  
 Secondly, a colorimetric proliferation assay was used to measure viability of wt MEFs 
with increasing multiplicity of infection with E. cuniculi spores. One day post infection, 
viability of infected cells was significantly reduced in dependence of IFNγ and this was even 
more pronounced after 2 days post infection (Figure 3.16 C). Thus, E. cuniculi infection 
seems to lead to the same consequences for the host cell in presence of IFNγ as infection with 
T. gondii, namely the death of the host cell itself. However, by which molecules this host cell 
death is triggered and executed remains to be elucidated. 
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Figure 3.16: E. cuniculi infection triggers IFNγ-dependent host cell death.  
(A, B) Wildtype MEFs were induced with IFNγ for 24 h and then infected with E. cuniculi spores for 24 h or left 
untreated. Without fixation, cells were stained with Propidium iodide and Hoechst dye, photographed under live-
cell conditions, and automatically enumerated with Volocity software. 10.000 cells per sample were counted in 
five independent experiments together, graph represents mean values of all experiments +/- SD; scale bar in A: 
200 µm. (C) Wt MEFs were seeded in 96-wells and induced with IFNγ for 24 h (black bars) or left untreated 
(white bars). Cells were infected with E. cuniculi spores at MOI=5-20 or with T. gondii ME49 tachyzoites 
(MOI=5) as positive control. Cell viability was assed 24 h or 48 h post-infection with a colorimetric assay and 
expressed as percentages of uninduced uninfected control cells. Graph represents mean value +/-SD of triplicates 
of one representative experiment. Significance in B and C was calculated with two-tailed T-Test: ** p > 0.005, 
*** p > 0.0005. Experiments in A and B were performed by Marialice Heider. IFNγ-stimulated MEFs infected 
with E. cuniculi show increased cell death as well as decreased cell viability 
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3.16 IDO is not responsible in IFNγ-mediated E. cuniculi restriction 
 Restricting nutrient acquisition is a common defence mechanism against intracellular 
parasites. One example is deprivation of tryptophan by the interferon-inducible indoleamine 
2, 3-dioxygenase (IDO), which is widely believed to be the main inhibitor of T. gondii 
replication in IFNγ-induced human fibroblasts (reviewed in (Konen-Waisman et al. 2007, 
MacMicking, 2012). It is based on early reports that replication can be rescued by 
supplementation of the medium with tryptophan (Pfefferkorn 1984; Daubener et al. 2001). In 
2009, a study by Choudhry and colleagues suggested IDO-mediated growth restriction of 
E. intestinalis in mouse enterocytic cell line CMT-93 (Choudhry et al. 2009). However, 
another study using E. cuniculi infection of activated mouse peritoneal macrophages showed 
that L-tryptophan supplementation failed to rescue the infection (Didier et al. 2010).  
 In view of these apparently inconsistent results, E. cuniculi growth in IFNγ-induced 
mouse cells was analysed by Western Blot analysis of whole cell lysates. Tryptophan 
supplementation would substitute the tryptophan, which has been degraded by the IDO and 
allow growth of an IDO-restricted parasite. In wildtype MEFs as well as in CMT-93 cells, 
IFNγ-mediated growth restriction on E. cuniculi could not be reversed by supplementation 
with increasing doses of excess tryptophan (Figure 3.17 A, B). Therefore, E. cuniculi is not 
restricted by the IFNγ-inducible IDO in fibroblasts. Taken together, with the complete loss of 
resistance caused by IRG protein deficiencies, it can be concluded that the IFNγ-mediated 
restriction of E. cuniculi in non-myeloid cells is mediated exclusively by the IRG system in 
mice.  
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Figure 3.17: Tryptophan supplementation cannot reverse the IFNγ-mediated E. cuniculi restriction.  
Wildtype MEFs (A) or mouse enterocytic CMT-93 cells (B) were treated with IFNγ for 24 h or left uninduced. 
30 minutes prior to infection with E. cuniculi spores, indicated doses of L-Tryptophan (W) were added to the 
medium. Whole cell lysates were prepared 5 days post infection and separated by one SDS-PAGE. Western 
Blots were probed with anti-meront mAB 6G2, anti-calnexin pAB as loading control and anti-Irga6 (10E7 mAB) 
as IFNγ-induction control. The asterisk marks an unknown E. cuniculi-derived protein, which is detected by 
calnexin antibody. There are no meront-positive protein bands in the IFNγ-induced and tryptophan-
supplemented samples.   
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Discussion 
 The immunity-related GTPase (IRG) protein family, subdivided in GKS and GMS 
proteins, has been established to be the major resistance system against a particular subset of 
intracellular parasites in mice. Microscopic studies showed that effector GKS proteins 
accumulate on the parasitophorous vacuolar membrane (PVM) of Toxoplasma gondii 
(T. gondii), followed by disruption of these vacuoles and death of the host cell. The function 
of the regulatory GMS proteins is less understood. They either they only act as inhibitors of 
the membrane-destructive GKS proteins or they also play a direct effector role on bacterial 
phagosomes. The aim of this study was to clarify possible roles of the regulatory GMS protein 
Irgm1. Furthermore, the underlying mechanism of membrane discrimination regarding IRG 
accumulation was investigated. In this context the microsporidian parasite Encephalitozoon 
cuniculi (E. cuniculi) has been identified as a novel target of the IRG resistance system.  
4.1 Differential subcellular localisation of Irgm1 isoforms  
 Several microscopic studies on endogenous and overexpressed Irgm1 in uninfected 
cells established a strong Golgi localisation due to an amphipathic targeting (αK) helix 
(Martens et al. 2004; Butcher et al. 2005; Tiwari et al. 2009; Zhao et al. 2010). It was also 
noted that Irgm1 shows a significant cytoplasmic punctuate staining outside the Golgi. The 
very first investigation did not connect this Irgm1 signal to the endolysosomal system, 
although the protein was seen on lysosomes enclosing recently phagocytosed latex beads 
(Martens 2004). Later, it was unambiguously shown that Irgm1 co-localises constitutively 
with LAMP1- and also weakly with transferrin-positive organelles (Zhao et al. 2010). Further 
co-localisation studies attributed endogenous Irgm1 to mitochondria (Tiwari et al. 2009; 
Chang et al. 2011).  
 However, subcellular localisation studies can be problematic, since tagged Irgm1 
constructs have been shown to mislocalise (Zhao et al. 2010). Moreover, the specificity of 
immunological reagents is not always guaranteed, because the design and production of the 
antibody/antiserum as well as the interpretation of obtained results are not trivial. Indeed, 
most of the published studies used either the relatively weak commercial polyclonal antibody 
A19 from Santa Cruz Biotechnology, Inc. (Springer et al. 2013) or cross-reactive polyclonal 
antibody ab69494/5 from Abcam plc (Figure 3.2 C). In addition, the existence of two splice 
forms of Irgm1 has not been considered in earlier studies. To this end, the subcellular 
localisation of both Irgm1 isoforms was examined in this study. As previously reported, the 
Golgi and mitochondrial localisations of Irgm1 could be confirmed in mouse fibroblasts using 
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new antisera (Figure 3.3 A + 3.4). Thus, while earlier reports of individual endogenous Irgm1 
localisations in uninfected, IFNγ-induced cells were certainly incomplete, there is no 
significant discrepancy in the results as they now stand.  
 It remains unclear, how membrane-binding of Irgm1 is mediated. Certainly, the 
amphipathic αK helix plays a key role, since this motif alone (GFP-tagged or as synthetic 
peptide) can target the compartments of Golgi and lysosomes (Zhao et al. 2010). Moreover, 
palmitoylation of Irgm1 at a cluster of cysteines near the Irgm1 αK helix strengthens 
membrane-binding potential, probably by adding hydrophobic character to the hydrophobic 
face of the amphipathic helix (Henry et al. 2014). In absence of both the amphipathic αK helix 
and palmitoylation, Irgm1 mainly loses its membrane-binding potential. Those Irgm1 mutants 
could not target the Golgi or mitochondria anymore, however the residual membrane-bound 
protein fraction targeted mainly the plasma membrane, similar to the truncated Irgm1 
G-domain only mutant. This suggests that Irgm1 has even more membrane-binding motifs 
(Martens et al. 2004; Henry et al. 2014). Similar to Irgm1, Golgi targeting for IFNγ-induced 
hGbp1 depends also on the nucleotide binding as well as on farnesylation (Modiano et al. 
2005). 
 Another puzzle is how Irgm1 can specifically target organelles. Recent lipid binding 
studies of MacMicking and colleagues using recombinant GST-tagged Irgm1 αK suggested 
binding to PtdIns(3,4)P2, weakly to PtdIns(4,5)P2, PtdIns(3,4,5)P3 and cardiolipin, which are 
marker lipids for early endosomes, plasma membrane, forming endosomes/phagosomes and 
inner mitochondria, respectively. Surprisingly, however, no association with PI4P specific for 
Golgi, or PtdIns(3,5)P2 for lysosomes could be detected (Tiwari et al. 2009; Kutateladze). 
Thus, Irgm1 seems not to exclusively recognize the phosphoinositide code. 
  Interestingly, only the long but not the short N-terminally truncated Irgm1 isoform 
was detected at endolysosomal organelles (Figure 3.3 B, C). This is in line with observations 
that Irgm1 does not co-localise with LAMP1, when it is altered by an N-terminal EGFP-tag, 
or furthermore when the nucleotide-binding site is mutated (S90N) (Zhao et al. 2010). Thus, a 
functional N-terminus and nucleotide binding site seem to be necessary for Irgm1 to target 
lysosomes. Even though biochemical information on Irgm1 is still missing, one can 
hypothesise a similar mechanism as proposed for Irga6: nucleotide binding would induce a 
conformational change of Irgm1 that allows lysosomal targeting; whereas without nucleotide, 
Irgm1 would localise to the Golgi. In such a scenario, one can now envision that either a) the 
N-terminus directly influences nucleotide binding or b) nucleotide binding induces a 
conformational change that unfolds the N-terminus to support or allow binding of the 
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amphipathic αK helix. In this study, two phosphorylated peptides, one short isoform-specific 
at the N-terminus and one derivable from both isoforms, could be detected by mass 
spectrometry (Figure 3.1 D and Appendix 2). Following from that, c) phosphorylation at the 
N-terminus of the short isoform may prevent a conformational change that is required for 
lysosomal targeting. Since no transfected short Irgm1 isoform was found at the lysosomes, 
this could mean all of the protein must have been phosphorylated by endogenous kinases. 
Even though the mass spectrometry data, which found also unphosphorylated short isoform of 
Irgm1, might argue against hypothesis c), it does not provide information about the ratio of 
endogenous phosphorylated vs. unphosphorylated short Irgm1 isoform. This could be further 
determined with specific quantitative mass spectrometry analysis (e.g. iTRAQ). In addition, 
future studies with mutants of the possible phosphorylation sites might resolve the importance 
of N-terminal phosphorylation for lysosomal targeting.  
 The other phosphorylation site, present in both Irgm1 isoforms, is most likely at 
Serine 79, which corresponds to the first β-sheet (S1) of the G-domain on the Irga6 crystal 
structure. Since the G-domain is responsible for nucleotide binding, this phosphorylation may 
also regulate the activation status of the protein. In case of Irga6, 30 amino acids further 
downstream just before the second β-sheet (S2), phosphorylation in the switch 1 region at 
threonines 102 and 108 by T. gondii virulence kinase ROP18 has been shown to 
biochemically inactivate the protein (Steinfeldt et al. 2010). Similar mechanisms are also 
discussed for Irgb6 (Fentress et al. 2010) but recent data indicate that Irga6 probably is the 
only ROP18 target within the family of IRG proteins [(Lim et al. 2013) and Tobias Steinfeldt, 
personal communication].  
 A possible functional difference for the two Irgm1 isoforms associated with their 
different intracellular localisation remains to be investigated. In the model of Irgm1 as 
negative regulator of GKS proteins and “protector of endomembranes”, different functions at 
different organelles are actually not required so far. Future biochemical studies of the 
recombinant protein (and a crystal structure) will hopefully elucidate, whether Irgm1 (and 
other GMS proteins) can actually bind and hydrolyse nucleotides to exert their function, since 
they lack the conserved lysine in the G1 motif.  
4.2 Irgm1 is not a direct effector protein on bacterial phagosomes 
 Functional analysis of Irgm1 has followed two “general tracks” in the past. One track 
describes Irgm1 as an effector of resistance at the bacterial phagosome, either by accelerating 
phagosome-lysosome fusion (MacMicking et al. 2003; Shenoy et al. 2007; Tiwari et al. 2009) 
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by the stimulation of autophagy (Gutierrez et al. 2004; Singh et al. 2006), or possibly by some 
other effect mediated through other organellar systems (Taylor et al. 2007). The second track 
stresses the role of Irgm1 as a regulator of other GKS proteins acting as a guanine nucleotide 
dissociation inhibitor (Hunn et al. 2008; Hunn et al. 2011) or as inhibitor of another GMS 
protein, Irgm3 (Henry et al. 2009; Coers et al. 2011; King et al. 2011).  
 In the past, several studies reported that endogenous or transfected Irgm1 co-localises 
with bacterial phagosomes, but data from the present study refute this claim. The first report 
on this topic (MacMicking et al. 2003) did not strictly show co-localisation, but rather 
co-purification via a procedure intended to purify phagosomes from cells infected by 
Mycobacteria. However the now known association of endogenous Irgm1 with Golgi 
membranes, LAMP1-positive compartments and mitochondria renders the conclusion from 
these experiments questionable, because these compartments were not clearly excluded from 
the putative phagosomal fraction (Li et al. 2010). The most direct support for a co-localisation 
of Irgm1 with both listerial and mycobacterial phagosomes was provided in an 
immunolocalisation study from Shenoy and colleagues [reprinted in Figure 1.6 for 
Mycobacteria (Shenoy et al. 2007)]. These authors showed effectively 100% co-localisation 
of intense immunofluorescent signals from either M. bovis BCG or L. monocytogenes and 
Irgm1 (detected by pAB A19) in IFNγ-induced RAW264.7 macrophages. Furthermore, 
another study showed a calculated overlap of 97.3% of M. bovis BCG and Irgm1 (stained by 
pAB A19) in mouse bladder urothelium (Saban et al. 2008). However, these observations 
raised suspicion, because one would expect Irgm1 accumulation in a ring-like pattern 
surrounding the bacterial phagosome instead of an entire co-localisation with the bacteria. 
Moreover, when two fluorescent signals exactly coincide it can also be an artefact due to 
cross-reactivity in the antibody staining procedure. Therefore, it was decided in the present 
study to reproduce the data, and indeed, cross-reaction of pAB A19 was microscopically 
observed on extracellular bacteria upon very long exposure times (Appendix 3). Another 
study attributes Irgm1 localisation to some but not all phagosomes of Brucella abortus, 
however this is not convincingly presented in the microscopic image (Ritchie et al. 2012). 
Furthermore, two other studies reported co-localisation of Mycobacteria with GFP-tagged 
Irgm1 and even with the GFP-tagged αK helix only (Deghmane et al. 2007; Tiwari et al. 
2009). However, besides the already discussed mislocalisation of GFP-tagged Irgm1 
constructs, EGFP-αK helix alone does not localise to latex bead phagosomes (Zhao et al. 
2010). 
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 The discrepancy of the data published recently and the results shown here for the same 
bacteria could only be explained by technical differences. The results in the present study are 
based on the analysis of exclusively intracellular organisms, defined by a two-stage staining 
protocol: only those organisms that were stained also after permeabilisation of the cells were 
used for analysis. Shenoy and colleagues did not distinguish between extracellular and 
intracellular organisms, however extracellular organisms are in the majority in such 
preparations (personal observations). Moreover, a new, high-titred and highly specific rabbit 
antiserum, rbMAE15, as well as the mouse monoclonal antibody 1B2, both detecting Irgm1, 
could be employed for Listeria-infected cells. Many different conditions were tested here – (I) 
time points ranging from 15 min to 4h post infection, (II) infection with wildtype 
L. monocytogenes, with the phagosome escape mutant ∆hly, or with M. bovis BCG, in (III) 
primary or RAW264.7 macrophages as well as mouse embryonic fibroblasts – but in no case 
did Irgm1 accumulate at the intracellular listerial or mycobacterial phagosome or at the 
LAMP1-positive vacuoles (Figures 3.5-3.8). The conclusion from these experiments is that 
Irgm1 is does not directly bind to bacterial phagosomes. This seriously weakens the model of 
Irgm1 as regulator of phagosomal maturation.  
 One the one hand, Irgm1 could also not be detected at phagocytosed heat-killed 
Listeria (Figure 3.6 B), conditions under which active modification on the phagosome by the 
parasite is excluded, or at phagosomes of opsonised or heat-killed T. gondii (Butcher et al. 
2005). On the other hand it was repeatedly observed in our laboratory that Irgm1 localises to 
the phagocytic cup and around phagocytosed latex beads [Figure 3.6 C, (Martens et al. 2004; 
Zhao et al. 2010)]. Moreover, proteome analysis of purified latex bead-containing 
phagosomes from IFNγ-treated RAW264.7 macrophages also identified Irgm1 [Prof. Stefan 
Höning, personal communication and (Jutras et al. 2008; Trost et al. 2009)]. However, Trost 
and colleagues only properly excluded contamination of ER and mitochondria in their 
purified fraction but not Golgi. It remains an open question, why Irgm1 can be detected on the 
latex bead phagosome but not on the bacterial phagosomes. One explanation could be that, 
since a latex bead phagosome is much bigger in comparison to a bacterial phagosome, it 
requires also more membranous material that is then provided not only by the plasma 
membrane, but also by endomembranes such as Golgi. A proteomic study of latex bead-
containing phagosomes report that about 1/3 of plasma membrane proteins and 2/3 of 
endolysosomal, ER and Golgi proteins constitute the phagosomal proteome and this ratio 
might also apply for the membrane composition (Campbell-Valois et al. 2012). Unfortunately, 
this analysis did not compare the results to bacteria-containing phagosomes, which are also 
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much more difficult to purify. Future microscopic analysis with Golgi and other organelle 
markers could also reveal, whether the membrane of latex bead-containing phagosomes 
versus bacteria-containing phagosomes might be derived from other organelles than the 
plasma membrane.  
 Taken together, these findings emphasize that results obtained from latex bead 
phagosomes should be treated with care, when they should serve as model for bacterial 
phagosomes. This problem is explicit in a recent proteome analysis of purified Mycobacteria-
containing phagosomes vs. latex bead-containing phagosomes from human cells showing that 
only 2/3 of the identified proteins overlap (Lee et al. 2010), indicating that these phagosomal 
membranes are not of the same composition.  
 IFN-inducible guanylate binding proteins (GBP) are also discussed to be critical in 
immunity to bacterial infection. Gbp1
-/-
 mice (Kim et al. 2012) and Gbp5
-/-
 mice (Shenoy et 
al. 2012) are more susceptible to Listeria monocytogenes infection whereas Gbp2
-/-
 mice are 
not (Degrandi et al. 2012). Although Gbp
chr3-/-
 mice are lacking these genes as well 
(Gbp1/2/3/5/7
-/-
), they display resistance to L. monocytogenes infection (Yamamoto et al. 
2012). SiRNA knock-down of four of the eleven murine GBP proteins (Gbp1, Gbp6, Gbp7, 
and Gbp10) caused loss of IFNγ-mediated cell-autonomous resistance to L. monocytogenes 
and Mycobacteria bovis BCG in macrophages. Since these GBP proteins partially co-localise 
with bacteria-containing vacuoles and interact with several components of the NADPH 
oxidase and the autophagy pathway, the authors claimed that GBP proteins transport these 
effectors to the bacterial phagosome in order to kill the bacteria (Kim et al. 2012). Two other 
recent studies reported that GBP proteins are required for Caspase-11-dependent pyroptosis 
upon infection with intracellular bacterial pathogens (Meunier et al. 2014; Pilla et al. 2014). 
Gbp2 was shown to localise to the bacterial phagosomes (in a ring-like pattern) and suggested 
to initiate killing of the bacteria by lysis of the bacterial vacuoles. This would then expose 
LPS to the cytosol, which is recognised by an unknown LPS receptor triggering Caspase-11-
dependent pyroptosis of the host cell. However, no significance of Irgm1 or Irgm3 could be 
attributed to this Caspase-11-mediated resistance to bacteria. Since the effector model of 
Irgm1 in phagosomal maturation can now largely be excluded, next the focus will be on the 
role of Irgm1 in facilitation of autophagy of Mycobacteria. 
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4.3 Role of Irgm1 in autophagy 
 The first experimental series on Irgm1 as autophagy regulator unfortunately did not 
test for co-localisation of Irgm1 with mycobacterial phagosomes and autophagosomes in 
IFNγ-induced macrophages and macrophage cell lines (Gutierrez et al. 2004; Singh et al. 
2006). Instead, an Irgm1-GFP fusion construct was overexpressed and an increase in 
autophagic organelles, as in IFNγ-induced cells, was reported. Moreover, overexpression of 
Irgm1 resulted in a two-fold increase of Mycobacteria co-localising with lysosomes. The 
authors concluded that Irgm1 mediates IFNγ-induced autophagy to eliminate Mycobacteria 
(Gutierrez et al. 2004; Singh et al. 2006). The drawback of these studies is that only an 
artificial overexpression system was used and that no mechanistic link between Irgm1 and 
autophagy could be provided. 
 Currently, there is opposing data on IFNγ-induced autophagy in cells from Irgm1-
deficient mice, most of which proposes Irgm1 as negative regulator of autophagy. The first 
insight was provided by EM images showing IFNγ-induced Irgm1/IFNγ-/- CD4+ T-cells with 
more membrane-bound vacuoles (Feng et al. 2008). Secondly, haemopoietic stem cells from 
Irgm1-deficient mice that were transgenic for GFP-LC3 showed increased number of 
autophagosomes, which was rescued by additional knock-out of Irgm3 or IFNγR1 (King et al. 
2011). Thirdly, staining of endogenous LC3 after 24 h of IFNγ-treatment in fibroblasts 
showed also increased number of autophagosomes (Traver et al. 2011). Finally, the number of 
LC3 punctae per LC3-positive Paneth cells from Irgm1-deficient mice was elevated 
independent of treatment. Increased co-localisation of LC3 and LAMP1 (autolysosomes) as 
well as more lipidated LC3II after 24 h IFNγ-stimulation could also be observed in Irgm1-/- 
MEFs in our laboratory (Jelena Maric, unpublished data).  
 When autophagy markers in IFNγ-induced Irgm1-/- cells are elevated, it is possible 
that either Irgm1 itself is really a direct inhibitor of autophagy or that aggregates of GKS 
proteins that form in the absence of Irgm1 deregulate autophagy. In addition, one has to 
distinguish whether elevated autophagy markers are the result of enhanced formation or 
impaired degradation of autophagosomes. In IFNγ-induced Irgm1-/- fibroblasts, lysosomes 
seem to be swollen, impaired in acidification and coated with Irga6 aggregates on the outside, 
which may suggest that GKS aggregates may hinder lysosomal degradation of 
autophagolysosomes and thus impair autophagic flux (Jelena Maric and Prof. Jonathan 
Howard, manuscript in preparation). Considering that selective macroautophagy is described 
to be a major contributor in the clearance of misfolded and aggregated protein in the cytosol 
in mammalian cells (Tyedmers et al. 2010), it remains to be investigated how much different 
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stimuli like GKS protein aggregates itself or IFNγ-stimulation contribute to the autophagy 
induction.  
 Contradictory to earlier reports, in shRNA knock-down of Irgm1 in RAW 
macrophages or primary macrophages derived from Irgm1
-/-
 mice no change in 
autophagosome, autolysosome or LC3 turnover was observed after 4 h of IFNγ-treatment 
(Matsuzawa et al. 2012). These results can be explained that after 4 h of IFNγ-treatment, only 
the conventional signalling pathways of autophagy are induced. However, elevated autophagy 
as seen in Irgm1
-/-
 cells 24 h after IFNγ-treatment, either due to blockage of 
autophagolysosomal breakdown or to selective clearance of GKS proteins would not have 
started 4 h after IFNγ-treatment, because the GKS (and other) proteins have not been fully 
expressed yet.  
 Lastly, it is also under debate whether the appearance of autophagy markers just 
before cell death (Feng et al. 2009) indicates that autophagy is involved in the cell death or 
rather that this is the last attempt of the cell to rescue itself (Deretic 2011).  
 In summary, it appears that two roles attributed to Irgm1 in IFNγ-induced murine 
cells, either being a direct effector on the phagosomal membrane or inducing autophagy to 
clear Mycobacteria, have not stood up for closer investigation. 
4.4 The main function of Irgm1 is to regulate GKS proteins 
 The only property of Irgm1 that is so far robust is its role as a negative regulator of the 
GKS subfamily of the IRG proteins. When GKS proteins are overexpressed without GMS 
regulators, GKS proteins form aggregates in the cell. Moreover, Irga6 overexpression causes 
an enlargement of the ER lumen as observed in EM images, which is dependent on its 
nucleotide binding activity. GKS aggregation is abolished either by co-expression of all GMS 
proteins or by induction of endogenous GMS proteins (Martens et al. 2004; Hunn et al. 2008). 
Moreover, GKS aggregates form in IFNγ-induced cells of GMS-deficient mice (Henry et al. 
2009; Traver et al. 2011) and seem to target unoccupied endomembranes. In Irgm1
-/-
 cells 
they co-localise with lysosomes; in Irgm3
-/-
 cells with ER markers and lipid droplets; and in 
Irgm1/Irgm3
-/-
 cells with oleic acid-induced lipid droplets [Jelena Maric, unpublished data, 
(Haldar et al. 2013)]. Moreover, Gbp1 and Gbp2 also form aggregates in absence of GMS 
proteins, and in case of Gbp2 also accumulate on oleic acid-induced lipid droplets (Traver et 
al. 2011; Haldar et al. 2013).  
 Together with the biochemical data showing that Irgm3 binds Irga6 in presence of 
GDP whereas Irga6-Irgb6 interaction is GTP-dependent (Hunn et al. 2008; Pawlowski et al. 
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2011), these findings support the hypothesis that the main function of GMS proteins is to 
prevent premature activation of GKS proteins on endomembranes by forming GMS-GKS 
heterooligomers in the GDP-bound inactive form. A tight regulation of GKS proteins is 
necessary, because the deregulated GKS aggregates on endomembranes may have cytopathic 
effects and block of autophagosome degradation.  
 The severe phenotype of Irgm1
-/-
 mice upon infection may be caused by these 
cytopathic GKS aggregates leading to the damage in proliferating IFNγ-induced 
lymphomyeloid cells (Hunn et al. 2010). Since hypothetical GKS aggregates in 
lymphomyeloid cells of Irgm1
-/-
 mice have not been analysed yet, experimental data that 
would proof this hypothesis are still missing. First experiments with fibroblasts and bone 
marrow-derived macrophages deficient for Irgm1 showed no effect on cell death upon IFNγ 
stimulation (Jelena Maric, unpublished data). One may argue that the hypothetical cytopathic 
GKS aggregates are more harmful in lymphomyeloid cells due to the smaller size of the cell. 
In fibroblasts, however, the cytopathic aggregates are more diluted in the cytosol. Another 
hypothesis is that in Irgm1
-/- 
cells, the GKS aggregates deregulate autophagy and this limits 
the proliferative potential of Irgm1
-/-
 lymphocytes upon infection rather than enhanced cell 
death (Jelena Maric, unpublished).  
 In contrast, there are less GKS aggregates in Irgm1/Irgm3
-/-
 cells, because the protein 
expression levels of GKS proteins are highly reduced (Henry et al. 2009). Moreover, also no 
increase in LC3 specks could be observed in Irgm1/Irgm3
-/-
 MEFs (Jelena Maric, unpublished 
data). In conjunction with the documented restoration of immunological competence in the 
Irgm1/Irgm3-deficient mouse (Henry et al. 2009), these results presented here favour the view 
that the loss of resistance to Mycobacteria, Listeria and many other organisms caused by 
Irgm1-deficiency is due to lymphomyeloid collapse and not to loss of a specific effector 
function of Irgm1 on the microbial phagosome. 
4.5 GKS proteins can directly target liposomes 
 To gain insight which kind of membranes IRG proteins can target in general, their 
association with liposomes was analysed. Co-sedimentation assays indicate that Irga6 and 
Irgb6 but not Irgd can directly bind to Folch lipid vesicles in a GTP-dependent manner 
(Nikolaus Pawlowski, unpublished data and Figure 3.9 A). These data demonstrate that Irga6 
and Irgb6 have an intrinsic capacity to bind lipids, independent of myristoylation, because the 
recombinant bacterially-expressed protein is not post-translationally lipid modified. The result 
that Irga6 and Irgb6 could co-sediment with the liposomes only in a GTP-dependent manner 
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(Figure 3.9 A) is further confirmed with the nucleotide-binding mutant Irga6-S83N, in which 
co-sedimentation is abolished (Nikolaus Pawlowski, unpublished data). This strongly 
suggests that GTP binding is essential for lipid binding, probably inducing a conformational 
change, which would increase the membrane avidity. Whether nucleotide binding or 
hydrolysis might be the driving force could be analysed by using non-hydrolysable 
nucleotides such as GTPγS. 
 Irgd alone did not co-sediment with liposomes (Figure 3.9 A). This is in line with 
results from membrane extraction assays, in which endogenous Irgd had the smallest 
membrane-bound pool of the IRG proteins tested (Martens et al. 2004). Interestingly, Irgd 
could associate with liposomes, when it was mixed with Irgb6 but not with Irga6 (Figure 3.9 
C/D). The fact that Irgd can only co-sediment with liposomes in presence of Irgb6 can have 
several reasons: a) Irgb6 forms mixed oligomers with Irgd that allow association with the 
membrane, b) Irgb6 acts as direct adaptor protein for Irgd on the membrane, or c) Irgb6 
induced a conformational change of Irgd that unfolds its membrane-binding capacity. This is 
again consistent with the hierarchal loading of IRG proteins on the T. gondii PVM, in which 
Irgd could only be found on Irgb6-positive but not on Irgb6-negative vacuoles (Khaminets et 
al. 2010). To explain why Irga6 is not able to induce co-sedimentation of Irgd, one can argue 
that at equimolar concentrations, Irga6 may form homooligomers with a higher affinity than 
heterooligomers with Irgd. Therefore, no mixed oligomers were formed that would allow Irgd 
to bind the liposomes. Titrating lower concentration of Irga6 to Irgd may resolve this 
question.  
 Because different sizes of liposomes (100 nm or 1 µm) behaved equally in such co-
sedimentation assays (Niko Pawlowski, unpublished data), one can assume that the curvature 
of the vesicles does not influence GKS binding. In fact, Irga6 oligomers accumulate on the 
T. gondii PVM or on the E. cuniculi PVM (see chapter 4.10), two vesicle types that 
dramatically differ in size and curvature. However, it was not tested yet, whether GKS 
proteins might also bind to negatively curved membranes such as the inner cytosolic phase of 
the plasma membrane.  
 Another characteristic of the target membrane to consider is the lipid composition. In 
this study, the liposomes were prepared with a mixture of polar lipids obtained from a Folch 
extraction of porcine brain. This mixture is composed mainly of phospholipids [(33% 
phosphadidylethanolamine (PE), 18% phosphatidylserine (PS), 12% phosphatidylcholine 
(PC)] and unknown components (Homepage Avanti Polar Lipids, Inc). The parasitophorous 
vacuoles, which are derived from the raft and non-raft microdomains of the plasma 
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membrane, are expected to have a similar lipid composition as the plasma membrane. The 
plasma membrane of a mammalian liver cell for example is approximately composed of 24% 
PC, 7% PE, 4% PS, 17% cholesterol and other components (Alberts et al. 2007), and this 
differs to the lipid mixture tested in this study. So far, only one systematic lipid affinity screen 
was performed with recombinant GST-tagged proteins but without nucleotides, in which only 
Irgm1 bound to certain lipids but not Irgm2, Irgm3 or Irga6 [see 4.1, (Tiwari et al. 2009)]. 
Future analysis may reveal whether IRG proteins bind to specific lipids or lipid compositions. 
However, it is unlikely that IRG proteins have a certain lipid preference, because there is no 
evidence yet that the lipid composition differ between the PVM, which is targeted by IRG 
proteins, and the plasma membrane, which is not targeted by IRG proteins.  
 Lastly, a series of experiments by Nikolaus Pawlowski, mixing recombinant protein 
with thin rehydrated lipid layers, so-called membrane sheets, revealed that recombinant GKS 
proteins were able to crinkle and deform the membrane in a GTP-dependent manner, strongly 
resembling the actions of dynamins (Itoh et al. 2005). Moreover, EM studies of liposomes 
mixed with recombinant Irgb6 showed formation of little tubules on the vesicle surface in a 
GTP-dependent manner (Nikolaus Pawlowski, unpublished data). Future studies with 
artificial membrane systems, such as the chemically induced blebs in mammalian cells or 
giant unilamellar vesicles, may help to further define the characteristics of an IRG-positive 
membrane. Taken together, these observations suggest that similar to dynamins, energy 
released from GTP hydrolysis may be transduced into mechanical force that results in 
deformation and ultimately rupture of the vacuolar membrane (Pawlowski et al. 2011).  
4.6 GKS proteins selectively target parasite vacuoles, but 
independent of residual host surface proteins  
 Several microscopic studies documented that GKS proteins accumulate on the 
parasitophorous vacuolar membrane (PVM) of T. gondii and C. trachomatis, that are both 
derived from the invaginated host plasma membrane and do not fuse with the endolysosomal 
system (see 1.4 and 1.6). However, it is still puzzling, how recognition of exactly these 
membranes is provided. In this study two specific aspects were investigated: the presence of 
residual plasma membrane proteins on the PVM as inhibitory factors of GKS protein binding 
and non-fusogenic compartments as a model membrane.  
 Firstly, biotinylation of host cell surface proteins prior T. gondii infection showed that 
the intensity of residual host plasma membrane proteins and the intensity of labelled Irga6 or 
Irgb6 did not negatively correlate (Figure 3.10). Since a negative correlation indicates a 
 D
is
cu
ss
io
n
 
91 
 
competitive behaviour, the obtained results here challenge the hypothesis that residual host 
cell plasma membrane proteins block GKS protein accumulation on the PVM. Therefore, the 
wide range of fluorescence intensities observed for IRG protein loading (Khaminets et al. 
2010) may not be explained with an inefficient exclusion of surface proteins, that would leave 
different amounts of residual proteins on the PVM. Another explanation for the different 
intensities of IRG proteins on the PVM may be different timing of IRG protein loading. Even 
though the parasites enter the host cells more or less synchronously, IRG proteins reach the 
PVM most likely by diffusion and this may be a stochastic event. When then once the first 
IRG proteins start to accumulate on the PV (and get stabilised), the IRG protein loading rises 
very fast (Khaminets et al. 2010). At two hours post infection, the weakly labelled vacuoles 
would represent those that just started to accumulate IRG proteins, whereas the strongly 
stained PVs started loading earlier.  
 The biotinylation method of host cell surface proteins has certain drawbacks. The 
fluorescence intensity of the Biotin-Streptavidin detection complex is just slightly above 
background level, and hence is difficult to measure. In addition, intracellular T. gondii PVs 
appeared in 3D images like a bulge from the otherwise flat and thin fibroblast (data not 
shown). Thus, in conventional Epi-fluorescence microscopy the rim around the parasite may 
also reflect several vertical stacks of plasma membrane. Lastly, phagocytosed latex beads 
should have served as positive control carrying Biotin on their phagosomal membrane. But 
the beads had lots of refraction light at high exposure times that outshined the Streptavidin 
signal (data not shown). Future studies should combine a systematic screen of host surface-
derived candidates as IRG protein competitors, including marker proteins of excluded 
transmembrane proteins and incorporated GPI-anchored proteins (Mordue et al. 1999). Better 
visualisation methods such as direct antibody staining of candidate proteins as well as the 
choice of a bigger host cell type, in which the parasite PV is not so entangled by the host cell 
host plasma membrane, might improve the experimental setup. 
 Another approach would be to test mutant Toxoplasma strains that are known to be 
impaired in formation of the moving junction and therefore probably also impaired in 
selective exclusion of host plasma membrane proteins during PVM formation. Initial 
experiments with the AMA1-deficient T. gondii strain (Mital et al. 2005), which is a major 
component of the moving junction complex spanning the PVM, however failed to show a 
dramatically altered IRG protein loading (Steffi Koenen-Waisman, unpublished data and own 
observations). A second member of the moving junction complex, RON8, has no homologue 
in Plasmodium berghei, and is therefore of special interest because the PVM of P. berghei is 
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not targeted by IRG proteins (Liesenfeld 2011). However, the TgΔRON8 stain, as well as 
conditional TgRON5 knock-down strain, are severely or entirely impaired in host cell 
invasion, respectively (Straub et al. 2011; Beck et al. 2014). This makes it difficult if not 
impossible to examine the invaded intracellular parasites that are relevant for IRG 
accumulation analysis.  
 The second aspect of this subject focuses on the question whether non-fusogenic 
vacuoles are general targets of the IRG resistance system. To this end, artificial Inc-induced 
membranous vesicles (Mital et al. 2013) were examined for Irga6 or Irgb6 co-localisation 
(Figure 3.11). Because the GKS proteins failed to accumulate on the Inc-induced vesicles, it 
can be concluded that the non-fusogenic character of a membrane is not enough to be 
recognised by IRG proteins. Thus, a membrane must carry additional features to be 
recognised and targeted by IRG proteins. Another possibility could be that the Inc proteins 
after transient overexpression occupy the vesicle surface so that IRG proteins cannot target 
these inclusions anymore.  
4.7 Interplay of ATG proteins and the IRG resistance system 
 It remains an open question by which mechanism IRG proteins can target membranes. 
Two other protein families, the autophagy-related (Atg) proteins and the interferon-inducible 
GBP proteins (see 4.8), also play a role in resistance to Toxoplasma, Neospora and 
Chlamydia and are discussed to mediate the recruitment of IRG proteins.  
 Detailed investigation of Atg5 started with the observations that IFNγ-dependent 
growth restriction of avirulent T. gondii strains was impaired in Atg5
-/-
 fibroblasts (Konen-
Waisman et al. 2007) and in activated Atg5
-/-
 macrophages (Zhao et al. 2008). Atg5-deficient 
mice were also susceptible to infection with T. gondii and L. monocytogenes (Zhao et al. 
2008). Interestingly, Atg5
-/-
 macrophages were impaired in accumulating Irga6 at the PVM, 
correlating with an inability to mediate the interferon-dependent damage and ruffling of the 
PVM as observed on EM level [see Figure 1.5 C, (Zhao et al. 2008)]. Failure of IRG protein 
accumulation onto the PVM was confirmed in Atg5
-/-
 fibroblasts and macrophages for the 
GKS proteins Irga6, Irgb6, Irgd, Irgb10, as well as for Gbp1 and Gbp2 (Khaminets et al. 
2010; Traver et al. 2011; Haldar et al. 2013; Selleck et al. 2013). In C. trachomatis infection, 
Meyer and colleagues described that Irga6 failed to accumulate at the inclusions in Atg5
-/-
 
fibroblasts, but Irgb10, Irgb6, Irgm2 and Irgm3 loading on inclusions was similar to wildtype 
host cells (Al-Zeer et al. 2009). In contrast, Coers and colleagues showed a reduced loading of 
all GKS proteins and Gbp2 in Atg5
-/- 
cells (Haldar et al. 2014).  
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 Similar to Irgm1/Irgm3-deficient cells, GKS protein levels are not only decreased, but 
also formed GTP-bound aggregates in Atg5-deficient cells (Zhao et al. 2008; Khaminets et al. 
2010; Traver et al. 2011). Both phenomena might explain the susceptibility of Atg5
-/-
 cells to 
avirulent T. gondii infection. When the GKS protein levels are decreased, there might not be 
enough protein to destroy the PVs. Moreover, because GKS aggregates, either caused by GKS 
protein overexpression or by IFNγ-induction in Irgm1/Irgm3-/-cells, cannot accumulate on the 
PVM anymore (Hunn et al. 2008; Henry et al. 2009), GKS proteins may also be impaired in 
PVM targeting in Atg5-deficient cells.  
 Taken together, these findings suggest that Atg5 functions as a regulator of IRG 
proteins to prevent inappropriate GKS activation. Since no accumulation of Atg5 itself on the 
PVM was found, a role of Atg5 as IRG-adaptor is rather unlikely. If Atg5 acts as a regulator 
of IRG proteins it could either directly bind GKS proteins and keep them in an inactive state 
(like GMS proteins) or support GMS proteins to exert their function.  
 Alternatively, IRG proteins are probably always aggregate in IFNγ-stimulated cells at 
low levels, but are constantly degraded by autophagic or possibly non-autophagic pathways 
involving Atg5. In Atg5-deficient cells, this protein degradation (or recycling) system would 
be impaired resulting in GKS protein aggregation in the cell, which then exert their cytopathic 
effects. Thus, Atg5 itself has then no direct effect on IRG proteins, but only its absence causes 
deregulation of GKS aggregate degradation. 
 Deregulation of the IRG protein turnover as an off-target effect is strongly supported 
by the fact that growth inhibition of T. gondii is not limited to Atg5. Impaired IRG loading 
onto T. gondii PVM was also reported in fibroblasts lacking the autophagy regulators Atg3, 
Atg7 and Atg16L1 but not for Atg9a or Atg14 (Yamamoto et al. 2012; Haldar et al. 2014; 
Ohshima et al. 2014). For autophagosome elongation, Atg5 is activated by Atg7 and forms a 
complex with Atg12 and Atg16L1 in order to mediate lipidation of LC3. Atg9a or Atg15 play 
a key role in the earlier step of orchestrating the autophagosomal membrane (Maiuri et al. 
2007). These findings implicate that deregulation of a certain step in autophagy, the 
autophagosome elongation, results in the deregulation of the IRG system acting against 
T. gondii in mice. In contrast, human ATG16L1 is not required for IFNγ-dependent inhibition 
of T. gondii growth in human cells (Ohshima et al. 2014), most likely because humans lack 
the IRG resistance system. 
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4.8 Interplay of GBP proteins and the IRG resistance system 
 Another IFN-inducible protein family that plays a role in Toxoplasma and Chlamydia 
resistance are the GBP proteins. Gbp1- and Gbp2-deficient mice show enhanced susceptibility 
to infection with avirulent T. gondii strains (Degrandi et al. 2012; Selleck et al. 2013). Knock-
out of the GBP cluster on chromosome 3 including Gbp1, Gbp2, Gbp3, Gbp5 and Gbp7 also 
results in enhanced susceptibility to T. gondii (Yamamoto et al. 2012) as well as to 
C. trachomatis (Haldar et al. 2014). Most of the mouse GBP proteins, Gbp1, Gbp2, Gbp3, 
Gbp6, Gbp7 and Gbp9 but not endogenous Gbp5, accumulate on the PVM of avirulent 
T. gondii strains but not on virulent strains that express the virulence factors ROP5 or ROP18 
(Degrandi et al. 2007; Virreira Winter et al. 2011; Selleck et al. 2013). Murine Gbp1 and 
Gbp2 but not Gbp5 also accumulate on the PVM of Neospora caninum (Spekker et al. 2013). 
Similar to IRG proteins, an intact nucleotide binding site is necessary for the PVM targeting, 
whereas the lipid modification (farnesylation) of mGbp1 is not necessary (Virreira Winter et 
al. 2011; Kravets et al. 2012). Furthermore, it was also demonstrated that PVM targeting by 
GBP proteins is dependent on other IFNγ-inducible factors (Virreira Winter et al. 2011). 
Therefore, several independent studies investigated the interplay of IRG and GBP proteins on 
the PVM. In macrophages of GBP
Chr3-/-
 mice, Irgb6 and Irgb10 but not Irga6 loading on the 
PVM was impaired (Yamamoto et al. 2012). Similar results were obtained in Gbp1
-/-
 
macrophages (Selleck et al. 2013). Vice versa, in Irga6
-/-
 fibroblasts the intensity of GBP 
proteins and number of positive vacuoles, detected with the pan-GBP antibody GBP1-5, was 
reduced on the PVM (Hermanns 2014).  
 Taken together, these data suggest that mainly Irga6 is prerequisite for the GBP 
accumulation on the PVM of T. gondii. GBP proteins (and Irga6) might then be prerequisite 
for Irgb6 and Irgb10 binding or alternatively stabilise their binding to the PVM. However, this 
specific order is not in line with the proposed hierarchical loading, in which Irgb6 and Irgb10 
arrive as pioneers and subsequently becoming stabilized by the arrival of Irga6 and Irgd 
(Khaminets et al. 2010). Considering that so far widely different method were used (staining 
in Irga6-deficient cells vs. co-staining of two IRG proteins), future studies might help to 
understand the role of Irgb6, Irgb10 and other IRG proteins in the hierarchy of IRG protein 
loading.  
So far, the T. gondii virulence factors ROP5 and ROP18 have been mainly described to act on 
IRG proteins (Fentress et al. 2010; Steinfeldt et al. 2010; Behnke et al. 2012; Fleckenstein et 
al. 2012; Niedelman et al. 2012). However, GBP proteins have not been shown to be direct 
targets of ROP virulence factors, only Gbp1 shows reduced loading in presence of ROP18. 
 D
is
cu
ss
io
n
 
95 
 
(Virreira Winter et al. 2011). Supporting the model that GBP proteins might act downstream 
of IRG proteins, the ROP5/ROP18 complex might particularly interact with Irga6, since 
ROP18 seems to be Irga6 specific (Tobias Steinfeldt, Thomas Hermanns and Jonathan 
Howard, manuscript in preparation) Such a hierarchical loading order may be specific for the 
target organism, because in GBP
chr3-/-
 cells, targeting of the C. trachomatis inclusion 
membrane is reduced for Irgb10 and Irga6 but not for Irgb6 (Haldar et al. 2014).  
 As already described for Atg5-deficiency (see chapter 4.9), impaired IRG protein 
loading correlates with an impaired membrane damage potential, since the PVM of T. gondii 
has no scalloped appearance on the EM level in IFNγ-treated cells of GBP-deficient mice 
(Yamamoto et al. 2012; Selleck et al. 2013).  
 Considering that about one third of the world population is infected with T. gondii, it 
is a serious question how the IFN-mediated resistance to Toxoplasma is regulated in humans. 
Therefore, it was of strong interest, if the GBP proteins can substitute the role of the IRG 
system in humans. However, hGbp1 could be detected only on extremely few vacuoles 
(below 1 %) of virulent or avirulent T. gondii strains [(Günther 2011) and Gerrit Praefcke 
personal communication]. In human haploid cells only 6% vacuoles were GBP1-5-positive 
and knock-out of the entire human GBP gene locus provided the final evidence, that hGBP 
proteins are not responsible for IFNγ-mediated Toxoplasma restriction (Ohshima et al. 2014). 
In contrast, Chlamydia trachomatis seems to be partially controlled by hGBP1 and hGBP2, 
which also accumulate on the inclusion membrane (Tietzel et al. 2009; Al-Zeer et al. 2012).  
 In summary, IRG and GBP proteins seem to clearly cooperate in mediating the IFNγ-
induced resistance to Toxoplasma or Chlamydia in mice. The level of interaction is still 
unknown, but it is very unlikely that GBP proteins may act as adaptor proteins for IRG 
effectors on the target membrane.  
4.9 Irgm2 or Irgm3 do not function as GKS adaptor proteins on the 
PVM 
 Besides GKS and GBP proteins, little amounts of Irgm2 and Irgm3 can be detected on 
the PVM of avirulent T. gondii strains (Martens et al. 2005; Khaminets et al. 2010; Haldar et 
al. 2013). With low amounts of GMS proteins and high amounts of GKS proteins on a PV, 
one may hypothesize that GMS protein loading onto a PV inhibits loading of GKS proteins. 
However, this can be excluded for several reasons. Firstly, it has been shown that transfected 
Irgm2 or Irgm3 can only target the PVM of T. gondii when co-expressed with other GKS 
proteins (Hunn et al. 2008). Secondly, co-staining of endogenous Irgm2 or Irgm3 against 
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Irga6 or Irgb6 showed that PVs of T. gondii were either positive for both proteins or for the 
GKS protein only but never for the GMS proteins only (Khaminets et al. 2010). Thirdly, 
intensity measurements of Irgm3 versus Irga6 or Irgb6 could confirm a positive correlation of 
fluorescent intensities, which excludes a competition of GMS and GKS proteins at the PVM 
(data not shown). Thus, a more reasonable explanation for the presence of GMS proteins on 
the PVM may be that the GMS proteins, because they have a certain cytoplasmic pool, bind 
secondarily to GKS proteins, which are massively abundant at the PVM. Because GMS - 
GKS protein interactions are GDP-dependent (Pawlowski et al. 2011), Irgm2 and Irgm3 may 
bind the GKS proteins when they just hydrolysed their GTP at the PVM. Whether Irgm2 and 
Irgm3 fulfil an important function at the PVM remains to be investigated.  
4.10 E. cuniculi is a novel target of the IRG resistance system 
 In order to better understand mechanism how IRG protein target membranes, certain 
pathogens have been examined that display different modes of host cell invasion. Most of the 
organisms that seem to be ignored by the IRG system, such as Salmonella, Listeria, 
Leishmania, Mycobacteria, and Rhodococcus, are taken up by phagocytosis and reside in a 
more or less modified phagosomes. In contrast, the pathogens that are targeted by the IRG 
resistance system, T. gondii, N. caninum and Chlamydia, enter the host cell by an unusual 
mechanism and reside in non-fusogenic vacuoles (see introduction 1.4.2 and 1.4.3 and Figure 
4.1 A). Hence, only organisms that enter cells without engaging the phagocytic mechanism 
may become preferential targets for IRG protein-mediated resistance, regardless of their 
taxonomic status. To generalise this idea, another intracellular organism with a non-
phagocytic mode of host cell invasion and a wide taxonomic divergence from the other two 
known IRG protein targets was examined: Encephalitozoon cuniculi. This microsporidian 
parasite has already been described for IFNγ-mediated growth restriction and its peculiar 
entry mechanism leading to a non-fusogenic parasitophorous vacuole as intracellular niche 
(see introduction 1.5). The experimental design in this study was based mainly on extensive 
knowledge and expertise concerning the interaction of the mouse IRG resistance system and 
the T. gondii PVM. Indeed, several aspects of the obtained results closely resembled features 
that have been studied in detail in T. gondii infection and partially for Chlamydia and 
Neospora infection. 
 IFNγ mediates cell-autonomous resistance against E. cuniculi in fibroblasts (Figure 
3.12) that is associated with accumulation of different IRG proteins onto a small proportion of 
E. cuniculi PVs (Figure 3.12). At the light microscopical level it is not possible to say 
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precisely where the IRG proteins are localised at early time points, but images from later time 
points after infection, when the vacuole is enlarged, suggest that IRG proteins are loaded onto 
the PVM. A decisive answer to this question will require electron microscopy. In accordance 
with T. gondii and C. trachomatis, all GKS proteins tested so far (Irga6, Irgb6, Irgd) 
accumulate at the PV of E. cuniculi (Figure 4.1 B). The appearance of Irgm1 next to 
E. cuniculi PVs can be explained by the observation that E. cuniculi is often found in the 
perinuclear region that also harbours the host Golgi, the main organelle for Irgm1 localisation. 
Moreover, the E. cuniculi PV has been shown to directly bind host mitochondria (Hacker et 
al. 2014); again organelles, which are also partially positive for Irgm1 (see Figure 3.4). 
However, Irgm1 does not at all load onto the E. cuniculi vacuoles as observed for other IRG 
proteins in a typical ring-like pattern. Like for vacuoles of T. gondii and C. trachomatis, 
Irgm1 does not load onto E. cuniculi PVs, while Irgm2 can be found on only a small 
percentage [Figure 3.13 and (Butcher et al. 2005; Martens et al. 2005; Coers et al. 2008; Al-
Zeer et al. 2009; Haldar et al. 2013)]. Nevertheless, in contrast to T. gondii, vacuoles with 
multiplying E. cuniculi meronts also were targeted by the IRG resistance system (Figure 
3.14 C). 
 Data from IRG proteins loading onto T. gondii PVMs indicates that loading of Irgb6 
might be stabilised by the loading of Irga6, and is thus clearly cooperative (Khaminets et al. 
2010). The frequency of E. cuniculi PVs loaded with IRG proteins at any time point 
investigated here is low, but the majority of loaded PVs accumulate both Irga6 and Irgb6 
(Figure 3.14) indicative for cooperativity of IRG loading. However, loading of more than one 
GKS member on E. cuniculi PVs can also arise, if only a few vacuoles, which carry specific 
properties, are receptive to IRG proteins at any time. Cooperative loading of IRG protein on 
Neospora or Chlamydia has not been studied yet.  
 The hierarchical loading of the IRG members onto the PVM is well described for 
T. gondii (Khaminets et al. 2010). In this study only little information on a possible hierarchy 
could be obtained, because triple staining (meront marker 6G2 + two IRG proteins) could be 
established only for the Irga6 + Irgb6 combination. However, the importance of individual 
IRG proteins is not necessarily the same for the different target organisms. For example, 
Irgb10 and Irgm3 have been described to be the major resistance factors against 
C. trachomatis (Bernstein-Hanley et al. 2006). 
 Unlike the IRG loading pattern onto the vacuoles, the timing differs for different target 
organisms (Figure 4.1 C). In case of avirulent T. gondii, the number of vacuoles loaded with 
IRG proteins rises roughly linear to about 90% of all vacuoles within 2 h after infection 
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(Khaminets et al. 2010). With E. cuniculi, the number of vacuoles loaded ranges between 5 
and 15% within 30 minutes of infection, and persists at that level for all time points 
investigated up to 24 h (Figure 3.13). For C. trachomatis, no time-course has been described 
yet; but two independent studies show 80% of Irga6-positive vacuoles after 3 h of infection 
[24 h IFNγ pre-stimulation, (Al-Zeer et al. 2009)] and 10% after 20 h [3 h IFNγ pre-
stimulation, (Coers et al. 2008)]. These different IRG loading behaviours can still reflect 
qualitatively similar processes, if (I) the initiation of IRG protein loading onto individual 
E. cuniculi vacuoles takes on average longer than onto T. gondii vacuoles, and if (II) E. 
cuniculi vacuoles subsequently disintegrate and are cleared with faster kinetics than T. gondii 
vacuoles. With increasing time after infection more and more parasites are cleared from the 
cells, accounting for the slow but linear loading of detectable meronts (Figure 3.12). 
 Another difference is that in contrast to E. cuniculi, intracellular T. gondii tachyzoites 
have a uniform size and shape. IRG proteins that accumulate on the PVM largely reflect this 
regular shape. Therefore, the disruption of the PVM can relatively easy be obtained by 
microscopic analysis as a nick in the ring like structure of IRG proteins (see Figure 1.5 A, 
arrow). In case of E. cuniculi, however, the shapes of the vacuoles are non-uniform and the 
IRG proteins usually do not accumulate resembling a regular ring (see for example Figures 
3.13 C, E or 3.14 A-C). Therefore, it was not possible to register clear–cut disruption of the 
E. cuniculi vacuole in live-cell imaging. Future studies with better microscopic resolution and 
a permanent labelling of meronts (lipids or DNA) will hopefully resolve whether the PVM of 
E. cuniculi is also disrupted as consequence of IRG protein accumulation. The disruption of 
the vacuole of T. gondii is followed by the death of the parasite and necrotic-like death of the 
infected cell with relatively invariant timing [chapter 1.4.2, (Zhao et al. 2009)]. Also in IFNγ-
treated and E. cuniculi-infected fibroblasts, excess of dead host cells, presumably via necrosis, 
could be observed (Figure 3.16). Even though in the experiments presented in this study, 
technically a mixture of infected and uninfected cells was evaluated, an increase in dead cells 
and decrease in viable cells could be recorded in infected IFNγ-treated samples. For T. gondii 
infection, the molecules triggering this type of cell death are not known yet, since it carries 
some (membrane permeabilisation, HMGB1 release), but not all features (Caspase 1 
cleavage) of typical necrosis (Zhao et al. 2009). IFNγ-induced death of Chlamydia-infected 
host cells has not been investigated yet.  
 Lastly, as for T. gondii resistance, the IRG system appears to be a crucial mechanism 
in IFNγ-induced mouse fibroblasts that is capable of restriction of E. cuniculi. In fibroblasts 
from Irgm1/Irgm3-deficient mice, all IFNγ-inducible resistance against the growth and 
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development of E. cuniculi was lost (Figure 3.15 C, D). A strong phenotype in the GMS-
deficient cells is expected, because these deficiencies deregulate the GKS effector subfamily 
(Hunn et al. 2010). There is a tendency of Irgm1
-/-
 fibroblasts being slightly impaired, Irgm3
-/-
 
being moderately impaired and the Irgm1/Irgm3
-/-
 being fully impaired in E. cuniculi growth 
restriction (Figure 3.15). This perfectly resembles the phenotype of the different GMS-
deficient fibroblasts that also cannot control T. gondii infection after IFNγ-stimulation (Steffi 
Koenen-Waisman, unpublished data). Moreover, Irgm1/Irgm3-deficient mice are highly 
susceptible to T. gondii infection (Henry et al. 2009). In case of C. trachomatis infection, 
Irgm1/Irgm3
-/-
 mice also have initially higher bacterial burdens than wildtype mice, but this is 
then later compensated by an execrated T-cell response. Still, the IFNγ-mediated cell-
autonomous response against C. trachomatis is entirely lost in Irgm1/Irgm3
-/-
 fibroblasts 
(Coers et al. 2011).  
 The undetectable effects of the two GKS effector knock-outs in controlling E. cuniculi 
(Figure 3.15 C, D) are consistent with the much weaker in vivo phenotypes both Irga6 and 
Irgd deficiencies upon in T. gondii infection (Collazo et al. 2001; Liesenfeld 2011). 
 Furthermore, the IFNγ-inducible tryptophan catabolic enzyme IDO plays no role in 
resistance against E. cuniculi in mouse fibroblasts or enterocytes (Figure 3.17). Though the 
role of IDO in mediating the IFNγ-response to T. gondii in mouse cells is under debate 
(Konen-Waisman et al. 2007; MacMicking 2012), tryptophan deprivation also does not 
mediate the IFNγ-induced restriction of Chlamydia trachomatis in mouse fibroblasts, 
epithelial cells or macrophages (Nelson et al. 2005; Roshick et al. 2006).  
 This study provides the first evidence that IFNγ-dependent restriction of the 
microsporidian Encephalitozoon cuniculi is mediated by the IRG system. Several features of 
the IRG resistance system are similar in the resistance against E. cuniculi, the best-studied 
target organism T. gondii and partially also C. trachomatis: (1) the relocalisation of different 
IRG proteins to the cytosolic face of the PVM of E. cuniculi; (2) cooperativity in IRG-
loading; (3) IFNγ- and infection-dependent host cell death and (4) IDO-independent IFNγ-
mediated parasite growth restriction in mouse cells. Thus, the IRG resistance system seems to 
act in a universal manner against parasites from three kingdoms of life, protozoa, bacteria and 
fungi. The comparison of the three classes of target organisms of the IRG resistance system is 
summarised in Figure 4.1.  
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Figure 4.1: Comparison of the three classes of organisms targeted by the IRG resistance system.  
(A) The microsporidian E. cuniculi, the protozoa T. gondii and N. caninum as well as the bacteria C. trachomatis 
and C. psittaci enter the host cell by an unusual entry mechanism, none of which resembles conventional 
phagocytosis. They form their intracellular niche in form of a parasitophorous vacuole or inclusion, which is 
derived from the plasma membrane, but does not fuse with the host endolysosomal system. (B) The same subset 
of IRG proteins accumulates on the vacuolar membranes of all three microorganisms. The effector mechanism of 
IRG proteins is likely to be the disruption of the vacuole and thereby killing of the parasite. (C) The dynamics of 
IRG loading on the vacuoles, the subsequent parasite death, as well as the death of the host cell are shown as 
time-dependent variables. 
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4.11 Model of the IRG resistance system  
 Several properties of the IRG-dependent resistance mechanism that have been 
analysed for T. gondii are also valid for resistance against E. cuniculi, and, as far as it has 
been analysed, also against Chlamydia (see chapter 4.10). Since effective resistance 
dependent on IRG proteins seems to perfectly correlate with the accumulation of IRG proteins 
on the PVM, the challenge is to determine the common features that enable IRG proteins to 
accumulate on the vacuoles of these three organisms but not on the vacuoles of other 
organisms. The phylogenetic range of the target organisms of the IRG resistance system - a 
protozoa, bacteria, and a fungus - and their vastly dissimilar biology, strongly suggests that 
the specificity of IRG proteins for certain PVs relates to a common feature of the host-derived 
vacuolar membranes rather than to a common ligand derived from the parasites themselves.  
 The proposed model builds on a hypothesis first formulated by Martens (Martens 
2004) describing the specific targeting of IRG proteins to the T. gondii vacuole rather than to 
other cellular organelles. Martens proposed the existence of a self-derived “Factor X” present 
on the membranes of cellular organelles (endomembranes) that inhibits the accumulation and 
activation of IRG proteins on these sites, thereby protecting these organelles from GKS 
protein-mediated damage. In contrast, PVs lacking Factor X would be exposed to IRG 
accumulation and activation. This elegant "missing-self" model was confirmed later and 
Factor X was revealed to be the three GMS proteins, Irgm1, Irgm2 and Irgm3, which are 
bound to distinct subsets of endomembranes, where they act as inhibitory GDIs of the effector 
GKS proteins (Hunn et al. 2008).  
 In scheme A of Figure 4.2 it is shown that in IFNγ-induced cells, GMS proteins 
normally occupy endomembranes (Golgi, ER, lysosomes, mitochondria and lipid droplets are 
confirmed) in order to mark them as “self”. GKS proteins are kept in the GDP-bound state 
and shuttle between ER and cytosol. However, in the absence of one or more GMS proteins, 
GKS proteins form activated, GTP-bound assemblies in the cytoplasm that are associated with 
“unprotected” endomembranes [Figure 4.2 B, (Hunn et al. 2010; Haldar et al. 2013)]. GKS 
aggregates also form in cells deficient in certain regulatory autophagic proteins (see chapter 
4.7), but the mechanistic link is still unknown. 
 However, GKS effector IRG proteins do not accumulate or activate on the plasma 
membrane, which is not protected by any GMS protein. Therefore, a new hypothetical 
inhibitor, here termed “Factor Y”, has to be introduced. This Factor Y would be associated 
with the plasma membrane and inhibit GKS activation at that location.  
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Figure 4.2: Model of the IRG resistance system 
(A) In IFNγ-stimulated mouse cells GMS proteins localise mainly to endomembranes and keep GKS proteins in 
a GDP-bound inactive state. The plasma membrane is protected by an unknown Factor Y that inhibits GKS 
proteins-mediated damage. (B) In GMS-deficient cells, GKS proteins activate on unprotected endomembranes, 
thus forming cytotoxic aggregates. (C) During host cell infection by T. gondii or E. cuniculi, invagination of the 
plasma membrane creates a parasitophorous vacuole that excluded Factor Y and also does not carry GMS 
proteins. This “missing-self” is recognised by GKS proteins, which then activate and accumulate on the PVM 
leading to the PV disruption and parasite death. However, parasites entering via phagocytic mechanisms do not 
actively exclude Factor Y and are therefore targeted for endolysosomal degradation. 
 
The IRG resistance system targets intracellular parasites such as T. gondii or E. cuniculi both 
of which reside in PV formed by invagination of the plasma membrane. The vacuoles resist 
fusion with the host endolysosomal system. Upon invasion of the host cell, GKS proteins 
reach their PV presumably by diffusion and recognise that the PVM misses “self proteins”. 
Because the PVM is receptive to IRG loading immediately after parasite entry (Khaminets et 
al. 2010), the entry of the parasite and formation of the PV should entail loss of the Factor Y. 
For T. gondii, Factor Y might be excluded by the moving junction complex; for E. cuniculi, 
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the fast invagination with the very thin polar tube may lead to the exclusion of Factor Y due 
to physical force. GKS proteins switch to the GTP-bound active form, likely by a 
conformational change, and exposing the myristoylation motif, thereby enhancing the 
membrane-binding capacity. Oligomers of GKS proteins and GBP proteins start to 
accumulate on the PVM in a particular order, where they stabilise each other, ultimately 
leading to the deformation and destruction of the PVM (Figure 4.2 C left). In contrast, 
organisms that enter the cell by conventional phagocytosis are not engaged by the IRG 
resistance system, because Factor Y is not excluded during formation of the phagosomal 
membrane. The host cell can initiate lysosomal fusion to the bacterial phagosome, unless the 
parasite does not block this resistance mechanism (Figure 4.2 C right).  
The IRG resistance system can thus recognise and distinguish intracellular parasites by 
missing-self motifs on vacuolar membranes that are not only deficient in regulatory GMS 
proteins, which usually protect endomembranes, but also have lost an inhibitory Factor Y 
during unusual, non-phagocytic host cell invasion processes.  
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Appendix 
Appendix table 1: Accession number of all ESTs retrieved from a BLAST of Mus musculus Irgm1 nucleotide 
sequence against C57BL/6 mouse genome (Annotation release 103). 170 ESTs were aligned in total, but in 
Figure 3.1 B only the ones relevant for isoform identification are shown. Therefore, the graph retrieved from the 
NCBI Map Viewer was modified and color-coded with the Software Paint. Irgm1 gene is encoded from 
48865249 to 48871346 on Chromosome 11. The homepage of the NCBI (http://www.ncbi.nlm.nih.gov; BLAST 
Irgm1 sequence; GRCm38.p2 used as reference genome, show Mm RNA, Map Viewer) was visited 2014-03-24. 
 
Start Stop Accession 
number 
Start Stop Accession 
number 
Start Stop Accession 
number 
48826140 48874714 AA517788.1 
48847978 48871276 CK019751.1 
48850321 48871326 CB945508.1 
48861968 48871683 AK083346.1 
48865151 48871683 BB654261.1 
48865245 48865623 CJ217401.1 
48865245 48865628 CJ218262.1 
48865245 48865629 CJ218257.1 
48865245 48865662 AA178702.1 
48865245 48865675 BY580975.1 
48865245 48865746 BI665430.1 
48865245 48865783 AA080447.1 
48865246 48865638 CJ214215.1 
48865247 48865479 BB323925.1 
48865247 48865538 BB107713.1 
48865247 48865556 BB520628.1 
48865247 48865586 BB797706.1 
48865247 48865623 BY687582.1 
48865247 48865630 BB739716.1 
48865247 48865652 BY482184.1 
48865247 48871367 AK002545.1 
48865248 48865658 CJ302279.1 
48865249 48865475 AV345311.1 
48865249 48865518 BB475932.1 
48865249 48865547 BB044267.1 
48865249 48865855 CO041867.1 
48865249 48865944 BE570459.1 
48865249 48871346 U19119.1 
48865249 48871346 NM_008326.1 
48865250 48865487 AV291659.1 
48865250 48865489 AV001243.1 
48865250 48865563 BY510602.1 
48865250 48865578 AV014538.1 
48865250 48865605 BB737352.1 
48865250 48865672 BY391797.1 
48865250 48865679 BY394521.1 
48865250 48865683 BE285311.1 
48865355 48865721 BG091391.1 
48865378 48865853 AA266999.1 
48865381 48865733 BY374259.1 
48865391 48865783 DT908179.1 
48865391 48865783 DT910296.1 
48865391 48865783 DT911310.1 
48865391 48865783 DT920057.1 
48865391 48865783 DT928637.1 
48865391 48865783 DT929844.1 
48865391 48865783 DT931518.1 
48865441 48865806 AA560463.1 
48865461 48871158 BC145957.1 
48865467 48865907 AA823118.1 
48865514 48865855 AA199976.1 
48865520 48866022 AA212456.1 
48865536 48866135 AA711254.1 
48865539 48866024 AA214784.1 
48865540 48866024 AA212463.1 
48865553 48866484 BI653806.1 
48865559 48865972 BY157015.1 
48865591 48865972 BY172752.1 
48865643 48866460 BF161711.1 
48865682 48866449 BF168437.1 
48865682 48866467 BG974799.1 
48865841 48866228 BG094936.1 
48865863 48866725 BI853562.1 
48865872 48866561 AA105762.1 
48865946 48866338 BY161130.1 
48866052 48866671 BI558790.1 
48866094 48866832 BI150356.1 
48866118 48871150 AI326713.1 
48866219 48866998 BI661643.1 
48866338 48871370 DV046798.1 
48866349 48866491 DY242460.1 
48866382 48871343 AW045127.1 
48866398 48871377 AI663521.1 
48866402 48871322 BG973420.1 
48866596 48871372 DT923229.1 
48866599 48871268 BF164781.1 
48866601 48871286 BE367794.1 
48866601 48871342 CB945745.1 
48866603 48867251 BI654829.1 
48866605 48871314 BI558163.1 
48866623 48871336 CN677533.1 
48866630 48871392 CB599188.1 
48866648 48871306 BI655161.1 
48866674 48871403 BY737226.1 
48866684 48871354 BU614132.1 
48866690 48871360 BF784652.1 
48866698 48871315 BF159067.1 
48866706 48871374 BI659468.1 
48866750 48871363 BX513271.1 
48866755 48871379 CN681579.1 
48866775 48871304 CN662778.1 
48866816 48871346 AA107502.1 
48866818 48871326 BY225443.1 
48866821 48871288 AW227839.1 
48866821 48871324 BY224648.1 
48866829 48871187 BB860839.1 
48866845 48871303 BY023068.1 
48866868 48871374 CF899916.1 
48866877 48871325 BY219280.1 
48866881 48871326 BY081400.1 
48866884 48871325 BY219925.1 
48866887 48871325 BY219624.1 
48866888 48871386 CJ165063.1 
48866889 48871395 BY033977.1 
48866923 48871386 BY231386.1 
48866929 48871420 BY159883.1 
48866938 48871386 BY100561.1 
48866944 48871393 BY142654.1 
48866952 48871395 BY037258.1 
48868000 48871372 CA542360.1 
48868245 48869061 CK021439.1 
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48865250 48865689 BY515945.1 
48865250 48865692 AI573450.1 
48865250 48865703 BI143589.1 
48865250 48865705 BY489498.1 
48865250 48865723 BB781910.1 
48865250 48865740 BY448752.1 
48865250 48865822 AW228222.1 
48865250 48865916 BY757575.1 
48865250 48871418 AK167558.1 
48865252 48865683 BY565805.1 
48865252 48865703 BY558051.1 
48865252 48865705 BY565476.1 
48865252 48865706 BY571806.1 
48865252 48865710 BY565942.1 
48865252 48865717 BY562711.1 
48865252 48865722 BY566436.1 
48865252 48865817 AI265670.1 
48865252 48871326 AK171743.1 
48865321 48871325 CB951333.1 
48865332 48865835 BY493343.1 
 
48866405 48866796 BY311823.1 
48866406 48871316 AA673803.1 
48866415 48871362 DV040401.1 
48866419 48871152 AA152951.1 
48866423 48871150 BF658590.1 
48866435 48871325 CJ083509.1 
48866436 48871335 BF119211.1 
48866443 48866796 BY308514.1 
48866445 48871315 BF786823.1 
48866455 48871378 AI789163.1 
48866457 48871325 CJ073108.1 
48866460 48868741 BI660095.1 
48866462 48871325 CJ086727.1 
48866487 48871338 BI558670.1 
48866490 48871366 BY703059.1 
48866498 48871337 BG919173.1 
48866501 48868638 CA579704.1 
48866552 48871384 CB238089.1 
48866589 48871326 CB601221.1 
48866596 48871372 AA184224.1 
 
48868622 48871366 BY226537.1 
48868651 48871326 BY221932.1 
48868656 48871326 BY216921.1 
48868660 48871326 BB841139.1 
48868669 48871320 BY214051.1 
48868670 48871326 BY219517.1 
48868681 48871342 BG862949.1 
48868683 48871366 BY150562.1 
48868684 48871366 BY139383.1 
48870856 48871305 AW227285.1 
48871093 48871362 AI227277.1 
48871096 48871205 DY247964.1 
48871202 48871326 BY154366.1 
48865337 48865688 BG229852.1 
48865339 48865698 BB809650.1 
48865339 48865710 BY507833.1 
48865339 48865882 BM246660.2 
48865340 48865654 BB550394.1 
48865341 48865752 BB733964.1 
 
Appendix Table IIA: N-terminal and Phospho-peptides of Irgm1 found by Sequest 
Collision-induced dissociation fragmentation of phospho-serine and phosphor-threonine results in favorable and neutral 
loss of phosphoric acid. The MS/MS spectrum is characterized by a peak corresponding to the loss of phosphoric acid 
from the parent mass and fewer low intensity fragments, making it difficult to determine the exact site of 
phosphorylation. The phosphoRS algorithm implemented in the Proteome Discoverer software calculates only 
probabilities. 
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E
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L
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 w
t 
M
E
F
 +
 I
F
N
 
1 
ETVATLSQIPVSIFVT
GDSGNGMSSFINALR 
1 
S12 
(Phospho) 
2,56 
3 
3291,61 
4,58 
T(2): 10.2; T(5): 10.2; S(7): 
10.2; S(12): 35.6; T(16): 10.2; 
S(19): 10.2; S(24): 10.2; 
S(25): 3.2 
30 
1 
MAETHYAPLSSAFPF
VTSYQTGSSR 
1   
3,59 
3 
2735,29 
4,42   
  
2 
ETVATLSQIPVSIFVT
GDSGNGMSSFINALR 
1 
S12 
(Phospho) 
2,40 
3 
3291,59 
-2,21 
T(2): 11.4; T(5): 11.4; S(7): 
2.5; S(12): 64.8; T(16): 2.5; 
S(19): 2.5; S(24): 2.5; S(25): 
2.5 
25 
2 
MAETHYAPLSSAFPF
VTSYQTGSSR 
1   
4,23 
3 
2735,28 
2,21     
3 
MAETHYAPLSSAFPF
VTSYQTGSSR 
1   
4,51 
3 
2735,29 
3,54     
E
x
p
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t 
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F
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F
N
 6 
MAETHYAPLSSAFPF
VTSYQTGSSR 
1   
4,50 
3 
2735,28 
0,60     
7 
MAETHYAPLSSAFPF
VTSYQTGSSR 
1   
4,66 
3 
2735,28 
0,26     
E
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p
 3
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9
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9 
MAETHYAPLSSAFPF
VTSYQTGSSR 
1   
3,61 
3 
2735,27 
-1,14     
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Sample 
(band) 
Sequence 
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pRS Site Probabilities 
p
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E
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L
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 I
F
N
 
1 
AETHYAPLSSAFPF
VTSYQTGSSR 
5 
N-Term 
(Acetyl) 
54,28 2 
2646,26 
3,31     
2 
AETHYAPLSSAFPF
VTSYQTGSSR 
3 
N-Term 
(Acetyl) 
53,47 2 
2646,25 
2,57     
2 
ETVATLSQIPVSIFV
TGDSGNGMSSFINA
LR 
1 
T5 
(Phospho) 
29,55 3 
3291,59 
-2,21 
T(2): 11.4; T(5): 11.4; S(7): 
2.5; S(12): 64.8; T(16): 2.5; 
S(19): 2.5; S(24): 2.5; S(25): 
2.5 
18 
2 
MKPSHSSCEAAPLL
PNMAETHYAPLSSA
FPFVTSYQTGSSR 
1 
N-Term 
(Acetyl) 
  4 
4497,11 
2,25   
  
3 
AETHYAPLSSAFPF
VTSYQTGSSR 
1 
N-Term 
(Acetyl) 
41,15 3 
2646,26 
3,40   
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p
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L
/6
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F
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F
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5 
AETHYAPLSSAFPF
VTSYQTGSSR 
3 
N-Term 
(Acetyl); S9 
(Phospho) 
37,58 3 
2726,21 
-1,86 
T(3): 83.2; Y(5): 12.4; S(9): 
2.0; S(10): 2.0; T(16): 0.4; 
S(17): 0.0; Y(18): 0.0; T(20): 
0.0; S(22): 0.0; S(23): 0.0 
58 
5 
AETHYAPLSSAFPF
VTSYQTGSSR 
6 
N-Term 
(Acetyl) 
47,62 3 
2646,25 
2,78   
  
6 
AETHYAPLSSAFPF
VTSYQTGSSR 
2 
N-Term 
(Acetyl); Y5 
(Phospho) 
34,39 3 
2726,22 
1,16 
T(3): 11.6; Y(5): 84.9; S(9): 
1.7; S(10): 1.7; T(16): 0.0; 
S(17): 0.0; Y(18): 0.0; T(20): 
0.0; S(22): 0.0; S(23): 0.0 
89 
6 
AETHYAPLSSAFPF
VTSYQTGSSR 
5 
N-Term 
(Acetyl) 
82,69 2 
2646,26 
3,59     
6 
MAETHYAPLSSAFP
FVTSYQTGSSR 
1   45,95 3 
2735,28 
0,60     
7 
AETHYAPLSSAFPF
VTSYQTGSSR 
3 
N-Term 
(Acetyl) 
45,44 3 
2646,25 
1,39     
7 
MAETHYAPLSSAFP
FVTSYQTGSSR 
1   61,18 3 
2735,28 
0,26     
8 
AETHYAPLSSAFPF
VTSYQTGSSR 
2 
N-Term 
(Acetyl) 
36,51 3 
2646,25 
1,32     
E
x
p
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C
3
H
 L
9
2
9
 
+
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F
N
 
9 
AETHYAPLSSAFPF
VTSYQTGSSR 
4 
N-Term 
(Acetyl) 
50,23 2 
2646,25 
2,20     
10 
AETHYAPLSSAFPF
VTSYQTGSSR 
3 
N-Term 
(Acetyl) 
43,21 3 
2646,25 
0,91     
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Appendix Figure 3: Crossreactivity of A19 antibody. 
(A) MEFs from Irgm1
-/-
 mice were stimulated with IFNγ for 24 h and infected with L. monocytogenes. (B) RAW 
264.7 were stimulated with IFNγ for 24 h and infected with M. bovis BCG. Differential staining of intra-and 
extracellular bacteria was performed (see Materials and Methods) as well as staining for Irgm1 with goat pAB 
A19. The A19 antibody cross-reacts on extracellular bacteria that are identified by the differential staining and 
the phase contrast image, in which they are clearly next to a host cell 
 
 
 
Appendix Figure 4: Positive correlation of GKS and GMS proteins on the T. gondii PVM.  
MEFs were stimulated with IFNγ for 24 h and infected with T. gondii ME 49 for 2h. Fixed cells were co-stained 
for (A) Irgm2 (rabbit pAS H53) and Irga6 (mouse mAB 10D7) or (B) Irgm2 (rabbit pAS H53) and Irgb6 (mouse 
mAB B34). The intensity of IRG staining at positive vacuoles was measured with AxioVision software.   
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Summary 
 Immunity–related GTPases (IRG) constitute a powerful resistance system against the 
protozoa Toxoplasma gondii and its close relative Neospora caninum as well as against two 
strains of the bacteria Chlamydia in mice. However, it remains a great mystery why all other 
organisms tested so far are not restricted by the IRG system. IRG-mediated restriction 
correlates with accumulation of effector IRG subfamily, the GKS proteins, at the 
parasitophorous vacuoles leading to the breakdown of the membrane barrier and death of the 
parasite. It is not known how GKS proteins can specifically recognise and bind to the 
parasitophorous vacuolar membranes (PVM), which is derived from the invaginated host 
plasma membrane and block fusion with the endolysosomal compartments. The second 
subfamily of IRG proteins, GMS proteins, prevents premature activation of GKS proteins and 
seems to protect endomembranes from GKS-mediated destruction. The GMS protein Irgm1 
has been alternatively proposed to directly mediate acidification and destruction of bacterial 
phagosomes. However, this theory is incompatible with the current model that IRG resistance 
system acts only on non-phagosomal vacuoles.  
 The present study demonstrated the predicted existence of two protein isoforms of 
Irgm1, which localised slightly different to subcellular endomembranes. Moreover, in striking 
contrast to earlier studies, Irgm1 could never be detected at listerial or mycobacterial 
phagosomes, arguing against the alterative proposed role of Irgm1 on phagosomes. In order to 
understand IRG target membranes, the present study showed that certain GKS proteins have 
an intrinsic property to bind liposomes in a GTP-dependent manner. However, the absence of 
residual host cell plasma membranes on the PVM of T. gondii did not trigger GKS 
accumulation. The non-fusogenic character of a vacuole was also not sufficient for a vacuole 
to be recognised by GKS proteins. Lastly, this study presented a novel role of the IRG system 
in resistance to the microsporidian Encephalitozoon cuniculi. Interferon-γ stimulation, 
inducing IRG proteins, suppresses meront development and spore formation in mouse 
fibroblasts in vitro, and effector GKS proteins cooperatively accumulate on the PVM of 
E. cuniculi. In addition, IFNγ-induced cells infected with E. cuniculi died by necrosis similar 
to T. gondii infection.  
 Thus, the IRG resistance system provides cell-autonomous immunity to specific 
parasites from three kingdoms of life: protozoa, bacteria and fungi. The phylogenetic 
divergence of these IRG target organisms strongly suggests that the IRG system does not 
recognise specific parasite components. The absence of certain host components on the 
vacuolar membrane, such as the protective GMS proteins, might act as missing-self motifs to 
trigger GKS protein accumulation on parasitophorous vacuoles.   
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Zusammenfassung 
 Die immun-verwandten GTPases (immunity-related GTPases, IRG) wirken als 
leistungsfähiges Resistenzsystem gegen die Protozoen Toxoplasma gondii und Neospora 
caninum sowie gegen zwei Stämme der Chlamydien Bakterien. Es ist bisher ein großes 
Rätsel, warum alle anderen bisher getesteten Organismen nicht von dem IRG System 
kontrolliert werden. Die IRG-vermittelte Resistenz korreliert mit der Akkumulation von IRG 
Effektoren der GKS Protein-Unterfamilie auf der parasitophoren Vakuole. Dies führt zur 
Zerstörung der Membran-Barriere und schließlich zum Tod des Parasiten. Es ist unklar, wie 
genau GKS Proteine die Membran der parasitophoren Vakuole (PVM) erkennen und auch 
daran binden. Die PVM wird aus der eingestülpten Wirtszell-Plasmamembran gebildet und 
fusioniert nicht mit dem Endolysosomalen Organelle. Die zweite IRG Protein-Unterfamilie 
sind die regulatorischen GMS Proteine. Sie verhindern die vorzeitige Aktivierung von GKS 
Proteinen und schützen vermutlich die Endomembranen vor Zerstörung durch GKS Proteine. 
Für das GMS Protein Irgm1 wurde außerdem alternativ vorgeschlagen, dass es direkt an der 
Ansäuerung und Zerstörung von bakteriellen Phagosomen beteiligt ist. Diese Theorie ist 
jedoch unvereinbar mit dem aktuellen Model, dass IRG Resistenzsystem nur auf nicht-
phagosomalen Vakuolen wirkt.  
 In der vorliegenden Arbeit wurde die vorhergesagte Existenz der zwei Isoformen von 
Irgm1 nachgewiesen, welche etwas unterschiedlich an subzelluläre Endomembranen 
lokalisieren. Außerdem wurde im starken Gegensatz zu vorherigen publizierten Studien kein 
Irgm1 an Phagosomen von Listerien oder Mykobakterien detektiert. Dies spricht deutlich 
gegen die alternativ vorgeschlagene Effektor-Rolle von Irgm1 an Phagosomen.  
 Um besser zu verstehen, an welche Membranen IRG Proteine binden, wurde in der 
vorliegenden Arbeit gezeigt, dass bestimmte GKS Proteine eine intrinsische Eigenschaft 
besitzen an Liposomen in GTP-abhängiger Weise zu binden. Das Fehlen von Wirtszell-
Plasmamembran Proteinen auf der PVM von T. gondii hat jedoch keine IRG Protein 
Akkumulierung ausgelöst. Auch die Eigenschaft einer Vakuole, Fusion mit dem 
Endolysosomalen System zu verhindern, reicht nicht aus um von IRG Proteinen erkannt zu 
werden.  
 Zuletzt wurde in der vorliegenden Arbeit eine neue Rolle des IRG Systems in der 
Kontrolle des Mikrosporidiums Encephalitozoon cuniculi präsentiert. Interferon-γ 
Stimulation, welches IRG Proteine induziert, supprimierte die Entwicklung von Meronten und 
Sporenbildung in vitro im murinen Fibroblasten. Die Effektor GKS Proteine akkumulieren 
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kooperativ auf der PVM von E. cuniculi. Weiterhin sterben Interferon-γ-behandelte und 
E. cuniculi- infizierte Zellen nekrotisch, ähnlich wie bei Infektion mit T. gondii.  
 Das IRG Resistenzsystem liefert somit Zell-autonome Immunität gegen spezifische 
Parasiten, die zu drei Reichen der Lebewesen gehören: Protozoen, Bakterien und Pilze. Das 
phylogenetische Spektrum dieser Organismen, die vom IRG System erkannt werden, weist 
darauf hin, dass das IRG System keine Parasiten-spezifische Komponente erkennt. Hingegen 
wird das Fehlen von bestimmen Wirtszell-Komponenten auf der Membran der fremden 
Vakuole erkannt, wie zum Beispiel die schützenden GMS Proteine. Dadurch wird ein 
“missing-self” Signal vermittelt, welches dann eine Akkumulierung von GKS Proteinen auf 
der PVM auslöst.  
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